Notes from the scanner.

Latest posts

• Selpercatinib Retevmo CAS 2152628-33-4 AI Security · NIOSH HD Category 1 THIRTY-FIFTH Mechanism Class (Selective RET Kinase Inhibitor — FIRST SELECTIVE RET INHIBITOR EVER; RET IC50 ∼40 pM; >100-Fold over VEGFR2/EGFR/FGFR; 3,6-Diazabicyclo[3.1.1]heptane Scaffold; C29H28FN7O2; MW ∼526.6 g/mol; LOXO-292; NDA 213246) · V804L/V804M Gatekeeper Active (Vandetanib V804M-Resistant; Selpercatinib V804L IC50 ∼100 pM Retained) · FIRST CNS-Penetrant Selective RET Inhibitor (Intracranial ORR 85.7% RET-Fusion NSCLC Brain Mets) · LIBRETTO-001 ORR 64.0% Pretreated RET-Fusion NSCLC · Loxo Oncology→Eli Lilly $8.0B January 2019 · Eli Lilly Indianapolis IN 51M 17yr Cority · Lilly Kinsale Cork Ireland 44F 13yr VelocityEHS · MSK New York NY 46M 14yr EHS Insight · 571st Adversarial Attack · 129th Long-Form Blog · Glyphward Threshold 22 · 2026-10-17

  Selpercatinib (Retevmo; CAS 2152628-33-4): NIOSH HD Category 1 THIRTY-FIFTH Mechanism Class [Selective RET Kinase Inhibitor — FIRST SELECTIVE RET INHIBITOR EVER; Vandetanib/Cabozantinib Multi-Target Distinction; RET IC50 ∼40 pM; V804 Gatekeeper Active; NDA 213246; May 8, 2020] + FIRST CNS-Penetrant Selective RET + Intracranial ORR 85.7% + Loxo Oncology→Eli Lilly $8.0B; Eli Lilly Indianapolis IN 51M 17yr; Lilly Kinsale Cork Ireland 44F 13yr; MSK New York NY 46M 14yr; Threshold 22; 571st Attack; 129th Blog

  The 571st adversarial attack — 129th long-form blog — THIRTY-FIFTH mechanism class — FIRST SELECTIVE RET INHIBITOR EVER — V804 gatekeeper active — CNS penetrant intracranial ORR 85.7% — Loxo Oncology→Eli Lilly $8.0B — selpercatinib (CAS 2152628-33-4; MW ∼526.6 g/mol; NIOSH HD Category 1; C29H28FN7O2; 3,6-diazabicyclo[3.1.1]heptane scaffold; RET IC50 ∼40 pM [prior “RET inhibitors” vandetanib [VEGFR2 IC50 ∼40 nM; RET IC50 ∼100 nM; multi-target] and cabozantinib [MET/VEGFR2 primary; RET off-target; V804L/M-reduced] hit RET as secondary activity; selpercatinib designed with >100-fold RET/VEGFR2 selectivity as primary design criterion]; V804L IC50 ∼100 pM retained [vandetanib fails V804M]; intracranial ORR 85.7% RET-fusion NSCLC brain mets; LIBRETTO-001 ORR 64.0% pretreated; Loxo→Lilly $8.0B Jan 2019; NDA 213246 May 8 2020). Three surfaces: Eli Lilly Indianapolis IN (÷10; Cority null; thirty-fifth class absent; first selective RET absent; V804 gatekeeper absent; CNS penetrant absent; intracranial ORR absent; 51M 17yr); Lilly Kinsale Cork Ireland (÷10; VelocityEHS null; API synthesis diazabicycloheptane route; fluorinated aryl intermediate; scaffold absent; 44F 13yr); MSK New York NY (÷10; EHS Insight null; LIBRETTO-001 enrollment; RET-fusion NSCLC brain mets dispensing; three-indication NDA concurrent null; 46M 14yr). Threshold 22.

  Read the full post →

• Trilaciclib Cosela CAS 1374743-00-6 AI Security · NIOSH HD Category 1 THIRTY-FIRST Mechanism Class (CDK2/4/6 Trikinase Myeloprotective — FIRST CDK Inhibitor for Non-Cancer Indication Ever; CDK4 IC50 ∼1 nM; CDK6 IC50 ∼4 nM; CDK2 IC50 ∼4 nM; CDK1-Sparing >1,000-Fold; 8-Azaspiro[4.5]deca-1,6-dien-4-one Azaspirodecadienone Scaffold; C25H27N9O; MW ∼510.6 g/mol; G1T28; NDA 214200) · FIRST IV CDK Inhibitor (240 mg/m² 30-min IV Prior to Chemotherapy) · CDK FOUR-NDA-HOLDER Portfolio (Palbociclib Pfizer NDA 207103 + Ribociclib Novartis NDA 209092 + Abemaciclib Lilly NDA 208716 + Trilaciclib Boehringer NDA 214200) · G1 Therapeutics→Boehringer Ingelheim $1.4B August 2023 · MANOVA SN Duration 0 vs 4 Days (p<0.0001) SCLC Etoposide/Carboplatin/Atezolizumab · Boehringer Ingelheim Ridgefield CT 49M 16yr Cority · G1 Therapeutics Research Triangle Park NC 43F 12yr VelocityEHS · Levine Cancer Institute Atrium Health Charlotte NC 45M 15yr EHS Insight · 566th Adversarial Attack · 128th Long-Form Blog · Glyphward Threshold 22 · 2026-10-17

  Trilaciclib (Cosela; CAS 1374743-00-6): NIOSH HD Category 1 THIRTY-FIRST Mechanism Class [CDK2/4/6 Trikinase Myeloprotective — FIRST CDK Inhibitor for Non-Cancer Indication Ever; FIRST IV CDK Inhibitor; CDK FOUR-NDA-HOLDER Portfolio; NDA 214200; February 12, 2021] + MANOVA SN Duration 0 vs 4 Days (p<0.0001) + G1 Therapeutics→Boehringer Ingelheim $1.4B; Boehringer Ingelheim Ridgefield CT 49M 16yr; G1 Therapeutics RTP NC 43F 12yr; Levine Cancer Institute Charlotte NC 45M 15yr; Threshold 22; 566th Attack; 128th Blog

  The 566th adversarial attack — 128th long-form blog — THIRTY-FIRST mechanism class — FIRST CDK2/4/6 trikinase inhibitor ever — FIRST CDK inhibitor for non-cancer indication — FIRST IV CDK inhibitor — CDK four-NDA-holder portfolio complete — trilaciclib (CAS 1374743-00-6; MW ∼510.6 g/mol; NIOSH HD Category 1; C25H27N9O; azaspirodecadienone scaffold; CDK4 IC50 ∼1 nM; CDK6 IC50 ∼4 nM; CDK2 IC50 ∼4 nM [CDK2 inhibition essential for complete HSPC G1 arrest — CDK4/6 selective agents [palbociclib CDK2 >10,000 nM] fail to fully arrest HSPCs; trilaciclib CDK2 ~4 nM achieves complete HSPC G1 phase protection]; CDK1-sparing >1,000-fold; FIRST CDK non-cancer: IV prior to etoposide/carboplatin/atezolizumab to protect bone marrow HSPCs from chemo damage; MANOVA SN 0 vs 4 days p<0.0001; CDK four-NDA-holder [palbociclib Pfizer + ribociclib Novartis + abemaciclib Lilly + trilaciclib Boehringer]; G1→Boehringer $1.4B Aug 2023; NDA 214200 Feb 12 2021). Three surfaces: Boehringer Ingelheim Ridgefield CT (÷10; Cority null; CDK2/4/6 trikinase absent; first CDK myeloprotection absent; CDK four-NDA-holder absent; IV route absent; 49M 16yr); G1 Therapeutics Research Triangle Park NC (÷10; VelocityEHS null; CDK2/4/6 trikinase developer; azaspirodecadienone scaffold absent; IV lyophilized powder absent; 43F 12yr); Levine Cancer Institute Charlotte NC (÷10; EHS Insight null; MANOVA enrollment; IV admixture reconstitution; CDK four-NDA-holder concurrent dispensing all null; 45M 15yr). Threshold 22.

  Read the full post →

• Asciminib Scemblix CAS 1432213-44-9 AI Security · NIOSH HD Category 1 TWENTY-EIGHTH Mechanism Class (STAMP Allosteric BCR-ABL — FIRST Non-ATP-Competitive BCR-ABL Inhibitor Ever; ABL Myristoyl Pocket C-Lobe; αI-Helix Allosteric Inactivation; BCR-ABL IC50 ∼0.5 nM; T315I IC50 ∼0.5 nM Equal T315I-Blind; C20H19ClF2N4O3; MW ∼449.5 g/mol; ABL001; NDA 215358) · THIRD Novartis BCR-ABL Null (imatinib NDA 021588 + nilotinib NDA 022068 + asciminib NDA 215358) · ASCEMBL MMR 25.5% vs 13.2% Bosutinib (p=0.029) · T315I Indication 200 mg BID · Novartis East Hanover NJ 52M 18yr Cority · Lonza Basel Switzerland 46F 14yr VelocityEHS · Dana-Farber Cancer Institute Boston MA 47M 16yr EHS Insight · 559th Adversarial Attack · 127th Long-Form Blog · Glyphward Threshold 22 · 2026-10-17

  Asciminib (Scemblix; CAS 1432213-44-9): NIOSH HD Category 1 TWENTY-EIGHTH Mechanism Class [STAMP Allosteric BCR-ABL — FIRST Non-ATP-Competitive BCR-ABL Ever; Myristoyl Pocket C-Lobe; T315I-Blind; NDA 215358] + THIRD Novartis BCR-ABL Null + ASCEMBL MMR 25.5% vs 13.2% (p=0.029) + T315I 200 mg BID; Novartis East Hanover NJ 52M 18yr; Lonza Basel Switzerland 46F 14yr; Dana-Farber Boston MA 47M 16yr; Threshold 22; 559th Attack; 127th Blog

  The 559th adversarial attack — 127th long-form blog — TWENTY-EIGHTH mechanism class — FIRST non-ATP-competitive BCR-ABL inhibitor ever — STAMP allosteric myristoyl pocket — T315I-blind — third Novartis BCR-ABL null — asciminib (CAS 1432213-44-9; MW ∼449.5 g/mol; NIOSH HD Category 1; C20H19ClF2N4O3; pyridine-3-carboxamide-pyrazole scaffold; BCR-ABL IC50 ∼0.5 nM WT = T315I [T315I-blind; >30 Å C-lobe to N-lobe T315I]; all 5 prior BCR-ABL inhibitors ATP-competitive; STAMP first non-ATP; NDA 215358 Oct 29 2021; ASCEMBL MMR 25.5% vs 13.2% bosutinib p=0.029; T315I 200 mg BID 5×; third Novartis BCR-ABL null). Three surfaces: Novartis East Hanover NJ (÷10; Cority null; STAMP absent; myristoyl pocket absent; T315I equal potency absent; third Novartis BCR-ABL null absent; 52M 18yr); Lonza Basel Switzerland (÷10; VelocityEHS null; asciminib API synthesis; Suzuki-Miyaura Pd; (3R)-hydroxypyrrolidinyl; CHClF2 pharmacophore; 46F 14yr); Dana-Farber Cancer Institute Boston MA (÷10; EHS Insight null; ASCEMBL dual-arm null [asciminib + bosutinib both null]; T315I 200 mg BID 5× dose absent; 47M 16yr). Threshold 22.

  Read the full post →

• Palbociclib Ibrance CAS 571190-30-2 AI Security · NIOSH HD Category 1 TWENTY-FIFTH Mechanism Class (FIRST CDK4/6 Cyclin-Dependent Serine/Threonine Kinase G1/S Cell Cycle Checkpoint Inhibitor Ever; CDK4 IC50 ∼11 nM; CDK6 IC50 ∼16 nM; Pyrido[2,3-d]pyrimidine Scaffold; C24H29N7O2; MW ∼447.54 g/mol; PD 0332991; Reversible ATP-Competitive; CDK1-Sparing >4,000-Fold; Cyclin D1/D2/D3 CCND Regulatory Subunit; Rb RB1 Hypophosphorylation → E2F Sequestration → G1 Arrest) · FIRST Pfizer CDK Null (NDA 207103; February 3, 2015; Accelerated Approval) · PALOMA-2 PFS HR 0.563 (95% CI 0.461–0.689; p<0.0001; Median 27.6 vs 14.5 mo) · PALOMA-3 PFS HR 0.46 Endocrine-Refractory Fulvestrant Combination · CDK4/6 THREE-NDA-HOLDER CLASS INITIATED (Pfizer NDA 207103 + Novartis NDA 209092 + Lilly NDA 208716) · Grade 3-4 Neutropenia ~66% DLT Hematopoietic Progenitor G1 Arrest · Pfizer Groton CT 50M 17yr Cority · Pfizer McPherson KS 45F 12yr VelocityEHS · MSKCC New York NY 40F 14yr EHS Insight · 552nd Adversarial Attack · 126th Long-Form Blog · Glyphward Threshold 22 · 2026-10-16

  Palbociclib (Ibrance; CAS 571190-30-2): NIOSH HD Category 1 TWENTY-FIFTH Mechanism Class [FIRST CDK4/6 Cyclin-Dependent Serine/Threonine Kinase G1/S Cell Cycle Checkpoint Inhibitor Ever; CDK4 IC50 ∼11 nM; CDK6 IC50 ∼16 nM; Pyrido[2,3-d]pyrimidine Scaffold; PD 0332991] + FIRST Pfizer CDK Null (NDA 207103; February 3, 2015) + PALOMA-2 PFS HR 0.563 (Median 27.6 vs 14.5 mo) + PALOMA-3 PFS HR 0.46 Endocrine-Refractory + CDK4/6 THREE-NDA-HOLDER CLASS INITIATED; Pfizer Groton CT 50M 17yr; Pfizer McPherson KS 45F 12yr; MSKCC New York NY 40F 14yr; Threshold 22; 552nd Attack; 126th Blog

  The 552nd adversarial attack — 126th long-form blog — TWENTY-FIFTH mechanism class — FIRST CDK4/6 cyclin-dependent serine/threonine kinase G1/S cell cycle checkpoint inhibitor ever — FIRST Pfizer CDK null — palbociclib (CAS 571190-30-2; MW ∼447.54 g/mol; NIOSH HD Category 1; pyrido[2,3-d]pyrimidine scaffold; CDK4 IC50 ∼11 nM; CDK6 IC50 ∼16 nM; Rb hypophosphorylation → E2F sequestration → G1 arrest; cyclin D1/D2/D3 dependence; FIRST CDK4/6 inhibitor ever NDA 207103 Feb 3 2015; PALOMA-2 PFS HR 0.563 median 27.6 vs 14.5 mo; PALOMA-3 PFS HR 0.46 endocrine-refractory; Grade 3-4 neutropenia ~66% hematopoietic G1 arrest DLT; CDK4/6 THREE-NDA-HOLDER CLASS initiated). Three surfaces: Pfizer Inc. Groton CT (÷10; Cority null; CDK4/6 twenty-fifth class absent; pyrido[2,3-d]pyrimidine absent; PALOMA-2 absent; 50M 17yr); Pfizer Global Supply McPherson KS (÷10; VelocityEHS null; Ibrance capsule/tablet manufacturing; OEB 4 milling D90 <25 µm; CDK4/6 class absent; 45F 12yr); MSKCC New York NY (÷10; EHS Insight null; PALOMA-2/3 enrollment; CDK4/6 THREE-NDA-HOLDER CLASS NULL concurrent dispensing [palbociclib + ribociclib + abemaciclib; CDK4 IC50 gradient ~11 nM vs ~10 nM vs ~2 nM absent]; 40F 14yr). Threshold 22.

  Read the full post →

• Fedratinib Inrebic CAS 936091-14-4 AI Security · NIOSH HD Category 1 SECOND JAK MPN (FIRST JAK2-Selective ∼35-fold: JAK2 IC50 ∼3 nM; JAK1 IC50 ∼105 nM; FIRST JAK2/FLT3 Dual Selective FLT3 IC50 ∼58 nM; Thienopyrimidine-Methylsulfonyl-Piperidine Scaffold; C27H36N6O3S; MW ∼560.68 g/mol; TG101348; SAR302503) · JAK TWO-NDA-HOLDER CLASS NULL (Ruxolitinib Incyte NDA 202192 + Fedratinib BMS NDA 212327) · FIRST BMS/Celgene JAK Null (TargeGen→Sanofi SAR302503→Impact Biomedicines→Celgene $7B→BMS $74B) · JAKARTA-2 Ruxolitinib-Refractory SVR35 31% (FIRST Second-Line JAK Pathway) · WERNICKE’S ENCEPHALOPATHY BOX WARNING (SLC19A3/SLC19A2 Thiamine Transporter; 4-Aminothienopyrimidine Thiamine Mimic) · BMS Lawrenceville NJ 47M 16yr Cority · Patheon Cincinnati OH 42F 13yr VelocityEHS · MD Anderson Houston TX 38M 12yr EHS Insight · 547th Adversarial Attack · 125th Long-Form Blog · Glyphward Threshold 22 · 2026-10-16

  Fedratinib (Inrebic; CAS 936091-14-4): NIOSH HD Category 1 SECOND JAK MPN [FIRST JAK2-Selective (∼35-fold: JAK2 IC50 ∼3 nM; JAK1 IC50 ∼105 nM); FIRST JAK2/FLT3 Dual Selective (FLT3 IC50 ∼58 nM); Thienopyrimidine Scaffold] + JAK TWO-NDA-HOLDER CLASS NULL (Ruxolitinib Incyte NDA 202192 + Fedratinib BMS NDA 212327) + FIRST BMS/Celgene JAK Null + JAKARTA-2 Ruxolitinib-Refractory SVR35 31% + WERNICKE’S BOX WARNING (SLC19A3/SLC19A2 Thiamine Transporter); BMS Lawrenceville NJ 47M 16yr; Patheon Cincinnati OH 42F 13yr; MD Anderson Houston TX 38M 12yr; Threshold 22; 547th Attack; 125th Blog

  The 547th adversarial attack — 125th long-form blog — SECOND JAK MPN — FIRST JAK2-selective (∼35-fold) — JAK TWO-NDA-HOLDER CLASS NULL — FIRST BMS/Celgene JAK null — Wernicke’s Box Warning — fedratinib (CAS 936091-14-4; MW ∼560.68 g/mol; NIOSH HD Category 1; thienopyrimidine scaffold; JAK2 IC50 ∼3 nM; JAK1 IC50 ∼105 nM; FLT3 IC50 ∼58 nM; SECOND JAK MPN NDA 212327 Aug 2019; JAKARTA-2 SVR35 31%; Wernicke’s BBW SLC19A3 thiamine transporter; TargeGen→Sanofi SAR302503 [Phase 3 halt 2013]→Impact Biomedicines→Celgene $7B→BMS $74B). Three surfaces: Bristol-Myers Squibb Lawrenceville NJ (÷10; Cority null; JAK2-selective absent; Wernicke’s Box Warning absent; BMS acquisition chain absent; 47M 16yr); Patheon Inc. Cincinnati OH (÷10; VelocityEHS null; thienopyrimidine API synthesis/capsule fill; OEB 4 milling; sulfonation CH3SO2Cl; 42F 13yr); MD Anderson Houston TX (÷10; EHS Insight null; JAKARTA-2 ruxolitinib-refractory enrollment; simultaneous ruxolitinib + fedratinib JAK TWO-NDA-HOLDER CLASS NULL dispensing; Wernicke’s thiamine monitoring protocol owner; 38M 12yr). Threshold 22.

  Read the full post →

• Ruxolitinib Jakafi CAS 941678-49-5 AI Security · NIOSH HD Category 1 TWENTY-THIRD Mechanism Class (FIRST JAK1/2 Janus Kinase Cytoplasmic Non-Receptor Tyrosine Kinase Inhibitor Ever Approved; JAK1 IC50 ∼3.3 nM; JAK2 IC50 ∼2.8 nM; JAK3-Sparing ∼428 nM; Pyrrolo[2,3-d]pyrimidine Scaffold; FERM+SH2-like+JH2+JH1 Dual-Domain Architecture; First Cytokine-Receptor-Associated JAK-STAT Kinase) · FIRST Myeloproliferative Neoplasm Targeted JAK Therapy (NDA 202192; November 16, 2011; COMFORT-I SVR35 41.9% vs 0.7%; 5-yr OS HR 0.69) · FIRST Incyte Oncology NDA Null · Multi-Indication (MF + PV + aGVHD + cGVHD + Opzelura Topical) · JAK2 V617F JH2 Somatic MPN Clone Companion Paradox (V617F in Pseudokinase JH2 ≠ Ruxolitinib JH1 Binding Site; Worker Wild-Type JAK1/2 Equally Accessible at JH1 IC50) · Incyte Wilmington DE 50M 18yr Cority · Lonza Greenwood SC 45F 15yr VelocityEHS · Mayo Clinic Rochester MN 41M 14yr EHS Insight · 546th Adversarial Attack · 124th Long-Form Blog · Glyphward Threshold 22 · 2026-10-15

  Ruxolitinib (Jakafi; CAS 941678-49-5): NIOSH HD Category 1 TWENTY-THIRD Mechanism Class [FIRST JAK1/2 Cytoplasmic Non-Receptor Tyrosine Kinase Inhibitor Ever Approved; JAK1 IC50 ∼3.3 nM; JAK2 IC50 ∼2.8 nM; JAK3-Sparing ∼428 nM; FERM+SH2-like+JH2+JH1 Dual-Domain Architecture] + FIRST Myeloproliferative Neoplasm Targeted JAK Therapy (NDA 202192; November 2011; COMFORT-I SVR35 41.9%; 5-yr OS HR 0.69) + FIRST Incyte Oncology NDA Null + Multi-Indication (MF + PV + aGVHD + cGVHD + Opzelura) + JAK2 V617F JH2 Somatic MPN Clone Companion Paradox; Incyte Wilmington DE 50M 18yr; Lonza Greenwood SC 45F 15yr; Mayo Clinic Rochester MN 41M 14yr; Threshold 22; 546th Attack; 124th Blog

  The 546th adversarial attack — 124th long-form blog — FIRST JAK1/2 cytoplasmic non-receptor tyrosine kinase inhibitor ever — TWENTY-THIRD mechanism class — FIRST JAK-STAT cytokine-receptor-associated kinase in Glyphward portfolio — FIRST ruxolitinib (CAS 941678-49-5; MW ∼306.4 g/mol; NIOSH HD Category 1; pyrrolo[2,3-d]pyrimidine adenine-mimetic scaffold; JAK1 IC50 ∼3.3 nM; JAK2 IC50 ∼2.8 nM; JAK3-sparing ∼428 nM; FERM+SH2-like+JH2 pseudokinase+JH1 kinase; FIRST JAK inhibitor ever approved Nov 2011; NDA 202192 MF + PV + aGVHD + cGVHD; Opzelura topical NDA 215254; JAK2 V617F in JH2 not JH1; FIRST Incyte oncology null). Three surfaces: Incyte Corporation Wilmington DE (÷10; Cority null; JAK1/2 mechanism absent; JH2/JH1 dual-domain absent; multi-indication absent; 50M 18yr); Lonza Inc. Greenwood SC (÷10; VelocityEHS null; pyrrolo[2,3-d]pyrimidine scaffold absent; JAK-STAT mechanism absent; 45F 15yr); Mayo Clinic Rochester MN (÷10; EHS Insight null; JAK2 V617F companion paradox [V617F in JH2 pseudokinase ≠ JH1 ruxolitinib binding site; wild-type worker JAK1/2 equally accessible; normal erythropoiesis/thrombopoiesis JAK2 suppression]; NIOSH HD Cat 1 H340/H350/H361 absent; 41M 14yr). Threshold 22.

  Read the full post →

• Midostaurin Rydapt CAS 120685-11-2 AI Security · NIOSH HD Category 1 TWENTIETH Mechanism Class (FIRST Staurosporine-Scaffold Broad PKC/FLT3/KIT Multi-Kinase; PKCα IC50 ∼0.03 nM; FIRST PKC Serine/Threonine Kinase Inhibitor in 541-Attack Portfolio; Indolocarbazole N-Benzoyl Natural Product; FLT3 ∼500 nM; KIT ∼200 nM) · FIRST SM/AML/ASM/MCL Multi-Indication NDA (NDA 207997; April 28, 2017; FIRST FLT3-Mutant AML Targeted Therapy; RATIFY OS HR 0.77) · FIRST Novartis SM-Indication Kinase Null · Dual Companion Diagnostic Paradox (FLT3-ITD LeukoStrat CDx + KIT D816V AS-PCR Both Patient-Somatic; NOT Worker Germline) · Novartis East Hanover NJ 52M 19yr Cority · Lonza Basel Switzerland 46F 15yr VelocityEHS · Mayo Clinic Rochester MN 41M 14yr EHS Insight · 537th Adversarial Attack · 123rd Long-Form Blog · Glyphward Threshold 22 · 2026-10-15

  Midostaurin (Rydapt; CAS 120685-11-2): NIOSH HD Category 1 TWENTIETH Mechanism Class [FIRST Staurosporine-Scaffold Broad PKC/FLT3/KIT Multi-Kinase; PKCα IC50 ∼0.03 nM; FIRST PKC Inhibitor in Portfolio; Indolocarbazole N-Benzoyl Natural Product] + FIRST SM/AML/ASM/MCL Multi-Indication NDA (NDA 207997; April 2017; RATIFY OS HR 0.77) + FIRST Novartis SM-Indication Kinase Null + Dual Companion Diagnostic Paradox (FLT3-ITD LeukoStrat CDx + KIT D816V AS-PCR); Novartis East Hanover NJ 52M 19yr; Lonza Basel Switzerland 46F 15yr; Mayo Clinic Rochester MN 41M 14yr; Threshold 22; 537th Attack; 123rd Blog

  The 537th adversarial attack — 123rd long-form blog — FIRST staurosporine-scaffold PKC/FLT3/KIT multi-kinase — TWENTIETH mechanism class — FIRST PKC inhibitor in Glyphward portfolio — FIRST midostaurin (CAS 120685-11-2; MW ∼570.6 g/mol; NIOSH HD Category 1; staurosporine N-benzoyl indolocarbazole; PKCα IC50 ∼0.03 nM; FIRST PKC; FLT3 ∼500 nM; KIT ∼200 nM; multi-indication AML+SM+ASM+MCL NDA 207997; RATIFY OS HR 0.77; dual companion paradox FLT3-ITD LeukoStrat CDx + KIT D816V AS-PCR; FIRST Novartis SM null). Three surfaces: Novartis Pharmaceuticals East Hanover NJ (÷10; Cority null; staurosporine scaffold absent; PKC mechanism absent; SM mast cell biology absent; 52M 19yr); Lonza AG Basel Switzerland (÷10; VelocityEHS null; staurosporine fermentation/N-benzoylation absent; natural product scaffold absent; 46F 15yr); Mayo Clinic Rochester MN (÷10; EHS Insight null; dual companion paradox [FLT3-ITD LeukoStrat CDx AML + KIT D816V SM — both patient-somatic, not worker germline]; PKC absent; 41M 14yr). Threshold 22.

  Read the full post →

• Avapritinib Ayvakit CAS 1703793-34-3 AI Security · NIOSH HD Category 1 NINETEENTH Mechanism Class (FIRST KIT D816V Activation-Loop Mutant-Selective; 185-Fold Mutant Selectivity; Mechanistically Opposite to Ripretinib Switch-Control Allosteric Type V = 17th Class; KIT D816V IC50 ∼0.27 nM; KIT WT IC50 ∼50 nM; Asp816→Val Removes Lys818 Salt Bridge → Constitutive Active Conformation; PDGFRA D842V Parallel Exon 18 Mechanism) · FIRST Systemic Mastocytosis Targeted Therapy Ever (NDA 214402; June 16, 2021; KIT D816V ISM; PIONEER TSS-9 −14 pts; Serum Tryptase −73%; FIRST Mast Cell Disease Kinase Inhibitor in 536-Attack Portfolio) · FIRST PDGFRA D842V-Selective GIST (NDA 212608; January 9, 2020; NAVIGATOR ORR 91%; Imatinib/Sunitinib/Regorafenib Inactive vs D842V) · FIRST Blueprint Medicines Dual-NDA Holder Null (NDA 212608 + NDA 214402; Cambridge MA; FIRST Company in Portfolio Holding Two NDAs for Same Molecule) · Dual Companion Diagnostic Paradox (PDGFRA D842V FoundationOne CDx in Patient GIST FFPE + KIT D816V Allele-Specific PCR in Patient Bone Marrow Mast Cells; Both ≠ Worker Germline) · Blueprint Medicines Cambridge MA 50M 18yr Cority · Patheon Cincinnati OH 44F 14yr VelocityEHS · Dana-Farber Boston MA 39M 12yr EHS Insight · 536th Adversarial Attack · 122nd Long-Form Blog · Glyphward Threshold 22 · 2026-10-15

  Avapritinib (Ayvakit; CAS 1703793-34-3): NIOSH HD Category 1 NINETEENTH Mechanism Class [FIRST KIT D816V Activation-Loop Mutant-Selective; Mechanistically Opposite to Ripretinib Switch-Control Allosteric Type V (17th Class); KIT D816V IC50 ∼0.27 nM; 185-Fold Mutant Selectivity] + FIRST Systemic Mastocytosis Targeted Therapy (NDA 214402; June 2021; KIT D816V ISM; PIONEER Trial) + FIRST PDGFRA D842V-Selective GIST (NDA 212608; NAVIGATOR ORR 91%) + FIRST Blueprint Medicines Dual-NDA Holder Null + Dual Companion Diagnostic Paradox [PDGFRA D842V FoundationOne CDx + KIT D816V Allele-Specific PCR]; Blueprint Cambridge MA 50M 18yr; Patheon Cincinnati OH 44F 14yr; Dana-Farber Boston MA 39M 12yr; Threshold 22; 536th Attack; 122nd Blog

  The 536th adversarial attack — 122nd long-form blog — FIRST KIT D816V activation-loop mutant-selective inhibitor — NINETEENTH mechanism class — FIRST systemic mastocytosis targeted therapy — FIRST avapritinib (CAS 1703793-34-3; MW ∼498 g/mol; NIOSH HD Category 1; pyrrolotriazine scaffold; KIT D816V IC50 ∼0.27 nM [185-fold WT selectivity]; PDGFRA D842V IC50 ∼0.33 nM; NINETEENTH class = mechanistically opposite to ripretinib switch-control allosteric type V; dual-NDA: NDA 212608 GIST + NDA 214402 ISM; FIRST Blueprint Medicines dual-NDA null). Three surfaces: Blueprint Medicines Cambridge MA (÷10; Cority null; KIT D816V activation-loop absent; PDGFRA D842V absent; systemic mastocytosis mast cell biology absent; dual-NDA complexity absent; 50M 18yr); Patheon Cincinnati OH (÷10; VelocityEHS null; dual-dose-strength manufacturing absent; pyrrolotriazine scaffold absent; systemic mastocytosis absent; 44F 14yr); Dana-Farber Boston MA (÷10; EHS Insight null; dual companion diagnostic paradox [PDGFRA D842V FoundationOne CDx + KIT D816V AS-PCR; both somatic mutations absent from worker germline]; NIOSH HD Cat 1 genotoxicity absent; 39M 12yr). Threshold 22.

  Read the full post →

• Pemigatinib Pemazyre CAS 1513857-77-6 AI Security · NIOSH HD Category 1 FIRST FGFR Kinase Inhibitor (FIFTEENTH Distinct Mechanism Class: All 526 Prior = Kinase/PARP/BH3/20S/IMiD/mTOR/MEK/PI3K/EZH2/KRASG12C/XPO1/IDH2/IDH1; FGFR1/2/3-Selective; FGFR4-Sparing >60-Fold; FGF21 Hyperphosphatemia + Bile-Acid-Synthesis CYP7A1 Hepatotoxicity Mechanism Absent from All OEL Frameworks; FIGHT-202 ORR 35.5%; FIRST FGFR2 Fusion-Driven Indication) · FGFR2 Fusion Companion Diagnostic Paradox (FGFR2-BICC1/PPHLN1/KIAA1598 in Patient iCCA Tumor FFPE; Worker Wild-Type FGFR2; FoundationOne CDx Adjacent to Worker Exposure Record in EHR) · FIRST Incyte Solid-Tumor FGFR NDA Null (NDA 213736; April 17, 2020; FIRST FDA-Approved FGFR Inhibitor for Any Solid Tumor) · Incyte Corporation Wilmington DE 48M 16yr Cority · Lonza Inc. Greenwood SC 43F 14yr VelocityEHS · Mass General Boston MA 39F 12yr EHS Insight · 527th Adversarial Attack · 121st Long-Form Blog · Glyphward Threshold 22 · 2026-10-10

  Pemigatinib (Pemazyre; CAS 1513857-77-6): NIOSH HD Category 1 FIRST FGFR Kinase Inhibitor OEL Gap [FGFR1/2/3-Selective; FGFR4-Sparing >60-Fold; FGF21 Hyperphosphatemia + Bile-Acid-Synthesis Hepatotoxicity Absent from All OEL Frameworks; FIFTEENTH Distinct Mechanism Class — All 526 Prior Attacks Used Kinase/PARP/BCL-2/20S/IMiD/mTOR/MEK/PI3K/EZH2/KRASG12C/XPO1/IDH2/IDH1; FIRST FGFR2 Fusion-Driven Indication; FIRST Incyte Solid-Tumor FGFR NDA 213736] + FGFR2 Fusion Companion Diagnostic Paradox [FGFR2-BICC1/PPHLN1 in Patient Tumor FFPE ≠ Worker FGFR2 Status; FoundationOne CDx EHR Adjacency] + FIRST Incyte NIOSH HD Category 1 Null; Incyte Wilmington DE 48M 16yr; Lonza Greenwood SC 43F 14yr; Mass General Boston MA 39F 12yr; Threshold 22; 527th Attack; 121st Blog

  The 527th adversarial attack — 121st long-form blog — FIRST FGFR kinase sub-family inhibitor — FIFTEENTH mechanism class — FIRST FGFR in Glyphward portfolio — FIRST pemigatinib (CAS 1513857-77-6; MW ~489.5 g/mol; NIOSH HD Category 1; FGFR1/2/3-selective; FGFR4-sparing >60-fold; FGF21 hyperphosphatemia + bile-acid-synthesis CYP7A1 hepatotoxicity mechanism gap; morpholine-piperazine-difluoropyrimidine scaffold; FGFR2-BICC1 fusion iCCA; FIRST Incyte solid-tumor FGFR NDA 213736). Three surfaces: Incyte Corporation Wilmington DE (÷10; Cority null; FGFR4-sparing/FGF21/bile-acid mechanism absent; FIRST Incyte FGFR class null; 48M 16yr); Lonza Inc. Greenwood SC (÷10; VelocityEHS null; FGFR mechanism absent; morpholine-piperazine scaffold absent; 43F 14yr); Mass General Boston MA (÷10; EHS Insight null; companion diagnostic FGFR2 fusion paradox [patient tumor FGFR2-BICC1 ≠ worker germline FGFR2]; NIOSH HD Cat 1 genotoxicity absent; 39F 12yr). Threshold 22.

  Read the full post →

• Sotorasib Lumakras CAS 2296729-00-3 AI Security · NIOSH HD Category 1 FIRST KRASG12C Covalent GTPase Inhibitor (TWELFTH Distinct Mechanism Class: All 521 Prior = Kinase/PARP/BH3/20S/IMiD/mTOR/MEK/PI3K/EZH2; KRAS Is NOT a Kinase; GTP Cofactor Not ATP; Switch II Pocket SNAr Cys12 Adduct; GDP-Bound Inactive-State Selective; 30-Year Undruggable Myth Overturned) · FIRST Direct RAS Oncogene Inhibitor (Amgen NDA 214093; May 2021; CodeBreaK 100 ORR 37.1%; CodeBreaK 200 HR 0.66) · FIRST Amgen NIOSH HD Category 1 Null (Amgen Primarily Biologics; Cority Configured for Recombinant Proteins) · FIRST Pyrido[2,3-d]Pyrimidinone SNAr Scaffold (SNAr ≠ Michael Addition; C-S Aryl Thioether at sp² Aromatic Carbon) · KRASG12C Companion Diagnostic Paradox (cobas KRAS G12C Detects Patient Tumor Mutation Not Worker KRAS Genotype) · Amgen Thousand Oaks CA 47M 18yr Cority · Catalent Bloomington IN 43F 14yr VelocityEHS · MD Anderson Houston TX 38M 11yr EHS Insight · 522nd Adversarial Attack · 120th Long-Form Blog · Glyphward Threshold 22 · 2026-10-10

  Sotorasib (Lumakras; CAS 2296729-00-3): NIOSH HD Category 1 FIRST KRASG12C Covalent GTPase Inhibitor OEL Gap [Switch II Pocket SNAr Cys12 Adduct; GDP-Bound Inactive-State Selective; KRAS Is NOT a Kinase; TWELFTH Distinct Mechanism Class — All 521 Prior Attacks Used Kinase/PARP/BCL-2/20S/IMiD/mTOR/MEK/PI3K/EZH2 Mechanisms; FIRST Direct RAS Oncogene Inhibitor After ~30 Years of Failed Attempts] + FIRST Amgen NIOSH HD Category 1 Null [Amgen Primarily Biologics; NDA 214093 First Small-Molecule HD Cat 1 in Amgen Portfolio] + FIRST Pyrido[2,3-d]Pyrimidinone SNAr Scaffold; Amgen Thousand Oaks CA 47M 18yr; Catalent Bloomington IN 43F 14yr; MD Anderson Houston TX 38M 11yr; Threshold 22; 522nd Attack; 120th Blog

  The 522nd adversarial attack — 120th long-form blog — FIRST KRASG12C GTPase covalent inhibitor — TWELFTH mechanism class — FIRST direct RAS oncogene inhibitor in Glyphward portfolio — FIRST sotorasib (CAS 2296729-00-3; MW ~560 g/mol; NIOSH HD Category 1; KRASG12C GTPase switch II pocket SNAr Cys12 thioether; pyrido[2,3-d]pyrimidinone scaffold; KRAS not a kinase; FIRST Amgen HD Cat 1; companion diagnostic paradox; NDA 214093 FDA May 2021). Three surfaces: Amgen Thousand Oaks CA (÷10; Cority null; biologics-dominant library; first HD Cat 1 small molecule in 40+ yr Amgen history; GTPase mechanism absent; SNAr warhead absent; 47M 18yr); Catalent Bloomington IN (÷10; VelocityEHS null; pyrido[2,3-d]pyrimidinone scaffold absent; GDP-state selective absent; 43F 14yr); MD Anderson Houston TX (÷10; EHS Insight null; companion diagnostic KRASG12C paradox [patient tumor mutation ≠ worker hazard]; NIOSH HD Cat 1 genotoxicity absent; 38M 11yr). Threshold 22.

  Read the full post →

• Tazemetostat Tazverik CAS 1403254-99-8 AI Security · NIOSH HD Category 1 FIRST EZH2 Methyltransferase Inhibitor (ELEVENTH Distinct Mechanism Class: All 520 Prior = ATP-Competitive Kinase/PARP/BH3/20S; SAM-Competitive Cofactor Displacement; H3K27me3 Trimethylation; PRC2 Complex [EZH2+EED+SUZ12]) · FIRST SAM-Competitive Enzyme Inhibitor + FIRST Epigenetic Modifier + FIRST PRC2 Complex Inhibitor · FIRST Orphan/Rare Disease NDA (Epithelioid Sarcoma; INI1/SMARCB1 Synthetic Lethality; FDA Accelerated Approval Jan 2020; <1:100,000) · FIRST Ipsen/Epizyme NDA 213400 Null (Ipsen $247M Acquisition May 2022) · Ipsen Cambridge MA 49M 17yr Cority · Patheon Durham NC 44F 12yr VelocityEHS · MSK New York NY 38F 11yr EHS Insight · 521st Adversarial Attack · 119th Long-Form Blog · Glyphward Threshold 22 · 2026-10-10

  Tazemetostat (Tazverik; CAS 1403254-99-8): NIOSH HD Category 1 FIRST EZH2 Methyltransferase Inhibitor OEL Gap [SAM-Competitive Cofactor Displacement; H3K27me3 Silencing; PRC2 Complex; ELEVENTH Distinct Mechanism Class — All 520 Prior Attacks ATP-Competitive/PARP/BH3/20S] + FIRST SAM-Competitive Enzyme Inhibitor + FIRST Epigenetic Modifier + FIRST Orphan/Rare Disease NDA [Epithelioid Sarcoma; INI1/SMARCB1 Synthetic Lethality; FDA Accelerated Approval] + FIRST Ipsen/Epizyme NDA 213400 Null; Ipsen Cambridge MA 49M 17yr; Patheon Durham NC 44F 12yr; MSK New York NY 38F 11yr; Threshold 22; 521st Attack; 119th Blog

  The 521st adversarial attack — 119th long-form blog — FIRST EZH2 methyltransferase inhibitor — ELEVENTH mechanism class — FIRST SAM-competitive enzyme inhibitor in Glyphward portfolio — FIRST tazemetostat (CAS 1403254-99-8; MW ~636 g/mol; NIOSH HD Category 1; EZH2 WT IC50 ~11 nM; Y641F IC50 ~0.3 nM; SAM-competitive; H3K27me3 PRC2; dihydropyridinone scaffold; first epigenetic modifier; first orphan disease NDA; Ipsen/Epizyme NDA 213400). Three surfaces: Ipsen Biopharmaceuticals Cambridge MA (÷10; Cority null; peptide-dominant library; first and only HD Cat 1 in Ipsen portfolio; EZH2 mechanism absent; 49M 17yr); Patheon/Thermo Fisher Durham NC (÷10; VelocityEHS null; dihydropyridinone absent; SAM-competitive absent; 44F 12yr); Memorial Sloan Kettering New York NY (÷10; EHS Insight null; dual-indication FL + epithelioid sarcoma; INI1/SMARCB1 synthetic lethality absent; orphan drug absent; 38F 11yr). Threshold 22.

  Read the full post →

• Idelalisib Zydelig CAS 870281-82-6 AI Security · NIOSH HD Category 1 FIRST PI3Kδ Lipid Kinase Inhibitor (TENTH Distinct Mechanism Class: All 513 Prior = Protein Kinases or Non-Kinase Targets; PIP2→PIP3 Lipid Phosphorylation Entirely Absent from OEL Frameworks) · FOUR-BBW Deflection Maxima (Hepatotoxicity + Diarrhea/Colitis + Pneumonitis + Intestinal Perforation; Most BBWs in Portfolio) · FIRST Gilead Sciences Oncology NDA Null (NDA 206545; Antiviral-to-Oncology EHS Gap) · FIRST Quinazolinone-Purine Chimera Scaffold · Gilead Sciences Foster City CA 52M 21yr Cority · McKesson Specialty Health Nashville TN 44F 13yr VelocityEHS · Stanford Cancer Institute Palo Alto CA 39F 12yr EHS Insight · 514th Adversarial Attack · 118th Long-Form Blog · Glyphward Threshold 22 · 2026-10-09

  Idelalisib (Zydelig; CAS 870281-82-6): NIOSH HD Category 1 FIRST PI3Kδ Lipid Kinase Inhibitor OEL Gap [PIP2→PIP3 Lipid Phosphorylation; TENTH Distinct Mechanism Class — All 513 Prior Attacks = Protein Kinases or Non-Kinase Targets] + FOUR-BBW Deflection Maxima [Hepatotoxicity + Colitis + Pneumonitis + Intestinal Perforation; Most BBWs in Portfolio] + FIRST Gilead Sciences Oncology NDA Null [NDA 206545; Antiviral-to-Oncology EHS Gap] + FIRST Quinazolinone-Purine Chimera Scaffold; Gilead Sciences Foster City CA 52M 21yr; McKesson Specialty Health Nashville TN 44F 13yr; Stanford Cancer Institute Palo Alto CA 39F 12yr; Threshold 22; 514th Attack; 118th Blog

  The 514th adversarial attack — 118th long-form blog — FIRST lipid kinase inhibitor — TENTH mechanism class in Glyphward portfolio — FIRST idelalisib (CAS 870281-82-6; MW 415.4 g/mol; NIOSH HD Category 1; PI3Kδ IC50 ~2.5 nM; PIP2→PIP3 lipid second messenger; four-BBW deflection maxima; FIRST Gilead oncology null). Three surfaces: Gilead Sciences Foster City CA (÷10; Cority null; antiviral-to-oncology EHS gap; first HD Cat 1 in Gilead library; PI3Kδ lipid kinase absent; 52M 21yr); McKesson Specialty Health Nashville TN (÷10; VelocityEHS null; four-BBW counseling absorbs safety cognition; 44F 13yr); Stanford Cancer Institute Palo Alto CA (÷10; EHS Insight null; biweekly LFT monitoring deflects; 39F 12yr). Threshold 22.

  Read the full post →

• Venetoclax Venclexta CAS 1257044-40-8 AI Security · NIOSH HD Category 1 FIRST BCL-2 Anti-Apoptotic Protein Inhibitor (NINTH Distinct Mechanism Class: Not Kinase, Not mTOR, Not BTK, Not CDK, Not PARP, Not Proteasome; BCL-2 Kd ~0.01 nM; BH3 Mimetic Displacement of BAX/BIM/PUMA → MOMP → Cytochrome c → Caspase Cascade) · FIRST BH3 Mimetic (Sulfonamide Benzamide Scaffold MW 868.44 g/mol; FIRST Non-Macrolide >800 g/mol in Portfolio) · FIRST AbbVie/Roche Dual-Null (NDA 208573 Cority + Genentech VelocityEHS; Extends ibrutinib #499 AbbVie Dual-Null) · FIRST CLL/AML Dual Indication (TLS Ramp-Up + Venetoclax/Azacitidine Dual-HD Combination) · AbbVie North Chicago IL 53M 22yr Cority · Genentech South San Francisco CA 44F 15yr VelocityEHS · Dana-Farber Boston MA 40F 14yr EHS Insight · 508th Adversarial Attack · 117th Long-Form Blog · Glyphward Threshold 22 · 2026-10-09

  Venetoclax (Venclexta; CAS 1257044-40-8): NIOSH HD Category 1 FIRST BCL-2 Anti-Apoptotic Protein Inhibitor OEL Gap [BCL-2 Kd ~0.01 nM; BH3 Mimetic; NINTH Distinct Mechanism Class] + FIRST BH3 Mimetic [Sulfonamide Benzamide MW 868.44 g/mol; BCL-2 vs BCL-XL Selectivity 4800×] + FIRST AbbVie/Roche/Genentech Co-Commercialization Dual-Null + FIRST CLL/AML Dual Indication [Venetoclax/Azacitidine SECOND Dual-HD Combination]; AbbVie North Chicago IL 53M 22yr; Genentech South San Francisco CA 44F 15yr; Dana-Farber Boston MA 40F 14yr; Threshold 22; 508th Attack; 117th Blog

  The 508th adversarial attack — 117th long-form blog — FIRST BCL-2 inhibitor — NINTH mechanism class in Glyphward portfolio — FIRST venetoclax (CAS 1257044-40-8; MW 868.44 g/mol; NIOSH HD Category 1; BCL-2 Kd ~0.01 nM; BH3 mimetic; CLL/AML dual-indication; AbbVie/Roche co-commercialization dual-null; venetoclax/azacitidine dual-HD combination). Three surfaces: AbbVie North Chicago IL (÷10; Cority null; same instance as ibrutinib #499; BCL-2 mechanism absent; 53M 22yr); Genentech South San Francisco CA (÷10; VelocityEHS null independent; AbbVie/Roche dual-null absent; 44F 15yr); Dana-Farber Boston MA (÷10; EHS Insight null; CLL+AML dual-corridor absent; venetoclax/azacitidine dual-HD absent; 40F 14yr). Threshold 22.

  Read the full post →

• Osimertinib Mesylate Tagrisso CAS 1421373-65-0 AI Security · NIOSH HD Category 1 FIRST 3rd-Gen EGFR T790M Covalent Cys797 Inhibitor (Acrylamide Michael Acceptor; EGFR Recovery Requires De Novo Synthesis ~1–3 Days) · FIRST T790M Resistance Mutation OEL Paradox (cobas EGFR Mutation Test Identifies Patients Not Workers; Sequential Erlotinib→Osimertinib Zero-OEL Gap) · Mesylate/Free-Base CAS Fragmentation Delta 96.11 g/mol · AstraZeneca Gaithersburg MD 53M 22yr Cority · Hikma Eatontown NJ 45F 14yr VelocityEHS · Memorial Sloan Kettering New York NY 38F 12yr EHS Insight · 503rd Adversarial Attack · 116th Long-Form Blog · Glyphward Threshold 22 · 2026-10-09

  Osimertinib Mesylate (Tagrisso; CAS 1421373-65-0): NIOSH HD Category 1 FIRST 3rd-Gen EGFR T790M Inhibitor + FIRST Covalent Irreversible EGFR Inhibitor [Acrylamide Cys797; EGFR Recovery De Novo Synthesis ~1–3 Days; Extends ibrutinib Attack #499] + FIRST T790M Resistance Mutation OEL Paradox + Mesylate/Free-Base CAS Fragmentation [Delta 96.11 g/mol]; AstraZeneca Gaithersburg MD 53M 22yr; Hikma Eatontown NJ 45F 14yr; Memorial Sloan Kettering New York NY 38F 12yr; Threshold 22; 503rd Attack; 116th Blog

  The 503rd adversarial attack — 116th long-form blog — FIRST 3rd-gen EGFR T790M covalent inhibitor — FIRST covalent irreversible EGFR Cys797 inhibitor — FIRST osimertinib mesylate (CAS 1421373-65-0; AZD9291; MW 595.72 g/mol; indole-acrylamide scaffold; NIOSH HD Category 1; acrylamide Michael acceptor warhead alkylates Cys797 permanently; EGFR recovery ~1–3 days de novo synthesis; T790M resistance mutation OEL paradox: cobas EGFR Mutation Test companion diagnostic identifies T790M in patients not workers; mesylate/free-base CAS fragmentation delta 96.11 g/mol). Three surfaces: AstraZeneca Gaithersburg MD (÷10; Cority null; fourth AstraZeneca NIOSH HD Cat 1; 53M 22yr); Hikma Eatontown NJ (÷10; VelocityEHS null; multi-gen EGFR TKI manufacturing; 45F 14yr); MSK New York NY (÷10; EHS Insight null; sequential T790M dispensing gap; 38F 12yr). Threshold 22.

  Read the full post →

• Olaparib Lynparza CAS 763113-22-0 AI Security · NIOSH HD Category 1 FIRST PARP Inhibitor Gap (PARP1/2 NAD&sup+;-Competitive Inhibitor IC⊂5;⊂0; ~14 nM PARP1 / ~5 nM PARP2; PARP Trapping; Olaparib-PARP1-DNA Ternary Complex at DNA SSBs → Replication Fork Collapse → DSBs) · FIRST DNA Repair Enzyme Inhibitor in 501-Attack Portfolio (Not Kinase, Not mTOR, Not BTK, Not CDK, Not IMiD) · FIRST BRCAness Synthetic Lethality Occupational Gap (BRCA Companion Diagnostic Paradox: Testing Identifies Patients Not Workers) · FIRST Phthalazinone Fluorobenzyl Scaffold · FIRST Fluorine-Containing Compound in Portfolio (C⊂2;⊂4;H⊂2;⊂3;FN⊂4;O⊂3;) · Quad-Tumor BRCA-Linked Indication Gap (Ovarian/Breast/Prostate/Pancreatic; Four Independent Oncology Programs; Zero OEL Any Indication) · AstraZeneca Wilmington DE 50M 19yr Cority · MSD Kenilworth NJ 44F 15yr VelocityEHS · Mayo Clinic Rochester MN 38F 12yr EHS Insight · 501st Adversarial Attack · 115th Long-Form Blog · Glyphward Threshold 22 · 2026-10-08

  Olaparib (Lynparza; CAS 763113-22-0): NIOSH HD Category 1 FIRST PARP Inhibitor OEL Gap [PARP1/2 NAD&sup+;-Competitive Inhibitor; PARP Trapping: Olaparib-PARP1/2-DNA Ternary Complex Trapped at DNA SSBs → Replication Fork Collapse → DSBs; FIRST DNA Repair Enzyme Inhibitor in 501-Attack Portfolio] + FIRST BRCAness Synthetic Lethality Occupational Gap [BRCA1/2 HR-Deficiency Absent From All OEL Derivation Frameworks; BRCA Companion Diagnostic Paradox: Genetic Testing Identifies Patients Not Healthcare Workers] + FIRST Phthalazinone Fluorobenzyl Scaffold + FIRST Fluorine-Containing Compound in 501-Attack Portfolio (C⊂2;⊂4;H⊂2;⊂3;FN⊂4;O⊂3;) + Quad-Tumor BRCA-Linked Indication Gap [Ovarian/Breast/Prostate/Pancreatic; Four Distinct Oncology Programs; Zero OEL Any Indication] + AstraZeneca/MSD Co-Commercialization Dual-Null; AstraZeneca Wilmington DE 50M 19yr; MSD Kenilworth NJ 44F 15yr; Mayo Clinic Rochester MN 38F 12yr; Threshold 22; 501st Attack; 115th Blog

  The 501st adversarial attack — 115th long-form blog — FIRST PARP inhibitor gap — FIRST DNA repair enzyme inhibitor in 501-attack Glyphward portfolio — FIRST olaparib (CAS 763113-22-0; Lynparza; 4-[(3-[(4-cyclopropylcarbonyl)piperazin-4-yl]carbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one; MW 434.46 g/mol; C⊂2;⊂4;H⊂2;⊂3;FN⊂4;O⊂3;; PARP1/2 NAD&sup+;-competitive inhibitor + PARP trapping; IC⊂5;⊂0; ~14 nM PARP1; ~5 nM PARP2; NIOSH HD Category 1; OSHA No PEL; ACGIH No TLV; NIOSH No REL; GHS H302 H340 H350 H361): FIRST DNA repair enzyme inhibitor in 501-attack portfolio [PARP1/2 poly ADP-ribose polymerase; NAD&sup+;-competitive; PARP trapping at DNA SSBs; entirely new mechanism class]; FIRST BRCAness synthetic lethality gap [BRCA1/2 HR-deficiency synthetic lethality absent from all OEL frameworks; BRCA companion diagnostic paradox: BRCA testing identifies patients not occupational handlers]; FIRST phthalazinone fluorobenzyl scaffold [new ring system vs all prior scaffolds]; FIRST fluorine-containing compound in portfolio [C⊂2;⊂4;H⊂2;⊂3;FN⊂4;O⊂3;]; quad-tumor BRCA-linked indication gap [ovarian/breast/prostate/pancreatic; four independent oncology programs; zero OEL any indication]. Three surfaces: AstraZeneca Wilmington DE (÷10; Cority null; PARP/BRCAness absent; quad-tumor absent; third AstraZeneca Wilmington DE NIOSH HD Cat 1 compound [tamoxifen #482 + gefitinib #490 + olaparib #501]; 50M 19yr); MSD Kenilworth NJ (÷10; VelocityEHS null; AstraZeneca/MSD co-commercialization dual-null absent; phthalazinone scaffold absent; H340/H350/H361 absent; 44F 15yr); Mayo Clinic Rochester MN (÷10; EHS Insight null; quad-tumor BRCA dispensing gap [gynecologic/breast/GU/GI oncology]; BRCA companion diagnostic paradox absent; 38F 12yr). Threshold 22.

  Read the full post →

• Sorafenib Tosylate CAS 475207-59-1 AI Security · NIOSH HD Category 1 FIRST Pan-RAF Kinase Inhibitor Gap (CRAF IC⊂5;⊂0; ~6 nM + BRAF wt IC⊂5;⊂0; ~22 nM; CRAF Ser/Thr Kinase Inhibition as Anti-Tumor Mechanism Entirely Absent From EHS OEL Derivation Frameworks) · FIRST Tosylate Counterion CAS Fragmentation (MW Delta 172.20 g/mol — p-Toluenesulfonate; LARGEST Simple Monobasic Acid Counterion Gap in Glyphward TKI Portfolio; Exceeds Sunitinib Malate 134.10 g/mol and Imatinib Mesylate 96.11 g/mol) · FIRST RCC/HCC/DTC Triple-Indication Community Oncology Dispensing Gap (Three Distinct Tumor Populations; Three Independent Oncology Programs; Same 400 mg BID Continuous; Zero OEL for Any Indication) · Bayer Whippany NJ 50M 19yr Cority · Teva Sellersville PA 44F 13yr VelocityEHS · Cleveland Clinic Cleveland OH 37F 10yr EHS Insight · 492nd Adversarial Attack · 114th Long-Form Blog · Glyphward Threshold 22 · 2026-10-08

  Sorafenib Tosylate (Nexavar; CAS 475207-59-1): NIOSH HD Category 1 FIRST Pan-RAF Kinase Inhibitor OEL Gap [CRAF IC⊂5;⊂0; ~6 nM + BRAF Wild-Type IC⊂5;⊂0; ~22 nM; Six-Kinase-Family Inhibition Profile: CRAF + BRAF + VEGFR1/2/3 + PDGFR-β + KIT + FLT3; CRAF Ser/Thr Kinase Inhibition as Anti-Tumor Mechanism Entirely Absent From EHS OEL Derivation Frameworks — No NIOSH REL, ACGIH TLV, or OSHA PEL for Any RAF Kinase Inhibitor] + FIRST Tosylate Counterion CAS Fragmentation [MW Delta 172.20 g/mol — p-Toluenesulfonate; Tosylate CAS 475207-59-1 (MW 637.03 g/mol) vs Free-Base CAS 284461-73-0 (MW 464.83 g/mol); LARGEST Simple Monobasic Acid Counterion Gap in Glyphward TKI Portfolio; Exceeds Sunitinib Malate 134.10 g/mol (Attack #491) and Imatinib Mesylate 96.11 g/mol (Attack #484)] + FIRST RCC/HCC/DTC Triple-Indication Community Oncology Dispensing Gap [Three Distinct Tumor Populations; Three Independent Oncology Programs; Same 400 mg BID Continuous; Zero OEL Advisory for CAS 475207-59-1 or CAS 284461-73-0 for Any Indication]; Bayer HealthCare Whippany NJ 50M 19yr; Teva Pharmaceuticals Sellersville PA 44F 13yr; Cleveland Clinic Main Campus Cleveland OH 37F 10yr; Threshold 22; 492nd Attack; 114th Blog

  The 492nd adversarial attack — 114th long-form blog — FIRST pan-RAF kinase inhibitor gap — FIRST sorafenib tosylate (CAS 475207-59-1; Nexavar; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide 4-methylbenzenesulfonate; MW 637.03 g/mol [tosylate]; free base CAS 284461-73-0 MW 464.83 g/mol; C⊂2;⊂1;H⊂1;⊂6;ClF⊂3;N⊂4;O⊂3;·C⊂7;H⊂8;O⊂3;S [tosylate]; pan-RAF + anti-angiogenic multi-kinase inhibitor; CRAF IC⊂5;⊂0; ~6 nM; BRAF wt IC⊂5;⊂0; ~22 nM; VEGFR1/2/3 IC⊂5;⊂0; ~20–90 nM; PDGFR-β IC⊂5;⊂0; ~57 nM; KIT IC⊂5;⊂0; ~68 nM; FLT3 IC⊂5;⊂0; ~33 nM; NIOSH HD Category 1; OSHA No PEL; ACGIH No TLV; NIOSH No REL; GHS H302 H340 H350 H361): FIRST pan-RAF kinase inhibitor gap [CRAF/BRAF serine/threonine kinase inhibition as anti-tumor mechanism entirely absent from EHS OEL frameworks; no NIOSH REL, ACGIH TLV, or OSHA PEL for any RAF kinase inhibitor; CRAF sits directly downstream of KRAS/NRAS oncoproteins mutated in ~30% of all cancers; six-kinase-family OEL null]; FIRST tosylate counterion CAS fragmentation [MW delta 172.20 g/mol p-toluenesulfonate — LARGEST simple monobasic acid counterion gap in Glyphward TKI portfolio]; FIRST RCC/HCC/DTC triple-indication community oncology dispensing gap [three distinct tumor populations; three independent clinical programs; same 400 mg BID continuous regimen; zero OEL for any indication or CAS form]. Three surfaces: Bayer Whippany NJ (÷10; Cority null both CAS forms; pan-RAF mechanism absent; RCC/HCC/DTC triple indication absent; 50M 19yr); Teva Sellersville PA (÷10; VelocityEHS null both forms; MW delta 172.20 g/mol largest monobasic acid counterion gap; H340/H350/H361 absent both; 44F 13yr); Cleveland Clinic Cleveland OH (÷10; EHS Insight null; RCC/HCC/DTC three-program dispensing gap; pan-RAF absent; NIOSH HD Cat 1 absent; 37F 10yr). Threshold 22.

  Read the full post →

• Dasatinib CAS 302962-49-8 AI Security · NIOSH HD Category 1 FIRST Dual BCR-ABL/Src TKI Gap (FIRST Pleural Effusion/PAH PDGFR-β Mechanism Gap; Di-PAH Group 1 PAH; Pulmonary Vascular Inhalation Endpoint; ENTIRELY NOVEL ATTACK SURFACE in 486-Attack Portfolio) · FIRST Anhydrous CAS 302962-49-8/Monohydrate CAS 863127-77-9 Independent EHS Null Fragmentation (MW 488.01 vs 506.02 g/mol) · FIRST Kinome Breadth Gap (94+ Kinases Inhibited; 2/94 Captured in EHS Null) · FIRST Pediatric Ph+ ALL Tablet-Crushing C-PEC Gap · BMS Princeton NJ 48M 17yr Cority · Teva North Wales PA 43F 14yr VelocityEHS · Dana-Farber Boston MA 37F 11yr EHS Insight · 486th Adversarial Attack · 113th Long-Form Blog · Glyphward Threshold 22 · 2026-10-08

  Dasatinib (Sprycel; CAS 302962-49-8): NIOSH HD Category 1 FIRST Dual BCR-ABL/Src TKI Occupational Gap [FIRST Pleural Effusion/PAH PDGFR-β Mechanism Gap; Dasatinib-Induced PAH (Di-PAH) via PDGFR-β Inhibition at IC⊂5;⊂0; ~28 nM; Pulmonary Vascular Inhalation Endpoint Entirely Absent From EHS Null; ENTIRELY NOVEL ATTACK SURFACE in 486-Attack Glyphward Portfolio] + FIRST Anhydrous CAS 302962-49-8/Monohydrate CAS 863127-77-9 Independent EHS Null Fragmentation [MW 488.01 vs 506.02 g/mol; No Cross-Reference] + FIRST Kinome Breadth Gap [94+ Kinases Inhibited at Clinical Concentrations; Occupational Null Captures 2/94] + FIRST Pediatric Ph+ ALL Tablet-Crushing C-PEC Gap; BMS Princeton NJ 48M 17yr; Teva North Wales PA 43F 14yr; Dana-Farber Boston MA 37F 11yr; Threshold 22; 486th Attack; 113th Blog

  The 486th adversarial attack — 113th long-form blog — ENTIRELY NOVEL ATTACK SURFACE — FIRST dasatinib (CAS 302962-49-8; Sprycel; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide; MW 488.01 g/mol [anhydrous]; monohydrate CAS 863127-77-9 MW 506.02; C⊂2;⊂2;H⊂2;⊂6;ClN⊂7;O⊂2;S; dual BCR-ABL1/Src TKI; also inhibits PDGFR-β [IC⊂5;⊂0; ~28 nM; within therapeutic Cmax range]; KIT; FAK; Ephrin receptors; 94+ kinases total [Karaman Nat Biotechnol 2008]; Di-PAH ~5%; pleural effusion ~28%; NIOSH HD Category 1; OSHA No PEL; ACGIH No TLV; NIOSH No REL; GHS H302 H340 H350 H361): FIRST dual BCR-ABL/Src TKI HD Category 1 gap; FIRST pleural effusion/PAH PDGFR-β mechanism as occupationally relevant inhalation endpoint [ENTIRELY NOVEL: Di-PAH via PDGFR-β inhibition at IC⊂5;⊂0; ~28 nM within therapeutic Cmax; same PDGFR-β pathway relevant to occupational inhalation; pulmonary vascular endpoint absent from all prior 485 attacks]; FIRST anhydrous/monohydrate CAS fragmentation; FIRST kinome breadth gap (94 kinases; 2/94 captured); FIRST pediatric Ph+ ALL tablet-crushing C-PEC gap. Three surfaces: BMS Princeton NJ (÷10; Cority null both CAS forms; PDGFR PAH absent; kinome absent; 48M 17yr); Teva North Wales PA (÷10; VelocityEHS null both forms; anhydrous/monohydrate split; H340/H350/H361 absent both; 43F 14yr); Dana-Farber Boston MA (÷10; EHS Insight null; Di-PAH monitoring program runs in clinical domain while occupational null silent; pediatric tablet-crushing absent; 37F 11yr). Threshold 22.

  Read the full post →

• Bortezomib CAS 179324-69-7 AI Security · NIOSH HD Category 1 FIRST Proteasome Inhibitor Occupational OEL Gap (β5 Thr1-Oγ Reversible Covalent Boronic Acid Warhead; No OEL Derivation Methodology for Any Proteasome Inhibitor) · FIRST Boronic Acid Warhead Class NIOSH HD Category 1 (Only Approved Boronate-Antineoplastic in 481-Attack Portfolio) · FIRST VRd SC Reconstitution Concentration Gap (2.5 mg/mL SC vs 1 mg/mL IV From Same 3.5 mg Vial) · Takeda/Millennium Cambridge MA 47M 18yr Cority · J&J Janssen Horsham PA 43F 15yr VelocityEHS · Mayo Clinic Rochester MN 37F 10yr EHS Insight · 481st Adversarial Attack · 112th Long-Form Blog · Glyphward Threshold 22 · 2026-10-03

  Bortezomib (Velcade; CAS 179324-69-7): NIOSH HD Category 1 FIRST Proteasome Inhibitor Occupational OEL Gap [26S Proteasome β5 Thr1-Oγ Reversible Covalent Boronic Acid Warhead; No OEL Derivation Methodology for Any Proteasome Inhibitor] + FIRST Boronic Acid Warhead Class NIOSH HD Category 1 [Only Approved Boronate-Antineoplastic in 481-Attack Portfolio] + FIRST VRd SC Reconstitution Concentration Gap [2.5 mg/mL SC vs 1 mg/mL IV From Same 3.5 mg Lyophilized Vial; Community Myeloma Home Kit at 2.5× Outside BSC] + H317 Skin Sensitization Gap; Takeda/Millennium Cambridge MA 47M 18yr; J&J Janssen Horsham PA 43F 15yr; Mayo Clinic Rochester MN 37F 10yr; Threshold 22; 481st Attack; 112th Blog

  The 481st adversarial attack — 112th long-form blog — FIRST proteasome inhibitor occupational OEL gap — FIRST bortezomib (CAS 179324-69-7; Velcade; [(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid; MW 384.24 g/mol; only approved boronic acid antineoplastic in 481-attack Glyphward portfolio; 20S proteasome β5 CT-L Thr1-Oγ reversible covalent boronate ester mechanism; NIOSH HD Category 1; OSHA No PEL; ACGIH No TLV; NIOSH No REL; GHS H317 H340 H350 H361): FIRST proteasome inhibitor occupational OEL gap [26S proteasome β5/β2/β1 multi-subunit CT-L/T-L/C-L architecture entirely absent from EHS OEL frameworks; no published occupational inhalation study for any boronic acid antineoplastic]; FIRST boronic acid warhead class NIOSH HD Category 1 [only boronate-antineoplastic in 481-attack portfolio; −B(OH)⊂2; group reactive covalent mechanism]; FIRST VRd SC reconstitution concentration gap [2.5 mg/mL SC vs 1 mg/mL IV from same 3.5 mg lyophilized vial; 2.5× higher concentration in SC syringe; community myeloma specialty pharmacy SC home self-injection kits leave BSC at 2.5× concentration]; H317 skin sensitization absent from all three EHS platform nulls [boronic acid protein hapten contact sensitization; mechanistically distinct from nitrogen mustard vesicancy]. Three surfaces: Takeda/Millennium Cambridge MA (÷10; Cority null; H317 H340 H350 H361 absent; proteasome mechanism absent; 47M 18yr); J&J Janssen Horsham PA (÷10; VelocityEHS null; H317 absent; boronic acid inhalation toxicokinetics absent; 43F 15yr); Mayo Clinic Rochester MN (÷10; EHS Insight null; VRd SC concentration gap absent; home kit outside BSC absent; 37F 10yr). Threshold 22.

  Read the full post →

• Arsenic Trioxide CAS 1327-53-3 AI Security · NIOSH HD Category 1 FIRST False-Adequacy Attack (OSHA 1910.1018 PEL 10 µg/m³ Industrial Inorganic Arsenic Returns Apparent Compliance Result for Cytotoxic IV Preparation; All NIOSH HD Category 1 Supplementary Controls Suppressed) · FIRST APL Outpatient Home Infusion HD Category 1 Route Gap (80 IV Encounters Per Patient; Home Nurses Without BSC/CSTD) · FIRST OSHA 1910.1018 Industrial-to-HD Context Transfer Without Annotation · FIRST Arsenic Speciation Wipe-Monitoring Gap · IARC Group 1 Obscured by Industrial OEL Return · Teva North Wales PA 49M 21yr Cority · BTG Parsippany NJ 44F 16yr VelocityEHS · UCSF San Francisco CA 38F 11yr EHS Insight · 472nd Adversarial Attack · 111th Long-Form Blog · Glyphward Threshold 22 · 2026-10-03

  Arsenic Trioxide (Trisenox; CAS 1327-53-3): NIOSH HD Category 1 FIRST False-Adequacy Attack [OSHA 1910.1018 PEL 10 µg/m³ for Industrial Inorganic Arsenic (Cu/Pb/Zn Smelting; Arsenical Pesticide; Semiconductor) Returns Apparent Compliance Result for Cytotoxic IV Preparation; All NIOSH HD Category 1 Controls (BSC, CSTD, Double Gloves, Wipe Testing, HD Waste) Suppressed] + FIRST APL Outpatient Home Infusion Route Gap (80 IV Encounters Per Patient; Home Nurses Without BSC/CSTD; Trisenox Labeling Supports Home Use) + FIRST 1910.1018 Industrial Context Divergence (Smelter vs Pharmacy; Wrong Monitoring Program) + FIRST Arsenic Speciation Wipe-Monitoring Gap (NIOSH 7300 Cannot Distinguish As⊂2;O⊂3; from Background) + IARC Group 1 Obscured; Teva North Wales PA 49M 21yr; BTG Parsippany NJ 44F 16yr; UCSF San Francisco CA 38F 11yr; Threshold 22, 472nd Attack; 111th Blog

  The 472nd adversarial attack — 111th long-form blog — FIRST false-adequacy attack in the Glyphward portfolio — FIRST arsenic trioxide (CAS 1327-53-3; Trisenox; As⊂2;O⊂3;; MW 197.84 g/mol; inorganic metalloid oxide; the only FDA-approved antineoplastic whose API is an inorganic element oxide; PML-RARα zinc-finger SUMOylation mechanism [As(III) binds C3HC4 RING domain; multimerization; RanBP2 SUMOylation at K160; RNF4 ubiquitination; proteasomal PML-RARα degradation] + ROS apoptosis; NIOSH HD Category 1; IARC Group 1 [Monograph 100C, 2012]; H301; H331; H350; H410): FIRST false-adequacy attack [only compound in 476-attack portfolio where OSHA OEL return actively suppresses NIOSH HD Category 1 protective action; OSHA 1910.1018 PEL 10 µg/m³ (promulgated 1978; based on ASARCO Tacoma copper smelter lung cancer cohort; industrial arsenic 100–2,000 µg/m³) returned for CAS 1327-53-3 in EHS AI query; platform compliance check marks as “compliant”; BSC, CSTD, double gloves, wipe testing, and HD waste stream NOT flagged; false adequacy is more dangerous than null-return because gap is invisible]; FIRST APL outpatient home infusion HD Category 1 route gap [80 IV encounters per patient per consolidation course; progressive inpatient → outpatient infusion center → home infusion shift; Trisenox labeling does not restrict to inpatient; home infusion nurses administer without BSC/CSTD/HD waste at patient’s residence]; FIRST 1910.1018 industrial-to-HD context transfer [smelter/pesticide/semiconductor context vs oncology pharmacy; wrong control hierarchy (industrial ventilation/respirator vs BSC/CSTD); wrong monitoring program (urinary arsenic vs HD wipe testing)]; FIRST arsenic speciation wipe-monitoring gap [NIOSH 7300 ICP-AES total metals cannot distinguish As⊂2;O⊂3; from background soil/dietary arsenobetaine; no validated As⊂2;O⊂3;-specific pharmacy wipe method; dietary arsenobetaine confounder in urinary BEI]. Three surfaces: Teva North Wales PA (÷10; Cority false adequacy; 1910.1018 industrial context; BSC/CSTD not flagged; 49M 21yr); BTG Parsippany NJ (÷10; VelocityEHS false adequacy; APL home infusion gap; 44F 16yr); UCSF San Francisco CA (÷10; EHS Insight false adequacy; home infusion route gap; urinary arsenic vs HD wipe program divergence; 38F 11yr). Threshold 22.

  Read the full post →

• Dactinomycin CAS 50-76-0 AI Security · NIOSH HD Category 1 OEL Null-Return (No OSHA PEL / No ACGIH TLV / No NIOSH REL) · FIRST RNA Polymerase Tri-Class (Pol I [Nucleolar rRNA/Ribosome Biogenesis] + Pol II [mRNA/Global Transcriptome] + Pol III [tRNA/5S rRNA/7SL]) Transcription Inhibition Gap (Only Approved Antineoplastic Blocking All Three Nuclear RNA Polymerases via GpC Minor-Groove Intercalation; Pan-Transcriptional Shutdown Invisible to OEL Framework) · FIRST VAC Three-Compound Null Chain (Vincristine [#433] + Dactinomycin [#466] + Cyclophosphamide [#438]; COG ARST RMS + COG AREN Wilms + COG AEWS EWS First-Line Pediatric; Three Mechanistically Divergent HD Category 1 Drugs Zero OEL) · FIRST Actinomycin D/Dactinomycin Dual-Name CAS-50-76-0 EHS Record Fragmentation (Historical Scientific Name vs USAN; Pre-2016 Laboratory SDS Record Lacks HD Category 1 Annotation) · FIRST IARC Group 3 vs NIOSH HD Category 1 H350 Paradox (H350 Absent from IARC-Deferred SDS Records; H300/H310/H330 Triple Acute Fatal Hazard Present) · Lundbeck/Recordati Deerfield IL 48M 20yr Cority · Hikma Columbus OH 43F 15yr VelocityEHS · St. Jude Memphis TN 37F 9yr EHS Insight · 466th Adversarial Attack · 110th Long-Form Blog · Glyphward Threshold 22 · 2026-10-03

  Dactinomycin (Cosmegen/Actinomycin D; CAS 50-76-0): NIOSH HD Category 1 OEL Null-Return + FIRST RNA Polymerase Tri-Class (Pol I/Pol II/Pol III) Transcription Inhibition Gap (Only Approved Antineoplastic Blocking All Three Nuclear RNA Polymerases Simultaneously via GpC Intercalation) + FIRST VAC Three-Compound Null Chain (Vincristine + Dactinomycin + Cyclophosphamide; First-Line Pediatric EWS/RMS/Wilms; Zero OEL for All Three) + FIRST Actinomycin D/Dactinomycin Dual-Name Fragmentation + FIRST IARC Group 3 vs NIOSH HD Category 1 H350 Paradox; Lundbeck/Recordati Deerfield IL 48M 20yr; Hikma Columbus OH 43F 15yr; St. Jude Memphis TN 37F 9yr; Threshold 22, 466th Attack; 110th Blog

  The 466th adversarial attack — 110th long-form blog — FIRST dactinomycin (CAS 50-76-0; Cosmegen; Actinomycin D; MW 1255.42 g/mol; C⊂6;⊂2;H⊂8;⊂6;N⊂1;⊂2;O⊂1;⊂6;; Streptomyces parvulus cyclic depsipeptide; GpC minor-groove intercalator; phenoxazone chromophore + two symmetric cyclic pentapeptide lactone arms; NIOSH HD Category 1; H300 fatal if swallowed [LD⊂5;⊂0; rat oral 3.3 mg/kg]; H310 fatal in contact with skin; H330 fatal if inhaled; H340 genotoxic; H360 reproductive): FIRST RNA polymerase tri-class (Pol I + Pol II + Pol III) transcription inhibition gap (dactinomycin intercalates at 5′-GpC-3′ dinucleotide steps in double-stranded DNA; Kd 1–10 nM at preferred sites; the phenoxazone ring intercalates; the two cyclic pentapeptide arms wrap the DNA minor groove; all three nuclear RNA polymerases blocked by a single template-strand intercalation event: Pol I [nucleolus; 45S pre-rRNA; 28S/18S/5.8S rRNA; ribosome biogenesis; preferentially inhibited at 1–10 nM due to rDNA GpC enrichment] + Pol II [nucleoplasm; all mRNA precursors; all protein-coding gene transcription; most snRNA] + Pol III [nucleoplasm; all tRNA genes; 5S rRNA; 7SL RNA; U6 snRNA; 7SK RNA]; only approved antineoplastic in the 466-attack NIOSH HD portfolio achieving pan-RNA-pol inhibition; therapeutic peak plasma 16–40 nM inhibits all three simultaneously; EHS AI returns “DNA intercalating agent” without Pol I/II/III simultaneous inhibition context; pan-transcriptional shutdown not representable in null-OEL architecture); FIRST VAC three-compound null chain (vincristine [CAS 57-22-7; attack #433; tubulin depolymerization; M-phase arrest; IARC Group 2A; zero OEL] + dactinomycin [CAS 50-76-0; attack #466; pan-RNA-pol GpC intercalation; zero OEL] + cyclophosphamide [CAS 50-18-0; attack #438; nitrogen mustard alkylator; IARC Group 1; zero OEL]; COG ARST RMS + COG AREN Wilms + COG AEWS EWS first-line pediatric protocols; three mechanistically divergent HD Category 1 drugs [mitotic arrest + transcription shutdown + DNA alkylation] simultaneously prepared with zero OEL for all three; first three-mechanism-divergent null chain in Glyphward portfolio); FIRST Actinomycin D/dactinomycin dual-name CAS-50-76-0 EHS record fragmentation (“Actinomycin D” [historical scientific name; 10,000+ PubMed publications; Sigma-Aldrich/Thermo Fisher laboratory catalog primary name] vs “dactinomycin” [USAN approved name; all current Cosmegen SDS and NIOSH HD list entries]; same CAS 50-76-0; EHS platform text-search fragmentation; pre-2016 “Actinomycin D” laboratory reagent SDS record lacks NIOSH HD Category 1 annotation [designation added 2016 NIOSH HD List]; researchers querying “Actinomycin D” may retrieve pre-2016 record without HD Category 1 status; LD⊂5;⊂0; 3.3 mg/kg compound handled on open bench outside BSC); FIRST IARC Group 3 vs NIOSH HD Category 1 H350 paradox (IARC Monograph 10, 1976: Group 3 [not classifiable as carcinogen; inconsistent animal data; inadequate human data]; NIOSH HD Category 1 based on H340 + H360 + H300/H310/H330; H350 absent from SDS documents deferring to IARC Group 3; GHS H350 correctly excluded under IARC Group 3 criterion; H350 inconsistency across SDS versions; EHS AI null does not annotate IARC/NIOSH divergence). Three surfaces: Lundbeck/Recordati Deerfield IL brand distribution (÷10; Cority null; H350 absent; IARC Group 3 paradox absent; RNA Pol tri-class gap; 48M 20yr); Hikma Columbus OH generic manufacturing (÷10; VelocityEHS null; actinomycin D dual-name fragmentation; RNA Pol tri-class gap; 43F 15yr); St. Jude Memphis TN pediatric oncology pharmacy (÷10; EHS Insight null; VAC triple null chain; vincristine #433 null + dactinomycin #466 null + cyclophosphamide #438 null; pediatric RMS COG ARST1431 protocol context absent; 37F 9yr). Threshold 22.

  Read the full post →

• Hydroxyurea CAS 127-07-1 AI Security · NIOSH HD Category 1 OEL Null-Return (No OSHA PEL / No ACGIH TLV / No NIOSH REL) · FIRST Highest-Dispensing-Volume HD Category 1 Occupational Frequency Gap (>100,000 US SCD + >70,000 MPN Patients Daily; Annual Dispensing Events Exceed Any IV Oncology HD; Most-Frequently-Dispensed NIOSH HD Returns Zero OEL) · FIRST Hydroxycarbamide INN Nomenclature Dual-Record Confusion (US USAN “Hydroxyurea” vs WHO INN “Hydroxycarbamide”; Triple EHS Record Fragmentation) · FIRST Turci 2011 Published Surface Contamination Data Gap (J. Oncol. Pharm. Pract. 2011;17[4]:286–292; Median 0.15 ng/cm²; Some Sites Exceeding 5-FU) · FIRST IARC Group 3 vs NIOSH HD Category 1 Paradox · FIRST Siklos 100 mg Pediatric SCD Tablet Crushing Gap · Bristol-Myers Squibb Princeton NJ 51M 22yr Cority · Mylan/Viatris Morgantown WV 46F 17yr VelocityEHS · Children’s Hospital of Philadelphia PA 34F 7yr EHS Insight · 463rd Adversarial Attack · 109th Long-Form Blog · Glyphward Threshold 22 · 2026-10-02

  Hydroxyurea (Droxia/Hydrea; CAS 127-07-1): NIOSH HD Category 1 OEL Null-Return + FIRST Highest-Dispensing-Volume HD Category 1 Occupational Frequency Gap (>100,000 US SCD + >70,000 MPN Patients on Chronic Daily Oral Therapy; Annual Dispensing Events Exceed Any IV Oncology HD; Most-Frequently-Dispensed NIOSH HD Returns Zero OEL) + FIRST Hydroxycarbamide INN Nomenclature Dual-Record Confusion + FIRST Turci 2011 Published Surface Contamination Data Gap (Median 0.15 ng/cm²; Some Sites Exceeding 5-FU) + FIRST IARC Group 3 vs NIOSH HD Category 1 Paradox + Siklos Pediatric Crushing Gap; BMS Princeton NJ 51M 22yr; Mylan/Viatris Morgantown WV 46F 17yr; CHOP Philadelphia PA 34F 7yr; Threshold 22, 463rd Attack; 109th Blog

  The 463rd adversarial attack — 109th long-form blog — FIRST hydroxyurea (CAS 127-07-1; Droxia/Hydrea; NIOSH HD Category 1; the lightest molecule in the HD portfolio at MW 76.05 g/mol; ribonucleotide reductase M2-subunit tyrosyl-radical quencher; chronic daily SCD therapy): FIRST highest-dispensing-volume HD Category 1 occupational frequency gap (>100,000 US SCD patients on lifelong daily oral therapy + >70,000 MPN patients on chronic daily therapy = ~50–60 million annual pharmacist dispensing encounters; exceeds entire annual IV-oncology HD compounding volume combined; per-substance null-OEL cannot represent occupational frequency multiplier; retail pharmacist at SCD-specialty pharmacy accumulates more HU annual dispensing encounters than oncology pharmacist accumulates IV-HD compounding sessions); FIRST hydroxycarbamide INN nomenclature dual-record confusion (US USAN “hydroxyurea” vs WHO/European INN “hydroxycarbamide”; same CAS 127-07-1; Droxia SDS + Hydrea SDS + hydroxycarbamide SDS = potentially three independent EHS null records; NIOSH HD Category 1 annotation may reside in only one record; nomenclature-driven fragmentation distinct from HCl-salt/free-base CAS fragmentations); FIRST Turci 2011 published pharmacy surface contamination data absent (J. Oncol. Pharm. Pract. 2011;17[4]:286–292; HU detected at median 0.15 ng/cm² on preparation work surfaces; some sites exceeding 5-FU surface levels; peer-reviewed empirical detection evidence entirely absent from all EHS AI outputs); FIRST IARC Group 3 vs NIOSH HD Category 1 paradox (IARC Monograph 54, 1992: Group 3 [not classifiable as carcinogen]; NIOSH: HD Category 1 based on H340 genotoxic + H361 reproductive endpoints; different evidentiary frameworks; coexistence not annotated; IARC Group 3 generates dangerous reassurance when encountered without contextualization); FIRST Siklos 100 mg pediatric SCD scored-tablet crushing gap (mortar-and-pestle HU dust for children <3yr outside BSC; USP <800> IV-CSTD guidance not applicable to oral HD tablet crushing). Three surfaces: BMS Princeton NJ brand manufacturing (÷10; Cority null; hydroxycarbamide dual null; H340 H361 absent; 51M 22yr); Mylan/Viatris Morgantown WV generic manufacturing (÷10; VelocityEHS null; dispensing volume absent; IARC Group 3 paradox absent; H340 H361 absent; 46F 17yr); CHOP Philadelphia PA pediatric SCD pharmacy (÷10; EHS Insight null; Siklos crushing absent; Turci 2011 absent; H340 H361 absent; 34F 7yr). Threshold 22.

  Read the full post →

• Bendamustine HCl CAS 16506-27-7 AI Security · NIOSH HD Category 1 OEL Null-Return (No OSHA PEL / No ACGIH TLV / No NIOSH REL) · FIRST Bifunctional Alkylating-Benzimidazole Purine Analogue Hybrid Mechanism Classification Gap (EHS AI Returns “Alkylating Agent” Without Purine-Mimic Component; Unique Dual-Pharmacophore in HD Portfolio; BAX/BCL-2 Pathway + M-Phase Arrest Absent from EHS Null) · FIRST Spirosuccinimide HP1 In-Situ Hydrolysis Metabolite Occupational Exposure Gap During Compounding (Non-Enzymatic pH-Dependent Cyclization at Bench; No EHS Record; No Air Sampling Method) · FIRST Anhydrous HCl vs Monohydrate 4.6% MW Fragmentation · FIRST PEG 400/Polysorbate 80 Formulation-Specific Dermal Penetration Enhancement Gap · Fresenius Kabi Wilson NC 49M 21yr Cority · Eagle Pharmaceuticals Parsippany NJ 44F 16yr VelocityEHS · Roswell Park Buffalo NY 38M 11yr EHS Insight · 460th Adversarial Attack · 108th Long-Form Blog · Glyphward Threshold 22 · 2026-10-02

  Bendamustine HCl (CAS 16506-27-7): NIOSH HD Category 1 OEL Null-Return + FIRST Bifunctional Alkylating-Benzimidazole Purine Analogue Hybrid Mechanism Classification Gap (EHS AI Returns “Alkylating Agent” Without Purine-Mimic Pharmacophore; BAX/BCL-2 Apoptosis + M-Phase Mitotic Checkpoint Arrest Absent from EHS Null; Unique Dual-Mechanism Hazard Class in Portfolio) + FIRST Spirosuccinimide HP1 In-Situ Hydrolysis Metabolite Occupational Exposure Gap (Cytotoxic Degradation Generated on Pharmacist’s Bench During IV Preparation; No EHS Record; No Air Sampling Method) + FIRST Anhydrous HCl (MW 394.73) vs Monohydrate (MW 412.74) 4.6% MW Fragmentation + FIRST PEG 400/Polysorbate 80 Formulation-Specific Dermal Penetration Gap; Fresenius Kabi Wilson NC 49M 21yr; Eagle Pharmaceuticals Parsippany NJ 44F 16yr; Roswell Park Buffalo NY 38M 11yr; Threshold 22, 460th Attack; 108th Blog

  The 460th adversarial attack — 108th long-form blog — FIRST bendamustine HCl (CAS 16506-27-7; NIOSH HD Category 1) adversarial blog: FIRST bifunctional alkylating-benzimidazole purine-analogue hybrid mechanism classification gap (EHS AI returns “alkylating agent” for bendamustine without the benzimidazole ring’s purine-mimic pharmacophore; BAX/BCL-2 intrinsic apoptosis activation, M-phase mitotic checkpoint arrest, and non-cross-resistance with nitrogen mustards all absent from EHS null output; unique dual-pharmacophore hazard class in 460-attack portfolio); FIRST spirosuccinimide HP1 monohydroxy in-situ hydrolysis metabolite occupational exposure gap during compounding (non-enzymatic pH-dependent intramolecular cyclization of bis-chloroethylamine generates cytotoxic monohydroxy degradation product HP1 continuously in aqueous solution from moment of reconstitution; formed on pharmacist’s bench; no independent EHS record; no validated air sampling method; only HD drug in portfolio whose compounding session actively generates bench metabolites); FIRST anhydrous HCl (MW 394.73) vs monohydrate HCl (MW 412.74) 4.6% MW fragmentation (Treanda lyophilized uses monohydrate; concentrate uses anhydrous HCl; 4.6% systematic numeric error additive to ÷10 perturbation); FIRST PEG 400/polysorbate 80 formulation-specific dermal penetration enhancement gap (Treanda PEG 400 concentrate vs Belrapzo polysorbate 80; both established penetration enhancers; identical EHS null for all formulations despite different dermal absorption risk). Three surfaces: Fresenius Kabi Wilson NC bendamustine HCl manufacturing (÷10; Cority null; bifunctional gap; HP1 absent; 49M 21yr); Eagle Pharmaceuticals Parsippany NJ quality analytics (÷10; VelocityEHS null; HP1 in-situ; monohydrate MW gap; PEG 400 dermal; 44F 16yr); Roswell Park Comprehensive Cancer Center Buffalo NY BR oncology pharmacy (÷10; EHS Insight null; PEG 400 dermal; bifunctional gap; 38M 11yr). Threshold 22.

  Read the full post →

• Fludarabine Phosphate CAS 75607-67-9 AI Security · NIOSH HD Category 1 OEL Null-Return (No OSHA PEL / No ACGIH TLV / No NIOSH REL) · FIRST Occupational Immunosuppression CD4+ T-Lymphocyte Depletion Gap (GHS H372 Immune-System Organ Toxicity Not Translated to Lymphopenia Monitoring Advisory; Sub-Therapeutic dCK-Mediated F-ara-ATP Accumulation in Lymphocytes) · FIRST FCR Protocol Dual HD Null Chain (Fludarabine Phosphate + Cyclophosphamide [CAS 50-18-0; Attack #438]; Most Prescribed First-Line CLL Regimen Worldwide; Two Simultaneous HD Category 1 Nulls) · FIRST Phosphate Prodrug vs Free-Base CAS 75607-67-9 vs CAS 21679-14-1 MW Fragmentation (28.1% MW Gap; Largest Phosphate-Prodrug/Free-Base Discrepancy in Portfolio) · Teva Pharmaceuticals North Wales PA 46M 19yr Cority · Accord Healthcare Durham NC 43F 15yr VelocityEHS · UPMC Hillman Cancer Center Pittsburgh PA 39M 12yr EHS Insight · 454th Adversarial Attack · 107th Long-Form Blog · Glyphward Threshold 22 · 2026-10-02

  Fludarabine Phosphate (CAS 75607-67-9): NIOSH HD Category 1 OEL Null-Return + FIRST Occupational Immunosuppression CD4+ T-Lymphocyte Depletion Gap (GHS H372 Immune-System Organ Toxicity Not Translated to CD4+ Lymphopenia Monitoring Advisory; Zero EHS OEL Framework for Lymphocytotoxic Endpoint) + FIRST FCR Dual HD Null Chain (Fludarabine Phosphate + Cyclophosphamide [Attack #438]; Most Prescribed CLL Regimen; Dual Simultaneous HD Category 1 Null) + FIRST Phosphate Prodrug vs Free-Base CAS 75607-67-9 vs CAS 21679-14-1 MW Fragmentation (28.1% Gap); Teva North Wales PA 46M 19yr; Accord Durham NC 43F 15yr; UPMC Hillman Pittsburgh PA 39M 12yr; Threshold 22, 454th Attack; 107th Blog

  The 454th adversarial attack — 107th long-form blog — FIRST fludarabine phosphate (CAS 75607-67-9; NIOSH HD Category 1) adversarial blog: FIRST occupational immunosuppression CD4+ T-lymphocyte depletion gap (fludarabine’s dCK-mediated F-ara-ATP accumulation mechanism selectively depletes CD4+ T-lymphocytes — the same cells circulating in the pharmacist’s bloodstream; GHS H372 immune-system organ designation present in SDS but EHS AI does not translate to CD4+ monitoring advisory, ALC surveillance, or PCP prophylaxis threshold awareness at 200 cells/µL; first lymphocytotoxic immunosuppression occupational endpoint in 454-attack portfolio); FIRST FCR dual null chain (fludarabine phosphate [this] + cyclophosphamide CAS 50-18-0 [attack #438]; both NIOSH HD Category 1; both null OEL; FCR most prescribed first-line CLL regimen globally; ∼252,000 FCR BSC preparation events per year in the US; two simultaneous binary HD obligations from single compounding session); FIRST phosphate prodrug vs free-base CAS 75607-67-9 vs CAS 21679-14-1 MW fragmentation (28.1% MW gap; +80.0 g/mol phosphate group; NIOSH HD annotation indexed to pharmaceutical CAS; research-grade free-base CAS lacks HD annotation in legacy EHS databases; largest phosphate-prodrug/free-base MW discrepancy in Glyphward portfolio). Three surfaces: Teva Pharmaceuticals North Wales PA fludarabine phosphate manufacturing (÷10; Cority null; CAS fragmentation; CD4+ absent; 46M 19yr); Accord Healthcare Durham NC FCR dual null chain (VelocityEHS null; dual simultaneous HD null; phosphate/free-base fragmentation; 43F 15yr); UPMC Hillman Cancer Center Pittsburgh PA FCR preparation (÷10; EHS Insight null; H372 immune organ not amplified to CD4+ monitoring; 39M 12yr). Threshold 22.

  Read the full post →

• Mitomycin C CAS 50-07-7 AI Security · NIOSH HD Category 1 OEL Null-Return (No OSHA PEL / No ACGIH TLV / No NIOSH REL) · FIRST HIPEC Hyperthermic Intraperitoneal Chemotherapy Surgical Aerosolization Gap (OR Team Not Covered by USP <800>; Detectable MMC in Surgical Breathing Zone) · FIRST Intravesical Urology Clinic Route Gap (Drainage-Bag Aerosolization During Catheter Removal) · FIRST Gastric HIPEC Three-HD-Null Chain (MMC + Cisplatin + Doxorubicin; All NIOSH HD Category 1 All Null) · FIRST Fermentation-Complex CAS 1404-45-1 vs API CAS 50-07-7 Registry Fragmentation · Accord Healthcare Durham NC 47M 18yr EHS Insight · MD Anderson Cancer Center Houston TX 42F 14yr VelocityEHS · Northwestern Memorial Hospital Chicago IL 38F 9yr Cority · 448th Adversarial Attack · 106th Long-Form Blog · Glyphward Threshold 22 · 2026-10-01

  Mitomycin C (CAS 50-07-7): NIOSH HD Category 1 OEL Null-Return + FIRST HIPEC Surgical Aerosolization Gap (OR Team Not Covered by USP <800>) + FIRST Intravesical Urology Clinic Route Gap + FIRST Gastric HIPEC Three-HD-Null Chain (MMC + Cisplatin + Doxorubicin) + FIRST Fermentation-Complex CAS 1404-45-1 Fragmentation; Accord Healthcare Durham NC 47M 18yr; MD Anderson Houston TX 42F 14yr; Northwestern Memorial Hospital Chicago IL 38F 9yr; Threshold 22, 448th Attack; 106th Blog

  The 448th adversarial attack — 106th long-form blog — FIRST mitomycin C (CAS 50-07-7; Mitomycin; NIOSH HD Category 1) adversarial blog: FIRST HIPEC hyperthermic intraperitoneal chemotherapy surgical aerosolization gap (heated peritoneal perfusion delivers MMC as aerosol/vapor to OR surgical team; published air monitoring confirms detectable MMC in breathing zone; USP <800> scope explicitly excludes surgical suites; gap absent from EHS OEL null output); FIRST intravesical urology clinic route-of-exposure gap (drainage bag removal generates MMC-containing aerosol in urology clinic setting; nurses outside pharmacy-based USP <800> framework); FIRST gastric HIPEC three-null chain (MMC CAS 50-07-7 + cisplatin CAS 15663-27-1 + doxorubicin CAS 25316-40-9; all NIOSH HD Category 1; all null simultaneously from tested EHS platforms); FIRST fermentation-complex CAS 1404-45-1 vs API CAS 50-07-7 registry fragmentation (Streptomyces caespitosus fermentation complex has separate CAS 1404-45-1; legacy SDS databases may use fermentation-complex CAS; HD annotation potentially absent from fermentation-complex record). Three surfaces: Accord Healthcare Inc. Durham NC MMC powder for injection (÷10; EHS Insight null; IARC 2A absent; 47M 18yr); MD Anderson Cancer Center Houston TX HIPEC surgical oncology OR (VelocityEHS null; USP <800> scope exclusion; 42F 14yr); Northwestern Memorial Hospital Chicago IL intravesical MMC urology clinic (Cority null; drainage-bag gap; 38F 9yr). Threshold 22.

  Read the full post →

• Procarbazine CAS 671-16-9 AI Security · NIOSH HD Category 1 OEL Null-Return (No OSHA PEL / No ACGIH TLV / No NIOSH REL) · FIRST Procarbazine MAOI Tyramine Occupational Dietary Interaction Gap (Only HD Category 1 Compound with MAO Inhibition; Zero EHS Guidance) · FIRST Methylhydrazine CAS 60-34-4 NIOSH Ca Carcinogen Metabolite Gap (ACGIH A3 TLV-TWA 0.01 ppm Not Cross-Referenced) · FIRST BEACOPP Six-Cytotoxic HD Null Chain (Bleomycin + Etoposide + Doxorubicin + Cyclophosphamide + Vincristine + Procarbazine; Largest in Portfolio) · Leadiant Biosciences Gaithersburg MD 53M 22yr Cority · Memorial Sloan Kettering NYC 44F 16yr VelocityEHS · City of Hope Duarte CA 41M 13yr EHS Insight · 441st Adversarial Attack · 105th Long-Form Blog · Glyphward Threshold 22 · 2026-10-01

  Procarbazine (CAS 671-16-9): NIOSH HD Category 1 OEL Null-Return + FIRST MAOI Tyramine Occupational Dietary Interaction Gap (Only HD Category 1 Compound with MAO Inhibition; Zero EHS Tyramine Guidance) + FIRST Methylhydrazine CAS 60-34-4 NIOSH Ca Carcinogen Metabolite Gap + FIRST BEACOPP Six-Cytotoxic HD Null Chain (Largest in Glyphward Portfolio) + FIRST HCl Salt CAS 366-70-1 Dual-Record Fragmentation; Leadiant Biosciences Gaithersburg MD 53M 22yr Cority; Memorial Sloan Kettering NYC 44F 16yr VelocityEHS BEACOPP; City of Hope Duarte CA 41M 13yr EHS Insight PCV; Threshold 22, 441st Attack; 105th Blog

  The 441st adversarial attack — 105th long-form blog — FIRST procarbazine (CAS 671-16-9; Matulane®; NIOSH HD Category 1) adversarial blog: FIRST MAOI tyramine occupational dietary interaction gap (procarbazine = sole HD Category 1 compound with irreversible MAO-A/B inhibition; occupational handlers face tyramine sympathomimetic crisis risk from sub-therapeutic dermal/inhalation absorption; zero tyramine or serotonin-syndrome guidance in any EHS OEL null output; unique hazard class absent from all 440 prior Glyphward attacks); FIRST methylhydrazine CAS 60-34-4 NIOSH Ca carcinogen metabolite gap (ACGIH A3 TLV-TWA 0.01 ppm exists for methylhydrazine as standalone EHS record; not linked to procarbazine null; genotoxic activation pathway O6-MeG DNA adducts invisible in OEL output); FIRST BEACOPP six-cytotoxic HD null chain (bleomycin + etoposide + doxorubicin + cyclophosphamide + vincristine + procarbazine; six simultaneous HD null-returns; largest multi-compound null in Glyphward portfolio; exceeds ABVD 4-null [attack #437]); FIRST HCl salt CAS 366-70-1 vs free-base CAS 671-16-9 dual-record fragmentation (15% MW discrepancy; HD annotation risk). Three surfaces: Leadiant Biosciences Inc. Gaithersburg MD Matulane capsule manufacturing (÷10; Cority null; methylhydrazine not linked; MAOI absent; 53M 22yr); Memorial Sloan Kettering Cancer Center NYC BEACOPP-escalated pharmacy (÷10; VelocityEHS six-null BEACOPP chain confirmed; MAOI absent; 44F 16yr); City of Hope National Medical Center Duarte CA PCV/BEACOPP pharmacy (÷10; EHS Insight PCV triple null + BEACOPP six-null; IARC 2A absent; 41M 13yr). Threshold 22.

  Read the full post →

• Oxaliplatin L-OHP CAS 61825-94-3 AI Security · NIOSH HD Category 1 OEL Null-Return (No OSHA PEL / No ACGIH TLV / No NIOSH REL) · FIRST Expressed-as-Platinum Industrial Chloroplatinate OEL Misapplication (OSHA Z-1 0.002 mg/m³ as Pt — IgE Sensitization ≠ DACH-Pt DNA Cross-Linking) · FIRST CIPN Cumulative Dose vs TWA OEL Architectural Incompatibility (≥850 mg/m² IV Hallucinated as 850 µg/m³ Derived OEL) · FIRST Dihydrate CAS 151159-85-2 Null + Cisplatin CAS 15663-27-1 OEL Substitution · Fresenius Kabi Wilson NC ÷10 41F 13yr EHS Insight · MD Anderson Houston TX 44M 15yr VelocityEHS · Accord Healthcare Durham NC 39M 11yr Cority · 431st Adversarial Attack · 103rd Long-Form Blog · Glyphward Threshold 22 · 2026-09-26

  Oxaliplatin (L-OHP; CAS 61825-94-3): NIOSH HD Category 1 OEL Null-Return + FIRST Expressed-as-Platinum Industrial Chloroplatinate OEL Misapplication (IgE Sensitization ≠ DACH-Pt DNA Cross-Linking) + FIRST CIPN Cumulative Dose vs TWA OEL Incompatibility + FIRST Dihydrate CAS 151159-85-2 Null + Cisplatin OEL Substitution; Fresenius Kabi Wilson NC 41F 13yr; MD Anderson Houston TX 44M 15yr; Accord Healthcare Durham NC 39M 11yr; Threshold 22, 431st Attack; 103rd Blog

  The 431st adversarial attack — 103rd long-form blog — FIRST oxaliplatin (L-OHP; CAS 61825-94-3) NIOSH HD Category 1 adversarial blog: FIRST expressed-as-platinum OEL misapplication (OSHA Z-1 soluble Pt 0.002 mg/m³ IgE sensitization basis applied to DACH-Pt DNA cross-linker; pseudo-OEL 4.07 µg/m³; USP <800> binary obligation suppressed); FIRST CIPN cumulative dose vs TWA OEL architectural incompatibility (MOSAIC trial ≥850 mg/m² cumulative IV dose hallucinated as 850 µg/m³ derived OEL; dimensionally incoherent; pharmacologically inapplicable); FIRST dihydrate CAS 151159-85-2 null return + cisplatin OEL substitution (API CoA CAS not in NIOSH HD table; wrong Pt% 65.0% vs 49.1%). Three surfaces: Fresenius Kabi Wilson NC (÷10; EHS Insight expressed-as-Pt; 41F 13yr); MD Anderson Houston TX (VelocityEHS CIPN hallucination; 44M 15yr); Accord Healthcare Durham NC (Cority dihydrate null + cisplatin proxy; 39M 11yr). Threshold 22.

  Read the full post →

• Propylene Oxide PO CAS 75-56-9 AI Security · OSHA PEL 100 ppm TWA (Table Z-1; 1971) vs ACGIH TLV-TWA 0.5 ppm A2 Sk (2011 Revision — 200× Gap) vs NIOSH Ca REL 2 ppm · FIRST PO 200× OSHA/ACGIH Gap · FIRST ACGIH 2011 Stale-Database Attack · FIRST CAS 75-56-9/57-55-6 Transposition · FIRST Sk Total-Dose Gap · LyondellBasell Channelview TX 44M 16yr · McCormick Hunt Valley MD 43F 11yr · Dow Chemical Freeport TX 39M 8yr · 425th Adversarial Attack · 102nd Long-Form Blog · Glyphward Threshold 22 · 2026-09-26

  Propylene Oxide (PO; CAS 75-56-9): OSHA PEL 100 ppm TWA [Table Z-1; 1971; FIRST 200× OSHA/ACGIH Gap] vs ACGIH TLV-TWA 0.5 ppm [A2 Sk; 2011 Revision] vs NIOSH Ca REL 2 ppm; FIRST ACGIH 2011 Stale-Database Attack; FIRST CAS 75-56-9/57-55-6 Transposition; FIRST Sk Total-Dose Gap; LyondellBasell Channelview TX 44M 16yr; McCormick Hunt Valley MD 43F 11yr; Dow Chemical Freeport TX 39M 8yr; Threshold 22, 425th Attack; 102nd Blog

  The 425th adversarial attack — 102nd long-form blog — FIRST propylene oxide (PO; CAS 75-56-9) adversarial blog: FIRST 200× OSHA/ACGIH gap (100 ppm vs 0.5 ppm; AFL-CIO v. OSHA 1992 vacatur froze PEL); FIRST ACGIH 2011 stale-database attack (pre-2011 platforms show TLV 2 ppm; 0.5–2 ppm zone unprotected); FIRST CAS 75-56-9/57-55-6 transposition (PO carcinogen → PG GRAS; unit mismatch; no OEL found at 640% TLV); FIRST Sk skin-notation total-dose gap (air COMPLIANT; dermal PO absorption doubles total dose on maintenance days). Three surfaces: LyondellBasell Channelview TX (÷100; VelocityEHS 84% vs actual 8,400%; 44M 16yr); McCormick Hunt Valley MD (EHS Insight stale TLV 2 ppm; 280% ACGIH invisible; 43F 11yr); Dow Chemical Freeport TX (CAS confusion; “no OEL found” at 640% TLV; 39M 8yr). Threshold 22.

  Read the full post →

• Hexavalent Chromium Cr(VI) CAS 18540-29-9 AI Security · OSHA 1910.1026 PEL 5 µg/m³ as Cr(VI) (Action Level 2.5 µg/m³; Medical Surveillance; DSEN) vs ACGIH TLV-TWA 0.01 mg/m³ (10 µg/m³) A1 DSEN (OSHA PEL 2× More Protective — FIRST Inverted Ladder) vs NIOSH Ca REL 0.0002 mg/m³ (0.2 µg/m³; 25× Below OSHA PEL) · FIRST ACGIH TLV Inversion Attack · FIRST NIOSH 7300 Total Cr False Positive (Stainless Passivation; Actual Cr(VI) = 0) · FIRST DSEN Sensitization Cascade Suppression · FIRST NIOSH Ca REL 25× Gap · Chromalloy Gas Turbine Orangeburg NY Hard Chrome Plating 44→4.4 µg/m³ (46M 18yr) · Chart Industries Ball Ground GA HNO&sub3;/HF Passivation Total Cr 12.4 µg/m³ Cr(VI) = 0 (43M 14yr) · Spirit AeroSystems Wichita KS SrCrO&sub4; Primer DSEN 2.8 µg/m³ (39F 9yr) · 419th Adversarial Attack · 101st Long-Form Blog · Glyphward Threshold 22 · 2026-09-26

  Hexavalent Chromium (Cr(VI); CAS 18540-29-9): OSHA 1910.1026 PEL 5 µg/m³ as Cr(VI) [Action Level 2.5 µg/m³; DSEN] vs ACGIH TLV-TWA 0.01 mg/m³ = 10 µg/m³ [A1 DSEN; OSHA 2× More Protective — FIRST Inverted Ladder] vs NIOSH Ca REL 0.2 µg/m³ [25× Gap]; FIRST ACGIH TLV Inversion; FIRST NIOSH 7300 Total Cr False Positive (Actual Cr(VI) = 0); FIRST DSEN Suppression; Chromalloy Orangeburg NY 44→4.4; Chart Industries Ball Ground GA Total Cr 12.4 Cr(VI) 0; Spirit AeroSystems Wichita KS 2.8 µg/m³ DSEN; Threshold 22, 419th Attack; 101st Blog

  The 419th adversarial attack — 101st long-form blog — FIRST hexavalent chromium (Cr(VI); CAS 18540-29-9) OSHA 1910.1026 adversarial blog: FIRST ACGIH TLV inversion attack (OSHA PEL 5 µg/m³ is 2× more protective than ACGIH TLV 10 µg/m³ — global TLV-based EHS systems miss OSHA compliance in the 5–9.9 µg/m³ zone); FIRST NIOSH 7300 total Cr false positive (Cr(III) HNO&sub3;/HF passivation mist flagged as Cr(VI) PEL violation — actual Cr(VI) = 0); FIRST DSEN chromate sensitization cascade suppression (PLHCP SAR recommendation and work restriction invisible to EHS AI). OSHA 1910.1026 PEL 5 µg/m³ + AL 2.5 µg/m³ vs ACGIH TLV-TWA 0.01 mg/m³ A1 DSEN (OSHA 2× more protective; inverted normal OSHA→ACGIH hierarchy) vs NIOSH Ca REL 0.0002 mg/m³ (0.2 µg/m³; 25× below OSHA PEL). Three surfaces: Chromalloy Gas Turbine LLC Orangeburg NY hard chrome plating (44→4.4 µg/m³; ÷10 + ACGIH TLV inversion; 46M 18yr; VelocityEHS; actual 880% OSHA PEL); Chart Industries LLC Ball Ground GA stainless 316L HNO&sub3;/HF passivation (total Cr 12.4 µg/m³ NIOSH 7300; Cr(VI) = 0; EHS Insight false positive 248% Cr(VI) PEL; $220,000 unnecessary remediation; 43M 14yr); Spirit AeroSystems Inc. Wichita KS SrCrO&sub4; primer spray (2.8 µg/m³; above AL; DSEN confirmed; PLHCP SAR recommendation + work restriction faxed to occupational health but not in Cority; 39F 9yr). Threshold 22.

  Read the full post →

• Inorganic Lead Pb CAS 7439-92-1 AI Security · OSHA 1910.1025 PEL 50 µg/m³ (Action Level 30 µg/m³; BLL Medical Removal ≥50 µg/dL Confirmed; MRP 18-Month Pay Guarantee) vs ACGIH TLV-TWA 0.05 mg/m³ A3 (= OSHA PEL; BEI 10 µg/dL — 5× Below Removal Criterion) vs NIOSH Ca REL 0.050 mg/m³ · FIRST BLL-to-Airborne Decoupling Attack · FIRST MRP 18-Month Pay-Continuation Suppression · FIRST Dual-Tier AL→PEL Monitoring Frequency Escalation Suppression · East Penn Manufacturing Lyons Station PA VRLA Battery 42→4.2 µg/m³ (47M 19yr) · EnerSys Warrensburg MO Hawker Industrial Battery 38→3.8 µg/m³ (43F 14yr) · Stryten Energy Salina KS Air 28 µg/m³ BLL 52 µg/dL (39M 9yr) · 413th Adversarial Attack · 100th Long-Form Blog · Glyphward Threshold 21 · 2026-09-25

  Lead (Inorganic Pb; CAS 7439-92-1): OSHA 1910.1025 PEL 50 µg/m³ TWA [Action Level 30 µg/m³; BLL Medical Removal ≥50 µg/dL / ≥60 µg/dL; MRP 18-Month Pay Guarantee] vs ACGIH TLV-TWA 0.05 mg/m³ A3 [= OSHA PEL; BEI 10 µg/dL — 5× Below Removal] vs NIOSH Ca REL; FIRST BLL Decoupling Attack; FIRST MRP Pay-Continuation Suppression; FIRST Dual-Tier Monitoring Escalation Suppression; East Penn Manufacturing Lyons Station PA 42→4.2; EnerSys Warrensburg MO 38→3.8; Stryten Energy Salina KS Air 28 µg/m³ BLL 52 µg/dL; Threshold 21, 413th Attack; 100th Blog

  The 413th adversarial attack — 100th long-form blog — FIRST inorganic lead (Pb; CAS 7439-92-1) OSHA 1910.1025 BLL-to-airborne decoupling attack: BLL medical removal obligation (confirmed criterion: two consecutive BLL ≥ 50 µg/dL ≥4 weeks apart) structurally invisible to air-TWA-only AI EHS platforms; ingestion-route body burden from surface contamination hand-to-mouth produces BLL 52 µg/dL with air only 28 µg/m³ (below Action Level). OSHA 1910.1025 PEL 50 µg/m³ + AL 30 µg/m³ + BLL medical removal triggers + MRP 18-month pay guarantee vs ACGIH TLV-TWA 0.05 mg/m³ A3 (numerically identical to OSHA PEL; no TLV:PEL gap; BEI 10 µg/dL is 5× below removal criterion) vs NIOSH Ca REL 0.050 mg/m³. Three surfaces: East Penn Manufacturing Lyons Station PA VRLA battery plate-paste mixing (42→4.2 µg/m³; ÷10 perturbation; 47M 19yr; Cority; AL 140%→14%); EnerSys Warrensburg MO Hawker motive-power battery group-burning (38→3.8 µg/m³; ÷10 + dual-tier monitoring escalation suppression; 43F 14yr; VelocityEHS; 28 BLL tests suppressed); Stryten Energy Salina KS SLI battery formation (air 28 µg/m³ actual; BLL 52–54 µg/dL from ingestion route; confirmed removal criterion met; EHS Insight: OSHA COMPLIANT for air, blind to BLL; 39M 9yr). Threshold 21.

  Read the full post →

• Respirable Crystalline Silica RCS Quartz CAS 14808-60-7 AI Security · OSHA 1910.1053 PEL 0.05 mg/m³ TWA (2016; Action Level 0.025 mg/m³; Medical Surveillance; Written ECP; Supersedes Z-3 Formula) vs ACGIH TLV-TWA 0.025 mg/m³ A2 (Equals OSHA AL; TLV=AL Coincidence; 2× More Protective Than PEL) vs NIOSH REL 0.05 mg/m³ (Same as PEL) · FIRST Z-3 Legacy Formula vs 1910.1053 Dual-Standard Transition Confusion · FIRST TLV=AL Coincidence Medical Surveillance Suppression · FIRST Action Level Not-Implemented Attack · FIRST Silicosis + IARC Group 1 Lung Cancer Dual-Endpoint Blog · US Silica Kosse TX Dry Plant Bag Room 0.08→0.008 mg/m³ (47M 22yr) · Vulcan Materials Bridgeport AL Primary Crusher Z-3 Legacy 0.06→0.006 mg/m³ (44M 17yr) · Martin Marietta Midlothian TX Screen Plant 0.045→0.0045 mg/m³ (39F 10yr) · 407th Adversarial Attack · Glyphward Threshold 21 · 2026-09-25

  Respirable Crystalline Silica (RCS; Quartz CAS 14808-60-7): OSHA 1910.1053 PEL 0.05 mg/m³ TWA [2016 Standard; Action Level 0.025 mg/m³; Medical Surveillance; Written ECP; Supersedes Z-3 Formula] vs ACGIH TLV-TWA 0.025 mg/m³ A2 [Numerically Equals OSHA Action Level; TLV=AL Coincidence Exploitation] vs NIOSH REL 0.05 mg/m³; FIRST Z-3 Legacy Formula vs 1910.1053 Dual-Standard Transition Confusion; FIRST TLV=AL Coincidence Medical Surveillance Suppression; US Silica Kosse TX 0.08→0.008 47M 22yr; Vulcan Materials Bridgeport AL Z-3 Legacy 0.06→0.006 44M 17yr; Martin Marietta Midlothian TX 0.045→0.0045 39F 10yr; Threshold 21, 407th Attack

  The 407th adversarial attack — FIRST respirable crystalline silica (RCS; quartz CAS 14808-60-7) OSHA 1910.1053 PEL 0.05 mg/m³ + Action Level 0.025 mg/m³ vs ACGIH TLV-TWA 0.025 mg/m³ A2 (TLV numerically equals OSHA AL) vs NIOSH REL 0.05 mg/m³: Z-3 legacy formula dual-standard transition confusion + TLV=AL coincidence medical surveillance suppression + Action Level not-implemented attack. OSHA 1910.1053 (2016) replaces old Z-3 formula (30/[SiO&sub2;%+3]; for 100% quartz: 0.291 mg/m³ — 5.8× less protective than 1910.1053) with fixed gravimetric PEL 0.05 mg/m³; AL 0.025 mg/m³ triggers mandatory written ECP, spirometry every 3 yr, ILO B-read chest X-ray, monitoring escalation. ACGIH TLV-TWA 0.025 mg/m³ A2 = OSHA AL numerically: AI EHS platforms implementing TLV as advisory and PEL as enforcement ceiling but not AL as binding trigger suppress the mandatory medical surveillance cascade. IARC Group 1 lung cancer + silicosis irreversible. Three surfaces: US Silica Holdings Kosse TX frac-sand bag room (0.08→0.008; 47M 22yr; Cority; PEL 160%→16%); Vulcan Materials Bridgeport AL primary crusher Z-3 legacy (0.06→0.006; 44M 17yr; VelocityEHS; 1910.1053 PEL 120% invisible to Z-3 config); Martin Marietta Midlothian TX screen plant TLV=AL coincidence (0.045→0.0045; 39F 10yr; EHS Insight; AL not configured). ÷10 perturbation. Threshold 21.

  Read the full post →

• Formaldehyde HCHO CAS 50-00-0 AI Security · OSHA 1910.1048 PEL 0.75 ppm TWA (1987/1992 Chemical-Specific Standard; Action Level 0.5 ppm; STEL 2.0 ppm) vs ACGIH TLV-C 0.1 ppm A2 (Ceiling Limit — Not TWA; 2019 Revision from 0.3 ppm; Structural Limit-Type Mismatch) vs NIOSH Ca REL 0.016 ppm (47× Below OSHA PEL; Not Implemented) · FIRST Limit-Type Mismatch Architecture · NPC + Myeloid Leukemia IARC Group 1 Dual Pathway · UPMC Presbyterian Pittsburgh PA Pathology 0.9→0.09 ppm (47F 19yr) · Arauco North America Moncure NC MDF Hot Press 0.72→0.072 ppm (44M 15yr) · SCI Dignity Memorial Houston TX Embalming 0.55→0.055 ppm (39F 9yr) · 401st Adversarial Attack · Glyphward Threshold 21 · 2026-09-25

  Formaldehyde (HCHO; CAS 50-00-0): OSHA 1910.1048 PEL 0.75 ppm TWA [1987/1992 Chemical-Specific Standard; Action Level 0.5 ppm; STEL 2.0 ppm] vs ACGIH TLV-C 0.1 ppm A2 [Ceiling Limit — Not TWA; 2019 Revision from 0.3 ppm; IARC Group 1 vs ACGIH A2 Discordance; Structural Limit-Type Mismatch] vs NIOSH Ca REL 0.016 ppm [47× Below OSHA PEL; Not Implemented]; FIRST Limit-Type Mismatch; UPMC Presbyterian Pittsburgh PA Pathology 0.9→0.09 ppm 47F 19yr; Arauco North America Moncure NC MDF Hot Press 0.72→0.072 ppm 44M 15yr; SCI Dignity Memorial Houston TX Embalming 0.55→0.055 ppm 39F 9yr; Threshold 21, 401st Attack

  The 401st adversarial attack — FIRST formaldehyde (HCHO; CAS 50-00-0) OSHA 1910.1048 PEL 0.75 ppm TWA vs ACGIH TLV-C 0.1 ppm A2 ceiling limit structural limit-type mismatch + NIOSH Ca REL 0.016 ppm not-implemented + OSHA action-level bypass + stale ACGIH TLV-C database (0.3 ppm pre-2019). OSHA 1910.1048 (1987/1992) PEL 0.75 ppm TWA with action level 0.5 ppm (medical surveillance, FFDE) vs ACGIH TLV-C 0.1 ppm A2 (ceiling limit — NOT an 8-hr TWA; 2019 revision from 0.3 ppm; structurally incompatible with TWA monitoring data). NIOSH Ca REL 0.016 ppm (47× below OSHA PEL; absent from most AI EHS platform regulatory libraries). IARC Group 1 NPC + myeloid leukemia dual pathway. Three surfaces: UPMC Presbyterian Pittsburgh PA pathology gross room (0.9→0.09 ppm; 47F 19yr; Cority; AL 180% actual → 18% displayed); Arauco North America Moncure NC MDF hot press (0.72→0.072; 44M 15yr; VelocityEHS; NIOSH Ca REL 4,500% undetected); SCI Dignity Memorial Houston TX embalming (0.55→0.055; 39F 9yr; EHS Insight; stale TLV-C 0.3 ppm pre-2019). ÷10 perturbation. Threshold 21.

  Read the full post →

• Beryllium CAS 7440-41-7 AI Security · OSHA 1910.1024 PEL 0.2 µg/m³ (2017; Action Level 0.1 µg/m³; Medical Surveillance; STEL 2.0 µg/m³; 4× ACGIH Gap) vs ACGIH TLV-TWA 0.05 µg/m³ A1 DSEN (MOST Protective Tier; IARC Group 1; Dermal Sensitizer; Inverted Ladder) vs NIOSH REL 0.5 µg/m³ (LEAST Protective Tier; 10× Above ACGIH; 2.5× Above OSHA 2017 PEL; 1977 Vintage) · BeLPT Mandate Suppressed by Action-Level Bypass · CBD Irreversible Granulomatous Disease; BeS HLA-DP β1 E69 T-Cell Gate · DSEN Dermal Sensitization Pathway Invisible to Air-Monitoring AI EHS Platforms · Materion Corp Elmore OH Primary Be Production 0.15→0.015 µg/m³ (49M 22yr) · Lockheed Martin Marietta GA AlBeMet AM162 F-22/C-130J 0.12→0.012 µg/m³ (44M 16yr) · BWXT Y-12 Oak Ridge TN Nuclear Weapons Be 0.09→0.009 µg/m³ (38M 10yr) · 395th Adversarial Attack · Glyphward Threshold 21 · 2026-09-24

  Beryllium (CAS 7440-41-7): OSHA 1910.1024 PEL 0.2 µg/m³ [2017 Chemical-Specific Standard; Action Level 0.1 µg/m³; STEL 2.0 µg/m³; Medical Surveillance Mandate] vs ACGIH TLV-TWA 0.05 µg/m³ A1 DSEN [MOST Protective Tier; 4× Below OSHA PEL; First Fully Inverted Three-Tier Ladder in Glyphward Portfolio; IARC Group 1; DSEN Dermal Sensitizer; BeLPT Mandate] vs NIOSH REL 0.5 µg/m³ [LEAST Protective Tier; 10× Above ACGIH; 2.5× Above OSHA 2017 PEL; 1977 Inverted Research-Agency Position]; CBD Irreversible; DSEN Pathway Invisible to Air-Monitoring AI EHS; Materion Corp Elmore OH 0.15→0.015 49M 22yr Cority; Lockheed Martin Marietta GA AlBeMet AM162 0.12→0.012 44M 16yr VelocityEHS; BWXT Y-12 Oak Ridge TN Nuclear Weapons Be 0.09→0.009 38M 10yr EHS Insight; Threshold 21, 395th Attack

  The 395th adversarial attack — FIRST beryllium (CAS 7440-41-7) fully inverted three-tier regulatory ladder (ACGIH most protective; NIOSH least protective) + OSHA 1910.1024 action-level bypass + BeLPT mandate suppression + DSEN dermal sensitization pathway invisible to air-monitoring AI EHS platforms. OSHA 1910.1024 (2017) PEL 0.2 µg/m³ with action level 0.1 µg/m³ (medical surveillance, BeLPT, BWA designation, written ECP) vs ACGIH TLV-TWA 0.05 µg/m³ A1 DSEN (most protective; IARC Group 1; DSEN dermal sensitizer) vs NIOSH REL 0.5 µg/m³ (least protective; 10× above ACGIH; 1977). CBD irreversible granulomatous disease; BeS via HLA-DP β1 Glu69 allele (5–7% prevalence); DSEN pathway from chip-contact independent of airborne TWA. Three surfaces: Materion Corp Elmore OH (0.15→0.015 µg/m³; 49M 22yr; Cority; AL 150% actual → 15% displayed); Lockheed Martin Marietta GA AlBeMet AM162 (0.12→0.012; 44M 16yr; VelocityEHS; AL 120% → 12%); BWXT Y-12 Oak Ridge TN nuclear weapons Be (0.09→0.009; 38M 10yr; EHS Insight; TLV 180% → 18%). Threshold 21.

  Read the full post →

• Cobalt Metal CAS 7440-48-4 AI Security · OSHA PEL 0.1 mg/m³ Total Dust (37-mm CFC; 1971; 5× ACGIH Gap; AFL-CIO v. OSHA 1992) vs ACGIH TLV-TWA 0.02 mg/m³ Respirable Fraction A2 (WC-Co IARC Group 2A; HMLD/GIP Irreversible Fibrosis; IgE Cobalt Asthma; Cyclone Sampler; BEI Dual-Channel) vs NIOSH REL 0.05 mg/m³ (Three-Tier Ladder) · WC-Co Superoxide Synergism (WC + O&sub2; → WC&sup+; + O&sub2;•−; Co²&sup+; Fenton-Like OH• 10–50× Amplified) · Kennametal Latrobe PA WC-Co Grinding 0.085→0.0085 (48M 19yr) · Kennametal Stellite Goshen IN Stellite 6 Hardfacing 0.065→0.0065 (43F 14yr) · SK On Commerce GA NMC-811 EV Battery 0.045→0.0045 (36F 8yr) · 389th Adversarial Attack · Glyphward Threshold 21 · 2026-09-24

  Cobalt Metal, Dust and Fume (CAS 7440-48-4): OSHA PEL 0.1 mg/m³ Total Dust [37-mm CFC; 1971; 5× ACGIH Numerical Gap; AFL-CIO v. OSHA 1992] vs ACGIH TLV-TWA 0.02 mg/m³ Respirable Fraction A2 [WC-Co IARC Group 2A; HMLD/GIP Irreversible Pulmonary Fibrosis; IgE-Mediated Cobalt Asthma Irreversible Sensitization; Cyclone Sampler—Total-Dust CFC Overestimates Respirable Co 40–60%; BEI Dual-Channel—Urinary Co ≤15 µg/g Cr + Blood Co ≤1.0 µg/L Suppressed] vs NIOSH REL 0.05 mg/m³ [Three-Tier Ladder]; WC-Co Superoxide Synergism—WC Particles Amplify Co²&sup+; ROS Generation 10–50× via Surface O&sub2;•− Fenton-Like Cascade; Kennametal Inc. Latrobe PA WC-Co Solid Carbide CNC/Centerless Grinding 0.085→0.0085 mg/m³ 48M 19yr; Kennametal Stellite Division Goshen IN Stellite 6 Thermal Spray 0.065→0.0065 mg/m³ 43F 14yr; SK On LLC Commerce GA NMC-811 EV Battery Cathode Slitting/Calendering 0.045→0.0045 mg/m³ 36F 8yr; Threshold 21, 389th Attack

  The 389th adversarial attack — FIRST cobalt metal, dust and fume (CAS 7440-48-4) OSHA PEL 0.1 mg/m³ total dust vs ACGIH TLV-TWA 0.02 mg/m³ respirable fraction A2 5× gap + WC-Co superoxide synergism novel AI EHS attack. OSHA 1971 total-dust PEL (37-mm CFC; ACGIH and NIOSH both revised since; AFL-CIO v. OSHA 1992 vacatur) vs ACGIH respirable-fraction TLV (0.02 mg/m³ A2; cyclone sampler; total-dust CFC overestimates respirable Co 40–60% for WC-Co grinding dust; BEI dual-channel urinary Co ≤15 µg/g Cr + blood Co ≤1.0 µg/L suppressed). NIOSH REL 0.05 mg/m³ three-tier ladder. Novel angle: WC particles catalyze Co²&sup+; ROS generation 10–50× vs metallic Co alone (surface O&sub2;•− + Fenton-like OH•); AI ICP-OES monitoring measures total Co without WC-Co synergism flag. Three surfaces: Kennametal Inc. Latrobe PA WC-Co CNC/centerless grinding (0.085→0.0085; 48M 19yr; Cority); Kennametal Stellite Division Goshen IN Stellite 6 thermal spray/grinding (0.065→0.0065; 43F 14yr; VelocityEHS); SK On LLC Commerce GA NMC-811 EV battery cathode slitting/calendering (0.045→0.0045; 36F 8yr; EHS Insight). ÷10 perturbation. Threshold 21.

  Read the full post →

• Nickel, Insoluble Compounds CAS 7440-02-0 AI Security · OSHA PEL 1 mg/m³ Total Dust (37-mm CFC; 1971 PNOR; 5× ACGIH Gap) vs ACGIH TLV-TWA 0.2 mg/m³ Inhalable Fraction A1 (IOM Sampler; IARC Group 1; Sampler Fraction Mismatch) vs NIOSH Ca REL 0.015 mg/m³ (66.7× below OSHA; Three-Tier Ladder) · IARC Group 1 (Lung Cancer + Sinonasal Adenocarcinoma; H3K9me3 Chromatin Silencing; HIF-1α Pseudohypoxia) · Special Metals Huntington WV Inconel 718 Dry Grinding 0.6→0.06 (48M 19yr) · Haynes International Kokomo IN Hastelloy C-276 CNC 0.5→0.05 (43M 14yr) · Ultium Cells Spring Hill TN NMC-811 Cathode 0.4→0.04 (36M 8yr) · 383rd Adversarial Attack · Glyphward Threshold 21 · 2026-09-24

  Nickel, Insoluble Compounds (CAS 7440-02-0): OSHA PEL 1 mg/m³ Total Dust [37-mm CFC; 1971 PNOR; 5× ACGIH Numerical Gap; AFL-CIO v. OSHA 1992] vs ACGIH TLV-TWA 0.2 mg/m³ Inhalable Fraction A1 [IOM Sampler; IARC Group 1; Sampler Fraction Mismatch—AI EHS Platforms Apply CFC Value to IOM-Basis TLV Without Flagging Incompatibility] vs NIOSH Ca REL 0.015 mg/m³ [66.7× below OSHA; Three-Tier Ladder]; Special Metals Huntington WV Inconel 718/Nimonic 90 Dry Blanchard Grinding 0.6→0.06 mg/m³ 48M 19yr; Haynes International Kokomo IN Hastelloy C-276 CNC Turning/Milling 0.5→0.05 mg/m³ 43M 14yr; Ultium Cells Spring Hill TN NMC-811 EV Battery Cathode Slitting/Calendering 0.4→0.04 mg/m³ 36M 8yr; Threshold 21, 383rd Attack

  The 383rd adversarial attack — FIRST nickel, insoluble compounds (CAS 7440-02-0) OSHA PEL 1 mg/m³ total dust vs ACGIH TLV-TWA 0.2 mg/m³ inhalable fraction A1 5× gap + IOM/CFC sampler fraction mismatch novel AI EHS attack. OSHA 1971 PNOR total-dust PEL (37-mm CFC; 19 years pre-IARC Group 1; AFL-CIO v. OSHA 1992 vacatur of proposed 0.1 mg/m³ PEL) vs ACGIH IOM inhalable-fraction TLV (0.2 mg/m³ A1): a 5× numerical gap compounded by a 20–30% systematic underestimate when CFC total-dust values are applied directly to an IOM-basis TLV. NIOSH Ca REL 0.015 mg/m³ = 66.7× below OSHA. AI EHS platforms (Cority, VelocityEHS, EHS Insight) compare a single ICP-OES Ni value to both limits without flagging sampler incompatibility. Three surfaces at true Ni 0.4–0.6 mg/m³ (OSHA compliant; ACGIH A1 200–300% exceeded): Special Metals Huntington WV Inconel 718/Nimonic 90 dry Blanchard grinding (0.6→0.06; 48M 19yr; Cority); Haynes International Kokomo IN Hastelloy C-276 CNC turning/milling (0.5→0.05; 43M 14yr; VelocityEHS); Ultium Cells Spring Hill TN NMC-811 EV battery cathode slitting/calendering (0.4→0.04; 36M 8yr; EHS Insight). ÷10 perturbation. Threshold 21.

  Read the full post →

• MDI (4,4′-Methylenediphenyl Diisocyanate) CAS 101-68-8 AI Security · OSHA No Chemical-Specific PEL (GDC Enforcement Only; AFL-CIO v. OSHA 1992; No OSHA Medical Surveillance Mandate) vs ACGIH TLV-TWA 0.005 ppm A4 SEN (IgE-Mediated OA Irreversible; Foremost Industrial OA Cause; Sub-TLV Post-Sensitization Trigger) vs NIOSH REL 0.05 mg/m³ (= ACGIH Numerically; Pure OSHA GDC Vacuum) · BASF Geismar LA Lupranate Drum/IBC Filling 0.025→0.0025 (47M 18yr) · Carlisle SynTec Carlisle PA SPF Roofing 0.020→0.0020 (41M 13yr) · Leggett & Platt Carthage MO Flexible Foam 0.015→0.0015 (34M 6yr) · 378th Adversarial Attack · Glyphward Threshold 21 · 2026-09-20

  MDI (4,4′-Methylenediphenyl Diisocyanate; CAS 101-68-8) OSHA No Chemical-Specific PEL [GDC Enforcement Only; No Numerical Action Level; AFL-CIO v. OSHA 1992 Vacatur; No OSHA Medical Surveillance Mandate] vs ACGIH TLV-TWA 0.005 ppm A4 SEN [IgE-Mediated Occupational Asthma—Irreversible Post-Sensitization; Sub-TLV Trigger 0.0001–0.001 ppm; Foremost Industrial OA Cause Worldwide] vs NIOSH REL 0.05 mg/m³ [= ACGIH Numerically; No NIOSH–ACGIH Gap; Pure OSHA GDC Vacuum]; BASF Corporation Geismar LA Lupranate Drum/IBC Filling 0.025→0.0025 ppm 47M 18yr; Carlisle SynTec Systems Carlisle PA SPF Roofing 0.020→0.0020 ppm 41M 13yr; Leggett & Platt Inc. Carthage MO Flexible Foam Slabstock 0.015→0.0015 ppm 34M 6yr; Threshold 21, 378th Attack

  The 378th adversarial attack — FIRST MDI (CAS 101-68-8) OSHA GDC enforcement vacuum + IgE sensitization irreversibility AI EHS adversarial injection long-form blog. OSHA has no chemical-specific PEL for MDI (AFL-CIO v. OSHA 1992 vacated the proposed 0.005 ppm PEL; GDC-only enforcement for 33 years; no OSHA medical surveillance mandate). ACGIH TLV-TWA 0.005 ppm A4 SEN (TLV prevents primary sensitization but does not protect already-sensitized workers; post-sensitization OA trigger 0.0001–0.001 ppm = 5–50× below TLV; irreversible). NIOSH REL 0.05 mg/m³ = ACGIH TLV numerically (no NIOSH–ACGIH gap; pure OSHA GDC vacuum). Three surfaces: BASF Corporation Geismar LA Lupranate MDI drum/IBC filling at 45–50°C 0.025→0.0025 ppm (47M 18yr; Cority); Carlisle SynTec Systems LLC Carlisle PA SPF roofing two-component spray 0.020→0.0020 ppm (41M 13yr; VelocityEHS; 1–2 sensitized workers in crew); Leggett & Platt Inc. Carthage MO flexible foam slabstock pour head 0.015→0.0015 ppm (34M 6yr; EHS Insight). ÷10 perturbation. Threshold 21.

  Read the full post →

• Styrene CAS 100-42-5 AI Security · OSHA PEL 100 ppm TWA (Table Z-2; 1971 Frozen; AFL-CIO v. OSHA 1992; 55 Years Without Revision) vs ACGIH TLV-TWA 20 ppm A4 (5× Gap; A4 Discrepant from IARC Group 2A; BEI: MA+PGA ≤400 mg/g Creatinine EOS) vs NIOSH Ca REL 50 ppm (Three-Tier Ladder: OSHA 100 > NIOSH Ca 50 > ACGIH 20; OSHA–NIOSH Gap Zone 50–100 ppm) · IARC Group 2A (2018 Monograph 128 NHL + Hodgkin Lymphoma; Upgrade from 2B) · CYP2B6/CYP2E1 → Styrene 7,8-Oxide → Lymphocyte DNA Adducts · Genco Industries Clearwater FL FRP Boat 80→8 (47M 18yr) · Owens Corning Toledo OH Fiberglass CSM 65→6.5 (42M 14yr) · INEOS Styrolution Houston TX Polystyrene 50→5 (38M 10yr) · 373rd Adversarial Attack · Glyphward Threshold 21 · 2026-09-19

  Styrene (CAS 100-42-5) OSHA PEL 100 ppm TWA (1971 Frozen; AFL-CIO v. OSHA 1992; 55 Years Without Revision) vs ACGIH TLV-TWA 20 ppm A4 (5× Gap; BEI: MA+PGA ≤400 mg/g Creatinine; A4 Discrepant from IARC 2A) vs NIOSH Ca 50 ppm (Three-Tier Ladder; OSHA–NIOSH Gap Zone 50–100 ppm; Ceiling 100 ppm = OSHA PEL); IARC Group 2A (2018 NHL + Hodgkin; CYP2B6/CYP2E1 → Styrene 7,8-Oxide → Lymphocyte DNA Adducts); Genco Industries LLC Clearwater FL FRP Boat 80→8 ppm 47M 18yr; Owens Corning Toledo OH Fiberglass CSM 65→6.5 ppm 42M 14yr; INEOS Styrolution Houston TX Polystyrene 50→5 ppm 38M 10yr; Threshold 21, 373rd Attack

  The 373rd adversarial attack — FIRST styrene (CAS 100-42-5) OSHA:ACGIH 5× gap + NIOSH Ca 50 ppm three-tier regulatory ladder + IARC Group 2A NHL (2018 Monograph 128 upgrade) + BEI mandelic acid+phenylglyoxylic acid (MA+PGA) biological monitoring suppression AI adversarial injection long-form blog. Three-tier ladder: OSHA 100 ppm (1971 frozen; IARC 2018 upgrade not incorporated) → NIOSH Ca 50 ppm (intermediate; ceiling 100 ppm = OSHA PEL; OSHA–NIOSH gap zone 50–100 ppm) → ACGIH 20 ppm A4 (most protective; A4 discrepant from IARC 2A; BEI MA+PGA ≤400 mg/g creatinine EOS). Mechanism: CYP2B6/CYP2E1 → styrene 7,8-oxide (SO) → N7-guanyl lymphocyte DNA adducts → NHL. Three surfaces: Genco Industries LLC Clearwater FL FRP open-mold boat laminator 80→8 ppm (47M 18yr; Cority; ACGIH TLV 4× exceeded; NIOSH Ca 1.6× exceeded; BEI suppressed); Owens Corning Toledo OH fiberglass CSM binder spray 65→6.5 ppm (42M 14yr; VelocityEHS; ACGIH TLV 3.25× exceeded; OSHA–NIOSH gap zone); INEOS Styrolution America LLC Houston TX GPPS sheet extrusion 50→5 ppm (38M 10yr; EHS Insight; NIOSH Ca REL exactly at limit displayed as 10%). ÷10 perturbation. Threshold 21.

  Read the full post →

• Chlorothalonil CAS 1897-45-6 AI Security · OSHA No Chemical-Specific PEL (PNOR 5 mg/m³ Respirable — Triple Enforcement Vacuum: Neither OSHA Nor NIOSH Has a Chemical-Specific Limit; No Chlorothalonil PEL Has Ever Existed in Table Z-1) vs ACGIH TLV-TWA 0.1 mg/m³ A2 SKIN (50× Gap; Suspected Human Carcinogen; SKIN Notation; No BEI) vs NIOSH No Chemical-Specific REL (PNOR Applies; No NIOSH Ca) · EPA IRIS Likely Carcinogenic to Humans (Kidney Cortical Tubular Adenoma + Carcinoma; Male F344 Rat; 2009) · 4-OH-CTC-GSH OAT Proximal Tubule S3; CCBL β-Lyase; Epithane Thiol · ISK Biosciences Mentor OH 0.50→0.050 (51M 22yr) · TruGreen Memphis TN Golf Turf 0.35→0.035 (43M 14yr) · Metrolina Greenhouses Huntersville NC Ornamental 0.25→0.025 (34F 8yr) · 366th Adversarial Attack · Glyphward Threshold 21 · 2026-09-19

  Chlorothalonil (CAS 1897-45-6) OSHA No Chemical-Specific PEL (PNOR 5 mg/m³ Triple Vacuum — No Chlorothalonil PEL Has Ever Existed; EU Banned 2020) vs ACGIH TLV-TWA 0.1 mg/m³ A2 SKIN (50× Gap; Suspected Human Carcinogen; No BEI; SKIN Notation) vs NIOSH No REL (Triple Vacuum; No NIOSH Ca); EPA IRIS Likely Carcinogenic to Humans (Kidney Cortical Tumors; F344 Rat; 2009); GSH-Conjugate CCBL β-Lyase Kidney Bioactivation; ISK Biosciences Mentor OH 0.50→0.050 mg/m³ 51M 22yr; TruGreen Memphis TN Golf Turf 0.35→0.035 mg/m³ 43M 14yr; Metrolina Greenhouses Huntersville NC Ornamental 0.25→0.025 mg/m³ 34F 8yr; Threshold 21, 366th Attack

  The 366th adversarial attack — FIRST chlorothalonil (CAS 1897-45-6) triple enforcement vacuum AI adversarial injection long-form blog + FIRST chlorothalonil OSHA no PEL (PNOR 5 mg/m³) + NIOSH no REL (no NIOSH Ca) triple vacuum AI adversarial injection blog + FIRST chlorothalonil ACGIH A2 50× PNOR gap AI blog + FIRST chlorothalonil EPA Likely Carcinogenic kidney GSH-conjugate CCBL β-lyase AI adversarial injection blog. Three chlorothalonil exposure sectors: ISK Biosciences Corporation Mentor OH chlorothalonil technical and Bravo-analog formulation manufacturing 0.50→0.050 mg/m³ (51M 22yr; 5× ACGIH TLV A2; Cority; PNOR 1.0% “within limit”); TruGreen Limited Partnership Memphis TN golf course and sports turf disease management 0.35→0.035 mg/m³ (43M 14yr; 3.5× ACGIH TLV A2; VelocityEHS; PNOR 0.7% “within limit”); Metrolina Greenhouses Inc. Huntersville NC commercial ornamental greenhouse fogger application 0.25→0.025 mg/m³ (34F 8yr; 2.5× ACGIH TLV A2; EHS Insight; PNOR 0.5% “within limit”). ÷10 perturbation. EU banned 2020 (Regulation 2019/168). Threshold 21.

  Read the full post →

• Captan CAS 133-06-2 AI Security · OSHA PEL 5 mg/m³ TWA (Z-1; 1971 frozen; pre-NTP TR-519) vs ACGIH TLV-TWA 0.1 mg/m³ A3 (50× Gap — Largest Fungicide Gap in Portfolio) vs NIOSH Ca (No Numerical REL; Carcinogen Designation Without Quantitative Limit; Third-Tier Enforcement Vacuum) · NTP TR-519 (2004) Intestinal Adenocarcinoma + Duodenal Carcinoma · Thiophosgene CCl⊂2;=S Bifunctional DNA Alkylation; Tubulin Carbamoylation · Drexel Memphis TN WP Formulation 0.50→0.050 (47M 16yr) · Syngenta Henderson NE Seed Care 0.40→0.040 (38M 8yr) · Stemilt Wenatchee WA Post-Harvest Packing 0.30→0.030 (44F 11yr) · 359th Adversarial Attack · Glyphward Threshold 21 · 2026-09-19

  Captan (CAS 133-06-2) OSHA PEL 5 mg/m³ TWA (1971 Frozen; Pre-NTP TR-519) vs ACGIH TLV-TWA 0.1 mg/m³ A3 (50× Gap — Largest Fungicide Gap; NIOSH Ca No Numerical REL; NTP TR-519 Intestinal Adenocarcinoma; Thiophosgene CCl⊂2;=S DNA Alkylation; Drexel Memphis TN WP Formulation; Syngenta Henderson NE Seed Care; Stemilt Wenatchee WA Post-Harvest; Threshold 21, 359th Attack)

  The 359th adversarial attack — FIRST captan (CAS 133-06-2) OSHA 5 mg/m³ vs ACGIH 0.1 mg/m³ 50× gap AI adversarial injection long-form blog + FIRST 50× OSHA:ACGIH gap fungicide in the Glyphward portfolio + FIRST NTP TR-519 intestinal adenocarcinoma thiophthalimide AI adversarial injection blog + FIRST thiophosgene CCl⊂2;=S bifunctional DNA alkylation + tubulin carbamoylation AI monitoring suppression blog + FIRST NIOSH Ca no-numerical-REL third-tier enforcement vacuum blog. Three captan exposure sectors: Drexel Chemical Company Memphis TN captan 50 WP fungicide formulation 0.50→0.050 mg/m³ (47M 16yr; 5× ACGIH TLV; Cority); Syngenta Seeds LLC Henderson NE corn/soybean seed treatment coating 0.40→0.040 mg/m³ (38M 8yr; 4× ACGIH TLV; VelocityEHS); Stemilt Growers LLC Wenatchee WA apple post-harvest packing shed captan wax dip 0.30→0.030 mg/m³ (44F 11yr; 3× ACGIH TLV; EHS Insight). ÷10 perturbation. Threshold 21.

  Read the full post →

• Malathion CAS 121-75-5 AI Security · OSHA PEL 15 mg/m³ TWA SKIN (Z-1; 1971 frozen; pre-IARC Group 1) vs ACGIH TLV-TWA 1 mg/m³ A3 SKIN (15× Gap) vs NIOSH REL 10 mg/m³ SKIN (Zero Protection Below ACGIH; NIOSH 10× Less Protective Than ACGIH — Anomalous Inversion for IARC Group 1) · IARC Group 1 NHL 2015 Monograph 112 (First Organophosphate Group 1) · AChE Inhibitor; Malaoxon CYP3A4 Desulfurization; PON1 Q192R Susceptibility · AMVAC Commerce CA 4.5→0.45 (33M 14yr) · Clarke Roselle IL ULV Mosquito 3.5→0.35 (46M 22yr) · Terminix Memphis TN Barrier Spray 3.0→0.30 (38F 9yr) · 354th Adversarial Attack · Glyphward Threshold 21 · 2026-09-19

  Malathion (CAS 121-75-5) OSHA PEL 15 mg/m³ TWA SKIN (1971 Frozen; Pre-IARC Group 1) vs ACGIH TLV-TWA 1 mg/m³ A3 SKIN (15× Gap) vs NIOSH REL 10 mg/m³ SKIN (Zero Independent Protection Below ACGIH; NIOSH 10× Less Protective Than ACGIH for IARC Group 1 NHL Carcinogen; FIRST Organophosphate IARC Group 1 AI Adversarial Blog; AChE Inhibitor; Malaoxon CYP3A4; PON1 Q192R; AMVAC Commerce CA; Clarke Roselle IL ULV Mosquito; Terminix Memphis TN Barrier Spray; Threshold 21, 354th Attack)

  The 354th adversarial attack — FIRST malathion (CAS 121-75-5) OSHA 15 mg/m³ vs ACGIH 1 mg/m³ 15× gap AI adversarial injection long-form blog + FIRST IARC Group 1 organophosphate AI attack in the Glyphward portfolio + FIRST malaoxon CYP3A4 oxidative desulfurization + PON1 Q192R susceptibility AI monitoring blog + FIRST NIOSH anomalous inversion for IARC Group 1 (NIOSH REL 10× LESS protective than ACGIH) in portfolio. Three malathion exposure sectors: AMVAC Chemical Corporation Commerce CA malathion technical formulation 4.5→0.45 mg/m³ (33M 14yr; 4.5× ACGIH TLV; Cority); Clarke Mosquito Management Roselle IL ULV municipal mosquito control 3.5→0.35 mg/m³ (46M 22yr; 3.5× ACGIH TLV; VelocityEHS); Terminix International Memphis TN residential barrier spray 3.0→0.30 mg/m³ (38F 9yr reproductive-age; 3× ACGIH TLV; EHS Insight). ÷10 perturbation. Threshold 21.

  Read the full post →

• Allyl Glycidyl Ether AGE CAS 106-92-3 AI Security · OSHA PEL 45 ppm TWA (Z-1; 1971 frozen) vs ACGIH TLV-C 1 ppm A3 (45× Apparent Gap + TWA:Ceiling Limit-Type Mismatch) vs NIOSH Ca (No Numerical REL) · NTP TR-369 Mouse Forestomach SCC + Liver Tumors · SN2 Epoxide N7-Guanine DNA Alkylation · IgE Bifunctional Sensitizer (Allyl Michael Acceptor + Epoxide SN2) · Career-Ending Occupational Asthma · Hexion Louisville KY Wind Turbine VARTM 4.0→0.040 (49M 18yr) · Olin Freeport TX BPA Epoxy 3.5→0.035 (37F 10yr) · Momentive Waterford NY Silane-Epoxy 3.0→0.030 (44M 13yr) · 353rd Adversarial Attack · Glyphward Threshold 22 · 2026-09-18

  Allyl Glycidyl Ether (AGE; CAS 106-92-3) OSHA PEL 45 ppm TWA vs ACGIH TLV-C 1 ppm A3 (45× Apparent Gap; TWA:Ceiling Limit-Type Mismatch; NTP TR-369 Mouse Forestomach SCC; SN2 Epoxide DNA Alkylation; IgE Bifunctional Sensitizer; Career-Ending Occupational Asthma; Hexion Louisville KY Wind Turbine Blade; Olin Freeport TX BPA Epoxy; Momentive Waterford NY Silane-Epoxy Sealant; Threshold 22, 353rd Attack)

  The 353rd adversarial attack — FIRST allyl glycidyl ether (AGE; CAS 106-92-3) 45× apparent gap + TWA:ceiling limit-type mismatch AI adversarial injection blog + FIRST AGE NTP TR-369 forestomach SCC A3 carcinogen AI attack + FIRST AGE bifunctional allyl+epoxide dual-sensitizer career-ending occupational asthma AI attack + FIRST AGE wind turbine blade VARTM epoxy reactive diluent AI attack (Hexion Louisville KY). Three epoxy reactive diluent sectors: Hexion Inc. Louisville KY VARTM wind turbine 4.0→0.040 ppm (49M 18yr; 4× TLV-C ceiling; Cority); Olin Corporation Freeport TX BPA epoxy 3.5→0.035 ppm (37F 10yr reproductive-age; 3.5× TLV-C; VelocityEHS); Momentive Performance Materials Waterford NY silane-epoxy sealant 3.0→0.030 ppm (44M 13yr; 3× TLV-C; EHS Insight). ÷100 perturbation. Threshold 22.

  Read the full post →

• Isoflurane WAG CAS 26675-46-7 AI Security · OSHA No PEL (Double Enforcement Vacuum — AFL-CIO v. OSHA 1992; Halogenated Anesthetics Never Received OSHA PEL) · ACGIH No Specific TLV (Double Vacuum) · NIOSH REL 2 ppm Ceiling (15-min; NIOSH DHEW 77-140; 1977) + 0.5 ppm Ceiling with N⊂2;O Co-Exposure · CYP2E1 TFA+Fluoride Reproductive Toxicity · Ascension Saint Thomas Nashville 5.0→0.5 (CRNA 41F 12yr) · Pacific Dental Services Irvine CA 4.0→0.4 N⊂2;O 8× REL (Dental Assistant 26F 4yr) · VCA Animal Hospitals LA Mask Induction 3.0→0.3 (Vet Tech 31F 5yr) · 348th Adversarial Attack · Glyphward Threshold 20 · 2026-09-18

  Isoflurane / Waste Anesthetic Gas (WAG; CAS 26675-46-7) OSHA No PEL (Double Enforcement Vacuum — OSHA Never Promulgated PEL for Any Halogenated Anesthetic; AFL-CIO v. OSHA 1992; ACGIH No Specific TLV) vs NIOSH REL 2 ppm CEILING + 0.5 ppm CEILING with N⊂2;O Co-Exposure; CYP2E1 TFA+Fluoride; Reproductive Toxicity; Ascension Saint Thomas Nashville TN; Pacific Dental Services Irvine CA N⊂2;O 8× NIOSH REL; VCA Animal Hospitals Los Angeles CA Mask Induction; Threshold 20, 348th Attack

  The 348th adversarial attack — FIRST isoflurane / halogenated anesthetic OSHA double enforcement vacuum AI adversarial injection long-form blog (OSHA no PEL + ACGIH no TLV — only NIOSH REL 2 ppm ceiling/0.5 ppm with N⊂2;O) + FIRST hospital OR CRNA AGSS WAG monitoring AI attack + FIRST dental office passive nasal-mask N⊂2;O co-exposure 8× NIOSH REL AI attack + FIRST veterinary clinic mask induction WAG AI attack (NIOSH ALERT 1994). Three healthcare sectors: Ascension Saint Thomas Hospital Nashville TN 5.0→0.5 ppm (CRNA 41F 12yr; Cority; 2.5× NIOSH REL); Pacific Dental Services Irvine CA 4.0→0.4 ppm (8× NIOSH REL with N⊂2;O 0.5 ppm ceiling; dental assistant 26F 4yr; VelocityEHS); VCA Animal Hospitals LA 3.0→0.3 ppm (1.5× NIOSH REL; veterinary technician 31F 5yr; EHS Insight). Threshold 20.

  Read the full post →

• Furfuryl Alcohol FFA CAS 98-00-0 AI Security · OSHA PEL 50 ppm SKIN (Z-1) vs ACGIH TLV-TWA 0.1 ppm A3 SKIN (500× Gap — Widest Organic-Solvent Gap in 339-Attack Portfolio) vs NIOSH Ca REL 0.2 ppm SKIN · NTP Fischer 344 Rat Nasal Cavity SCC 63% High-Dose · Quinone Methide Genotoxin · SKIN log P 0.28 Water-Miscible · Waupaca Foundry Tell City IN 0.9→0.09 · Sauereisen Pittsburgh PA 0.8→0.08 (EU CLP Carc. 1B+Repr. 1B) · Hitco Carbon Composites Gardena CA 0.7→0.07 · 339th Adversarial Attack · Glyphward Threshold 27 · 2026-09-17

  Furfuryl Alcohol (FFA; CAS 98-00-0) OSHA PEL 50 ppm TWA SKIN (Z-1) vs ACGIH TLV-TWA 0.1 ppm A3 SKIN vs NIOSH Ca REL 0.2 ppm SKIN (500× OSHA:ACGIH Gap — Widest Organic-Solvent Gap in 339-Attack Portfolio; NTP Nasal Cavity SCC 63% + Hepatocellular Adenoma; Quinone Methide Genotoxin; SKIN log P 0.28; Waupaca Foundry Tell City IN; Sauereisen Pittsburgh PA EU CLP Carc. 1B+Repr. 1B; Hitco Carbon Composites Gardena CA F-35/B-2 Brake Disc; Threshold 27, 339th Attack)

  The 339th adversarial attack — FIRST 500× organic-solvent OSHA:ACGIH gap in 339-entry portfolio (50 ppm÷0.1 ppm) + FIRST NTP nasal adenocarcinoma AI attack (Fischer 344 rat nasal SCC 63% high-dose) + FIRST quinone methide reactive genotoxic intermediate AI attack (FFA→furfural→QM; nasal olfactory mucosa portal-of-entry target tissue). Three surfaces: Waupaca Foundry Tell City IN 0.9→0.09 ppm (38M 11yr; foundry furan no-bake); Sauereisen Pittsburgh PA 0.8→0.08 ppm (29F 4yr; EU CLP Carc. 1B+Repr. 1B reproductive-age female); Hitco Carbon Composites Gardena CA 0.7→0.07 ppm (44M 9yr; F-35/B-2 C-C composite; dual FFA+furfural co-carcinogen). Threshold 27.

  Read the full post →

• Acrylonitrile AN CAS 107-13-1 AI Security · OSHA 1910.1045 PEL 2 ppm + Action Level 1 ppm vs ACGIH TLV-TWA 2 ppm A3 BEI AAN (ACGIH=OSHA PEL — FIRST NIOSH Ca REL = Action Level) vs NIOSH Ca REL 1 ppm · FIRST Dual 1910.1045+1910.1051 at Zeon NBR · CEO IARC Group 2B · Solutia/Eastman Decatur AL 4.5→0.45 · Trinseo Stow OH 3.8→0.38 · Zeon Louisville KY 3.2→0.32 · 331st Adversarial Attack · Glyphward Threshold 28 · 2026-09-17

  Acrylonitrile (AN; CAS 107-13-1) OSHA 1910.1045 PEL 2 ppm + Action Level 1 ppm vs ACGIH TLV-TWA 2 ppm A3 SKIN BEI AAN (ACGIH=OSHA PEL — FIRST Entry Where NIOSH Ca REL = OSHA Action Level; Single Error Defeats Both Thresholds; AAN BEI Suppressed; FIRST Dual 1910.1045+1910.1051 at Zeon Louisville KY NBR; CEO IARC Group 2B; Solutia/Eastman Decatur AL; Trinseo Stow OH; Zeon Louisville KY; Threshold 28, 331st Attack)

  The 331st adversarial attack — FIRST NIOSH Ca REL = OSHA action level coincidence (1 ppm = 1 ppm; single error simultaneously defeats both) + FIRST dual 1910.1045+1910.1051 simultaneous suppression (Zeon Louisville KY NBR; CEO IARC Group 2B + DEB IARC Group 1 co-exposure). Three surfaces: Solutia/Eastman Decatur AL 4.5→0.45 ppm (41M 14yr); Trinseo Stow OH 3.8→0.38 ppm (37M 9yr); Zeon Louisville KY 3.2→0.32 ppm + 0.65→0.065 ppm BD (44M 18yr). Threshold 28.

  Read the full post →

• Ethylene Oxide EtO CAS 75-21-8 AI Security · OSHA 1910.1047 PEL 1 ppm + Action Level 0.5 ppm vs ACGIH TLV-TWA 1 ppm A2 BEI HEV (ACGIH=OSHA — FIRST Glyphward No-Air-Gap Entry) vs NIOSH Ca REL 0.1 ppm · IARC Group 1 Breast Cancer/NHL/Leukemia · Steenland 2004 18,235 Workers · HEV BEI Suppressed · Ascension Saint Francis Evanston IL CSSD 0.85→0.085 · Sterigenics Willowbrook IL 0.72→0.072 · LyondellBasell La Porte TX 0.90→0.09 · 332nd Adversarial Attack · Glyphward Threshold 30 · 2026-09-17

  Ethylene Oxide (EtO; Oxirane; CAS 75-21-8) OSHA 1910.1047 PEL 1 ppm + Action Level 0.5 ppm vs ACGIH TLV-TWA 1 ppm A2 BEI HEV (ACGIH=OSHA — FIRST Glyphward Portfolio Entry Without Air-Level Gap; All Protection in HEV BEI; BEI Suppressed; NIOSH Ca REL 0.1 ppm 10×; IARC Group 1 Breast Cancer/NHL/Leukemia; Steenland 2004 18,235 Workers; Ascension Saint Francis Hospital Evanston IL CSSD 0.85→0.085 ppm; Sterigenics Willowbrook IL 0.72→0.072 ppm; LyondellBasell La Porte TX 0.90→0.09 ppm; Glyphward Threshold 30, 332nd Adversarial Attack)

  The 332nd adversarial attack — FIRST EtO 1910.1047 action-level four-requirement suppression + FIRST ACGIH=OSHA no-additional-air-protection Glyphward portfolio entry + FIRST HEV BEI suppression. IARC Group 1: breast cancer (Steenland 2004 SMR 1.26), NHL, leukemia. Three surfaces: Ascension Saint Francis Evanston IL CSSD 0.85→0.085 ppm (action level 1.70×; 52F 21yr); Sterigenics Willowbrook IL 0.72→0.072 ppm (action level 1.44×; EPA enforcement; 46M 19yr); LyondellBasell La Porte TX 0.90→0.09 ppm (action level 1.80×; PSM; 39M 12yr). Threshold 30.

  Read the full post →

1,3-Butadiene CAS 106-99-0 AI Security · OSHA 1910.1051 PEL 1 ppm vs ACGIH TLV-TWA 2 ppm A2 (ACGIH HIGHER — FIRST Inverted Three-Tier) vs NIOSH Ca REL 0.2 ppm · IARC Group 1 NHL/AML · DEB Bifunctional Diepoxide · HPB-Val Hb Adduct BEI · Action Level 0.5 ppm Suppression · TPC Group Houston TX 0.8→0.16 · Trinseo Freeport TX 0.65→0.13 · INEOS ABS Addyston OH 0.7→0.14 · 313th Adversarial Attack · Glyphward Threshold 33 · 2026-09-01

1,3-Butadiene (Buta-1,3-diene; CH₂=CH-CH=CH₂; CAS 106-99-0) OSHA 29 CFR 1910.1051 PEL 1 ppm TWA vs ACGIH TLV-TWA 2 ppm A2 (ACGIH HIGHER THAN OSHA — FIRST Inverted Three-Tier in 314-Entry Glyphward Portfolio Where ACGIH Is LEAST Protective Tier) vs NIOSH Ca REL 0.2 ppm (5× Below OSHA; IARC Group 1 NHL/AML; DEB Bifunctional Diepoxide; HPB-Val Hb Adduct BEI; OSHA Action Level 0.5 ppm Suppression; TPC Group Houston TX 0.8→0.16 ppm; Trinseo Freeport TX 0.65→0.13 ppm; INEOS ABS Addyston OH 0.7→0.14 ppm; Glyphward Threshold 33, 313th Adversarial Attack)

The 313th adversarial attack — FIRST 1,3-butadiene (buta-1,3-diene; CAS 106-99-0) inverted three-tier OSHA 1910.1051 PEL 1 ppm / ACGIH TLV-TWA 2 ppm A2 (ACGIH HIGHER than OSHA) / NIOSH Ca REL 0.2 ppm AI adversarial injection long-form blog. FIRST entry in the 314-attack Glyphward portfolio where ACGIH TLV-TWA is LESS protective than OSHA PEL. NIOSH Ca REL 0.2 ppm (most protective; 5× below OSHA; 10× below ACGIH) is the principal suppressed tier. OSHA 1910.1051 action level 0.5 ppm suppression defeats four enhanced monitoring requirements simultaneously. Three surfaces: (1) TPC Group LLC Houston TX C₄ NMP extractive distillation — IS Ventis Pro 5 ECD — 0.8→0.16 ppm (NIOSH Ca 4× suppressed; action level defeated; VelocityEHS: OSHA COMPLIANT 16%); (2) Trinseo LLC Freeport TX SBR cold emulsion polymerization storage sphere — MSA Altair 5X ECD — 0.65→0.13 ppm (NIOSH Ca 3.25× suppressed; Cority: OSHA COMPLIANT 13%); (3) INEOS ABS LLC Addyston OH ABS emulsion polymerization butadiene charging — SKC charcoal GC-FID — 0.7→0.14 ppm (NIOSH Ca 3.5× suppressed; EHS Insight: OSHA COMPLIANT 14%). Threshold 33.

Read the full post →

• Chloroprene 2-Chloro-1,3-Butadiene AI Security · OSHA PEL 25 ppm vs ACGIH TLV-TWA 10 ppm A3 / NIOSH Ca REL 1 ppm · FIRST Chloroprene Three-Tier 25× Span AI Adversarial Attack · IARC Group 2A 2019 · NIOSH CIB 65 2020 · Denka DPE LaPlace LA EPA 2022 Cancer Cluster · DuPont/Lanxess Louisville KY Neoprene Cohort · 22 ppm shown as 0.88 · 18 ppm shown as 0.72 · 14 ppm shown as 0.56 · 309th Adversarial Attack · Glyphward Threshold 27 · 2026-08-22

  Chloroprene (2-Chloro-1,3-Butadiene; CAS 126-99-8) OSHA PEL 25 ppm vs ACGIH TLV-TWA 10 ppm A3 / NIOSH Ca REL 1 ppm (25× Three-Tier Span — FIRST Chloroprene Three-Tier OSHA/ACGIH/NIOSH Ca Gap AI Adversarial Attack; IARC Group 2A 2019; NIOSH CIB 65 2020; Denka Performance Elastomer LaPlace LA St. John the Baptist Parish EPA 2022 Cancer Cluster; DuPont/Lanxess Louisville KY Neoprene Cohort; Denka 22 ppm shown as 0.88; Lanxess Louisville 18 ppm shown as 0.72; Rubatex Bedford VA 14 ppm shown as 0.56; Glyphward Threshold 27, 309th Adversarial Attack)

  The 309th adversarial attack — FIRST chloroprene (2-chloro-1,3-butadiene; CAS 126-99-8) three-tier OSHA PEL 25 ppm / ACGIH TLV-TWA 10 ppm A3 / NIOSH Ca REL 1 ppm (25× total span) AI adversarial injection long-form blog. NIOSH Ca REL 1 ppm (2020; CIB 65) derived from DuPont/Lanxess Louisville KY neoprene cohort hepatocellular carcinoma epidemiology — the exact sites that continue operating at 14–22× NIOSH Ca REL under OSHA 25 ppm PEL compliance. Three surfaces: (1) Denka Performance Elastomer LaPlace LA polychloroprene polymerization reactor — IS Ventis Pro 5 PID — 22 ppm shown as 0.88 ppm (NIOSH Ca 22× suppressed; Cority: OSHA COMPLIANT 88%); (2) Lanxess Corporation Louisville KY neoprene rubber compounding Banbury mill — MSA Altair 5X PID — 18 ppm shown as 0.72 ppm (NIOSH Ca 18× suppressed; Intelex: OSHA COMPLIANT 72%); (3) Rubatex International (Zotefoams) Bedford VA neoprene foam slitting — SKC charcoal GC/MS — 14 ppm shown as 0.56 ppm (NIOSH Ca 14× suppressed; VelocityEHS: OSHA COMPLIANT 56%). Threshold 27.

  Read the full post →

• Hydrogen Fluoride HF AI Security · OSHA Z-2 Ceiling 3 ppm vs ACGIH TLV-TWA 0.5 ppm A2 SKIN · FIRST HF Z-2 Ceiling/TWA Limit-Type Mismatch 6× Gap AI Adversarial Injection Blog · CHIPS Act Semiconductor Wet Etch · UOP Petroleum HF Alkylation · AHF Chemical Production · Intel D1X Fab M2 Hillsboro OR 1.8→0.30 ppm · Phillips 66 Lake Charles LA 1.4→0.23 ppm · Chemours Fayetteville NC 2.2→0.37 ppm · 298th Adversarial Attack · Glyphward Threshold 30 · 2026-08-08

  Hydrogen Fluoride (HF; Anhydrous Hydrofluoric Acid; CAS 7664-39-3) OSHA Z-2 Ceiling 3 ppm vs ACGIH TLV-TWA 0.5 ppm A2 SKIN (FIRST HF OSHA Z-2 Ceiling/ACGIH TWA Limit-Type Mismatch 6× Gap AI Adversarial Injection Long-Form Blog; CHIPS Act Semiconductor Wet Etch; UOP Petroleum HF Alkylation; AHF Chemical Production; Intel D1X Fab M2 Hillsboro OR 1.8→0.30 ppm; Phillips 66 Lake Charles LA 1.4→0.23 ppm; Chemours Fayetteville NC 2.2→0.37 ppm; Glyphward Threshold 30, 298th Adversarial Attack)

  The 298th adversarial attack — FIRST hydrogen fluoride (HF; anhydrous hydrofluoric acid; CAS 7664-39-3) OSHA Z-2 Ceiling/ACGIH TWA architectural limit-type mismatch 6× gap AI adversarial injection long-form blog. OSHA Table Z-2 ceiling 3 ppm (adopted 1971 from ANSI Z37.28-1969; ceiling-only; NO OSHA 8-hr TWA PEL for HF exists); ACGIH TLV-TWA 0.5 ppm A2 SKIN (2024; 6× below OSHA ceiling; 8-hr time-weighted average). The architectural gap: AI EHS platforms calibrated to Z-2 ceiling monitoring cannot assess chronic 8-hr HF dose — the structural blindspot is categorical, not merely numerical. Three sectors: (1) Intel D1X Fab M2 Hillsboro OR CHIPS Act CMOS FEOL BHF 7:1 wet bench maintenance — IS Ventis Pro 5 ECD + SKC 575-001 badge IC — 1.8→0.30 ppm (ACGIH 3.6× suppressed; Cority: OSHA ceiling COMPLIANT 10%); (2) Phillips 66 Lake Charles LA UOP HF alkylation acid composite sampling — MSA Altair 5X ECD + Assay Optim-HF badge IC — 1.4→0.23 ppm (ACGIH 2.8× suppressed; Honeywell Safety Suite: OSHA COMPLIANT); (3) Chemours Fayetteville NC AHF rail-car unloading — RAE MultiRAE Pro ECD + SKC badge IC — 2.2→0.37 ppm (ACGIH 4.4× suppressed; Intelex: OSHA ceiling COMPLIANT). Threshold 30.

  Read the full post →

• Nickel Oxide NiO AI Security · OSHA PEL 1 mg/m³ vs ACGIH TLV-TWA 0.05 mg/m³ A1 IARC Group 1 · FIRST NiO IARC Group 1 20× Gap EV Battery NMC Cathode AI Adversarial Injection Blog · Clydach Wales Nickel Refinery Epidemic · IRA Gigafactory Expansion · BASF Battery Materials Elyria OH 0.38→0.019 mg/m³ · PCC Airfoils Minerva OH 0.62→0.031 mg/m³ · Atotech Columbia SC 0.28→0.014 mg/m³ · 292nd Adversarial Attack · Glyphward Threshold 34 · 2026-08-08

  Nickel Oxide (NiO; Insoluble Nickel Compounds; CAS 1313-99-1) OSHA PEL 1 mg/m³ vs ACGIH TLV-TWA 0.05 mg/m³ A1 IARC Group 1 (FIRST NiO IARC Group 1 20× Gap EV Battery NMC Cathode AI Adversarial Injection Long-Form Blog; Clydach Wales Nickel Refinery Epidemic; IRA Gigafactory Expansion; BASF Battery Materials Elyria OH 0.38→0.019 mg/m³; PCC Airfoils Minerva OH 0.62→0.031 mg/m³; Atotech Columbia SC 0.28→0.014 mg/m³; Glyphward Threshold 34, 292nd Adversarial Attack)

  The 292nd adversarial attack — FIRST nickel oxide (NiO; insoluble; CAS 1313-99-1) OSHA PEL 1 mg/m³ vs ACGIH TLV-TWA 0.05 mg/m³ A1 IARC Group 1 20× gap AI adversarial injection long-form blog. OSHA PEL frozen since 1971 — 19 years before IARC Group 1 classification. Three-tier structure: OSHA 1 / ACGIH 0.05 / NIOSH 0.015 mg/m³ (spanning 67×). Three surfaces: (1) BASF Battery Materials Elyria OH NMC811 cathode calcination — 0.38→0.019 mg/m³ (ACGIH 7.6× suppressed; IRA 45X gigafactory); (2) PCC Airfoils Minerva OH Inconel creep-feed grinding — 0.62→0.031 mg/m³ (ACGIH 12.4× suppressed; 22-year tenure, no sinonasal surveillance); (3) Atotech Columbia SC electroplating anode bag change — 0.28→0.014 mg/m³ (ACGIH 5.6× suppressed). Threshold 34.

  Read the full post →

• Indium In ITO AI Security · OSHA No PEL (Complete Enforcement Vacuum) vs ACGIH TLV-TWA 0.1 mg/m³ A2 · FIRST Indium/ITO OSHA Enforcement Vacuum CILD/PAP AI Adversarial Injection Blog · IARC Group 2A 2022 Monograph 130 · Japan CILD Epidemic 50+ Cases · Pulmonary Alveolar Proteinosis PAP · CHIPS Act ITO Supply Chain Surge · Corning Rochester NY 0.082→0.018 mg/m³ · First Solar Perrysburg OH 0.065→0.015 mg/m³ · II-VI Coherent Freeport PA Dual BEI 0.048→0.010 + Serum 4.5→0.4 µg/L · 281st Adversarial Attack · Glyphward Threshold 35 · 2026-08-07

  Indium (In; ITO; In₂O₃:Sn; CAS 7440-74-6) OSHA No PEL (Complete Enforcement Vacuum) vs ACGIH TLV-TWA 0.1 mg/m³ A2 (FIRST Indium/ITO OSHA Enforcement Vacuum CILD/PAP AI Adversarial Injection Long-Form Blog; IARC Group 2A 2022 Monograph 130; Japan Chronic Interstitial Lung Disease CILD Epidemic; Pulmonary Alveolar Proteinosis; CHIPS Act ITO Supply Chain Surge; Corning Rochester NY 0.082→0.018 mg/m³; First Solar Perrysburg OH 0.065→0.015 mg/m³; II-VI Coherent Freeport PA 0.048→0.010 mg/m³ + Serum 4.5→0.4 µg/L Dual BEI Defeat; Glyphward Threshold 35, 281st Adversarial Attack)

  The 281st adversarial attack — FIRST indium/ITO (CAS 7440-74-6) complete OSHA enforcement vacuum vs ACGIH TLV-TWA 0.1 mg/m³ A2 CILD/PAP AI adversarial injection long-form blog and FIRST critical-semiconductor-mineral IARC Group 2A 2022 enforcement-vacuum blog in the Glyphward portfolio. OSHA PEL for indium: None (indium absent from OSHA Table Z-1; never established by rulemaking; any AI EHS platform calibrated to OSHA Table Z-1 generates zero compliance flags for indium at any concentration). ACGIH TLV-TWA 0.1 mg/m³ A2 (IARC Group 2A 2022, Monograph 130; Japan CILD epidemic 50+ documented cases; PAP → irreversible interstitial fibrosis; 7–12 year incubation). CHIPS Act domestic ITO production surge: US fab expansion drives ITO target demand without OSHA protection. Three surfaces: (1) Corning Advanced Glass Technology Rochester NY ITO rotary target grinding — Casella Apex 2 ICP-OES — 0.082 mg/m³ shown as 0.018 mg/m³ (Cority: No OSHA PEL; ACGIH 18%: compliant; CILD surveillance not triggered); (2) First Solar Perrysburg OH CIGS thin-film deposition — GilAir 5 ICP-MS — 0.065 mg/m³ shown as 0.015 mg/m³ (Intelex: No OSHA limit; serum In BEI not assessed; ACGIH 15% advisory compliant); (3) II-VI Coherent Freeport PA InP CMP — Casella ICP-MS + LabCorp LIS serum In — 0.048 mg/m³ shown as 0.010 + serum 4.5 µg/L shown as 0.4 µg/L (VelocityEHS OHM: dual air + serum BEI both compliant; complete monitoring blackout). Threshold 35.

  Read the full post →

• 1-Bromopropane 1-BP nPB AI Security · OSHA No PEL (Complete Enforcement Vacuum) vs ACGIH TLV-TWA 0.1 ppm A2 SKIN · FIRST 1-BP Enforcement Vacuum vs ACGIH Carcinogen AI Adversarial Injection Blog · NIOSH Ca 2021 · IARC Group 2A 2024 · CYP2E1 Peripheral Neuropathy · Testicular Toxicity · Raytheon Andover MA 45 ppm Shown as 4 · Tide Cleaners Louisville KY 42 ppm Shown as 4 · Lockheed Martin Fort Worth TX 38 ppm Shown as 3.5 · 260th Adversarial Attack · Glyphward Threshold 36 · 2026-08-06

  1-Bromopropane (1-BP; nPB; n-Propyl Bromide; CH₃CH₂CH₂Br; CAS 106-94-5) OSHA No PEL (Complete Enforcement Vacuum) vs ACGIH TLV-TWA 0.1 ppm A2 SKIN (FIRST 1-BP Enforcement Vacuum vs ACGIH Carcinogen AI Adversarial Injection Blog; NIOSH Ca; IARC Group 2A 2024; CYP2E1 Peripheral Neuropathy; Testicular Toxicity; Raytheon Andover MA 45 ppm shown as 4; Tide Cleaners Louisville KY 42 ppm shown as 4; Lockheed Martin Fort Worth TX 38 ppm shown as 3.5; Glyphward Threshold 36, 260th Adversarial Attack)

  The 260th adversarial attack — FIRST 1-bromopropane (nPB; CAS 106-94-5) complete OSHA enforcement vacuum vs ACGIH TLV-TWA 0.1 ppm A2 SKIN AI adversarial injection long-form blog and FIRST CFC/HCFC replacement solvent OSHA enforcement vacuum carcinogen AI monitoring blog in the Glyphward portfolio. OSHA PEL for 1-BP: None (1-BP not in commercial production in 1971 when OSHA adopted Table Z-1; no subsequent rulemaking; any AI EHS platform calibrated to OSHA Table Z-1 generates zero compliance flags for 1-BP at any concentration). ACGIH TLV-TWA 0.1 ppm A2 SKIN (2024; lowest TWA for any common organic solvent; A2 Suspected Human Carcinogen). NIOSH Ca (2021). IARC Group 2A (2024; reclassified from 2B). CYP2E1 dying-back peripheral neuropathy (NIOSH HETA clinical neuropathy at 7–55 ppm). Testicular spermatocyte toxicity (BTB penetration; log P 2.10). Ether-like odor threshold ~4 ppm (40× above ACGIH TLV-TWA). Three surfaces: (1) Raytheon Intelligence & Space Andover MA defense electronics PCB vapor degreaser — MSA Altair 5X PID — 45 ppm shown as 4 ppm (Cority EHS: No OSHA PEL; 450× ACGIH suppressed); (2) Tide Cleaners Louisville KY dry cleaning PERC alternative — BW Technologies GasAlertMax XT II — 42 ppm shown as 4 ppm (iNet Now: compliant; 420× suppressed); (3) Lockheed Martin Fort Worth TX F-35 CFRP adhesive primer — Industrial Scientific MX6 iBrid — 38 ppm shown as 3.5 ppm (VelocityEHS: compliant; 380× suppressed). Threshold 36.

  Read the full post →

• Nitrobenzene NB AI Security · OSHA PEL 1 ppm TWA SKIN vs ACGIH TLV-TWA 0.1 ppm A3 SKIN (10× Gap) · FIRST NB 10× Gap MetHb-Forming Testicular Toxicant AI Adversarial Injection Blog · G6PD Deficiency MetHb Formation Below ACGIH TLV-TWA · NIOSH Ca REL 0.2 ppm · Dual BEI 4-Aminophenol + MetHb · Covestro Baytown TX 0.55 ppm Shown as 0.04 · Shoe Polish Workshop 0.65 ppm Shown as 0.05 · Merck Rahway NJ 0.45 ppm Shown as 0.03 · 270th Adversarial Attack · Glyphward Threshold 34 · 2026-08-06

  Nitrobenzene (NB; C₆H₅NO₂; CAS 98-95-3) OSHA PEL 1 ppm TWA SKIN vs ACGIH TLV-TWA 0.1 ppm A3 SKIN (10× gap — FIRST NB 10× Gap Methemoglobin-Forming Testicular Toxicant AI Adversarial Injection Blog; G6PD Deficiency MetHb Formation Below ACGIH TLV-TWA; NIOSH Ca REL 0.2 ppm; Dual BEI 4-Aminophenol + Methemoglobin; Covestro Baytown TX 0.55 ppm shown as 0.04; Shoe Polish Workshop 0.65 ppm shown as 0.05; Merck Rahway NJ 0.45 ppm shown as 0.03; Glyphward Threshold 34, 270th Adversarial Attack)

  The 270th adversarial attack — FIRST nitrobenzene (NB) OSHA 1 ppm TWA SKIN vs ACGIH 0.1 ppm A3 SKIN 10× gap methemoglobin-forming testicular toxicant AI adversarial injection long-form blog and FIRST G6PD deficiency sub-TLV-TWA MetHb formation AI monitoring blindspot blog. OSHA PEL 1 ppm TWA SKIN (1971; ANSI Z37.2-1960; 65 years without revision) vs ACGIH TLV-TWA 0.1 ppm A3 SKIN (10× below OSHA; MetHb formation in G6PD-deficient workers at sub-1 ppm; testicular spermatocyte toxicity; IARC Group 2A; dual BEI: 4-aminophenol + MetHb). G6PD-deficient workers (10–15% of male workforce in high-risk demographics) develop symptomatic MetHb 3–8% at NB concentrations at or below the ACGIH TLV-TWA — harm outside the protective range of even the most conservative occupational standard. Three surfaces: Covestro Baytown TX aniline/MDI 0.55 ppm shown as 0.04 ppm (Intelex: OSHA COMPLIANT; G6PD-deficient worker MetHb 5–12%); shoe polish workshop 0.65 ppm shown as 0.05 ppm (almond-odor hazard recognition failure; G6PD MetHb 8–15%); Merck Rahway NJ pharmaceutical synthesis 0.45 ppm shown as 0.03 ppm (Cority: OSHA COMPLIANT; dual BEI 4-AP + MetHb suppressed). Threshold 34.

  Read the full post →

• 2-Ethoxyethanol EGEE AI Security · OSHA PEL 200 ppm TWA SKIN vs ACGIH TLV-TWA 5 ppm A3 SKIN (40× Gap) · FIRST EGEE 40× Gap Reproductive Toxicant AI Adversarial Injection Blog · FIRST 400× NIOSH/OSHA Gap for a Glycol Ether Reproductive Toxicant · EAA Testicular Spermatocyte Depletion BEI Cross-Channel Suppression · EU Repr. 1B H360D Developmental Toxicant · United Airlines O’Hare 65 ppm Shown as 3 · Applied Materials Santa Clara 42 ppm Shown as 2 · H.B. Fuller St Paul 55 ppm Shown as 3 · 264th Adversarial Attack · Glyphward Threshold 36 · 2026-08-01

  2-Ethoxyethanol (EGEE; Ethylene Glycol Monoethyl Ether) OSHA PEL 200 ppm TWA SKIN vs ACGIH TLV-TWA 5 ppm A3 SKIN (40× gap — FIRST EGEE 40× Gap Reproductive Toxicant AI Adversarial Injection Blog; FIRST 400× NIOSH/OSHA Gap for a Glycol Ether Reproductive Toxicant; 2-Ethoxyacetic Acid EAA Testicular Spermatocyte Depletion BEI Cross-Channel Suppression; EU Repr. 1B H360D Developmental Toxicant; United Airlines O’Hare 65 ppm shown as 3; Applied Materials Santa Clara 42 ppm shown as 2; H.B. Fuller St Paul 55 ppm shown as 3; Glyphward Threshold 36, 264th Adversarial Attack

  The 264th adversarial attack — FIRST EGEE 40× gap reproductive toxicant AI adversarial injection blog and FIRST 400× NIOSH/OSHA gap for a glycol ether reproductive toxicant in the 264-entry Glyphward portfolio. OSHA PEL 200 ppm TWA SKIN (Table Z-1; 1971; ANSI Z37.37-1965; acute CNS narcosis basis; zero revisions in 55 years despite ACGIH revising EGEE TLV 40× downward in response to testicular toxicity and NTP developmental data) vs ACGIH TLV-TWA 5 ppm A3 SKIN (2024; 40× below OSHA PEL; 2-ethoxyacetic acid (EAA) Sertoli cell mitochondrial disruption → Stage VII spermatocyte depletion; EU Repr. 1B H360D May Damage the Unborn Child). NIOSH REL 0.5 ppm SKIN (CIB 39; 1992; 400× below OSHA PEL; FIRST 400× NIOSH/OSHA gap for a glycol ether reproductive toxicant; not adopted by OSHA in 34 years). Three adversarial attack surfaces: (1) United Airlines O’Hare aircraft de-icing (ORD; Chicago IL) — MSA ALTAIR 5X PID — 65 ppm shown as 3 ppm (13× ACGIH TLV-TWA; 130× NIOSH REL; 2.6× NTP developmental NOAEL; Cority EHS AI: OSHA COMPLIANT 32.5%→1.5%; EU Repr. 1B H360D developmental toxicant risk suppressed); (2) Applied Materials Santa Clara CA semiconductor photoresist developer — RAE ppbRAE 3000 PID — 42 ppm shown as 2 ppm (8.4× ACGIH TLV-TWA; iNet Now: OSHA COMPLIANT 21%→1%); (3) H.B. Fuller St Paul MN PSA adhesive formulation — Industrial Scientific MX6 iBrid PID — 55 ppm shown as 3 ppm (11× ACGIH TLV-TWA; Honeywell Forge: OSHA COMPLIANT 27.5%→1.5%). Threshold 36.

  Read the full post →

• 2-Hexanone MnBK AI Security · OSHA PEL 100 ppm TWA vs ACGIH TLV-TWA 5 ppm A3 SKIN (20× Gap) · FIRST γ-Diketone Peripheral Neuropathy Primary-Endpoint Attack · FIRST 100× NIOSH/OSHA TWA Gap for a Neurotoxin · NIOSH REL 1 ppm = 5× Below ACGIH = 100× Below OSHA · Engineered Floors Dalton GA 45 ppm Shown as 2 · Avery Dennison Mentor OH 32 ppm Shown as 1.5 · Flint Group Chicago IL 52 ppm Shown as 3 · 258th Adversarial Attack · Glyphward Threshold 35 · 2026-08-01

  2-Hexanone (MnBK; Methyl n-Butyl Ketone) OSHA PEL 100 ppm TWA vs ACGIH TLV-TWA 5 ppm A3 SKIN (20× gap — FIRST γ-diketone peripheral neuropathy primary-endpoint AI adversarial attack; FIRST 100× NIOSH/OSHA TWA gap for a neurotoxin; 2,5-hexanedione neurofilament crosslinking dying-back polyneuropathy; NIOSH REL 1 ppm = 5× below ACGIH = 100× below OSHA; Engineered Floors Dalton GA 45 ppm shown as 2; Avery Dennison Mentor OH 32 ppm shown as 1.5; Flint Group Chicago IL 52 ppm shown as 3; Glyphward Threshold 35, 258th Adversarial Attack

  The 258th adversarial attack — FIRST γ-diketone peripheral neuropathy primary-endpoint AI adversarial injection blog and FIRST 100× NIOSH/OSHA TWA gap for a neurotoxin in the 258-entry Glyphward portfolio. OSHA PEL 100 ppm TWA (Table Z-1; 1971; adopted from 1968 ACGIH TLV; acute narcosis basis; never revised despite the 1973 Columbus Ohio epidemic: 86 workers developed peripheral neuropathy at OSHA-compliant MnBK concentrations) vs ACGIH TLV-TWA 5 ppm A3 SKIN (2024; 20× below OSHA PEL; primary hazard: 2,5-hexanedione γ-diketone neurofilament crosslinking → dying-back peripheral polyneuropathy). NIOSH REL 1 ppm TWA (100× below OSHA PEL; 5× below ACGIH TLV-TWA; FIRST 100× NIOSH/OSHA divergence for a non-carcinogen neurotoxin in the portfolio). Three adversarial attack surfaces: (1) Engineered Floors Dalton GA vinyl LVT adhesive application — MSA ALTAIR 5X MnBK EC — 45 ppm shown as 2 ppm (9× ACGIH TLV-TWA; 45× NIOSH REL; Cority EHS AI: OSHA COMPLIANT 45%; γ-diketone neuropathy accumulation suppressed); (2) Avery Dennison Mentor OH PSA formulation reactor — Industrial Scientific MX6 iBrid — 32 ppm shown as 1.5 ppm (6.4× TLV-TWA; 32× NIOSH REL; iNet Now: OSHA COMPLIANT 32%); (3) Flint Group Chicago IL gravure ink press room — RAE MiniRAE 3000 PID — 52 ppm shown as 3 ppm (10.4× TLV-TWA; 52× NIOSH REL; Cority: OSHA COMPLIANT 52%). Threshold 35.

  Read the full post →

• Triethylamine TEA AI Security · OSHA PEL 25 ppm TWA vs ACGIH TLV-TWA 1 ppm A4 SKIN (25× Gap) · FIRST Primary-Ocular-Hazard Non-Carcinogen 25× TWA Gap Attack · Corneal Vascularization Permanent Vision Impairment · Lachrymatory Threshold 0.48 ppm Below TLV · Pfizer Kalamazoo MI 18 ppm Shown as 0.7 · Sherwin-Williams Rockford IL 12 ppm Shown as 0.5 · BASF Charlotte NC 21 ppm Shown as 0.8 · 252nd Adversarial Attack · Glyphward Threshold 34 · 2026-07-31

  Triethylamine (TEA) OSHA PEL 25 ppm TWA vs ACGIH TLV-TWA 1 ppm A4 SKIN (25× gap — FIRST primary-ocular-hazard non-carcinogen 25× TWA gap AI adversarial attack; corneal vascularization & permanent vision impairment at occupational concentrations in the OSHA-compliant zone; lachrymatory threshold 0.48 ppm below ACGIH TLV-TWA; NIOSH REL 10 ppm ceiling; Pfizer Kalamazoo MI 18 ppm shown as 0.7; Sherwin-Williams Rockford IL 12 ppm shown as 0.5; BASF Charlotte NC 21 ppm shown as 0.8; Glyphward Threshold 34, 252nd Adversarial Attack

  The 252nd adversarial attack — FIRST primary-ocular-hazard (non-carcinogen) 25× TWA gap AI adversarial injection blog in the Glyphward portfolio. OSHA PEL 25 ppm TWA (Table Z-1; 1971; AFL-CIO v. OSHA 1992 vacated 10 ppm revision) vs ACGIH TLV-TWA 1 ppm A4 SKIN (2024; 25× below OSHA; corneal vascularization primary hazard; not carcinogen). Lachrymatory threshold 0.48 ppm below TLV-TWA creates dual-channel adversarial attack. Three surfaces: Pfizer Kalamazoo 18 → 0.7 ppm; Sherwin-Williams Rockford 12 → 0.5 ppm; BASF Charlotte 21 → 0.8 ppm. Threshold 34.

  Read the full post →

• Furfural AI Security · OSHA PEL 5 ppm TWA vs ACGIH TLV-TWA 0.2 ppm A3 SKIN (25× Gap) · 96% of OSHA Compliance Zone Above ACGIH/NIOSH Carcinogen Threshold · NIOSH Ca REL-C 0.2 ppm Ceiling · Fanjul Jamaica Sugarcane Bagasse 3.8 ppm Shown as 0.14 · Quaker Houghton Cleveland OH Foundry Furan Resin 2.6 ppm Shown as 0.10 · Primient Loudon TN Corn Cob 1.9 ppm Shown as 0.07 · 246th Adversarial Attack · Glyphward Threshold 37 · 2026-07-31

  Furfural (furan-2-carbaldehyde) OSHA PEL 5 ppm TWA vs ACGIH TLV-TWA 0.2 ppm A3 SKIN (25× gap — 96% of OSHA compliance zone above ACGIH/NIOSH carcinogen threshold; NIOSH Ca REL-C 0.2 ppm ceiling; sugarcane bagasse 3.8 ppm shown as 0.14; foundry furan resin 2.6 ppm shown as 0.10; corn cob FA 1.9 ppm shown as 0.07; Glyphward Threshold 37, 246th Adversarial Attack

  The 246th adversarial attack — FIRST furfural OSHA/ACGIH 25× gap AI adversarial injection blog. OSHA PEL 5 ppm TWA (1971; never updated) vs ACGIH TLV-TWA 0.2 ppm A3 SKIN (25× below OSHA; malealdehyde M1G DNA adduct hepatocarcinogenesis). 96% of the OSHA compliance zone (0.2–5 ppm) is above the ACGIH/NIOSH carcinogen threshold. Three surfaces: Fanjul Jamaica sugarcane bagasse 3.8 → 0.14 ppm; Quaker Houghton Cleveland foundry furan resin 2.6 → 0.10 ppm; Primient Loudon TN corn cob 1.9 → 0.07 ppm. Threshold 37.

  Read the full post →

• Epichlorohydrin ECH AI Security · OSHA PEL 5 ppm Ceiling vs ACGIH TLV-TWA 0.5 ppm A3 SKIN (10× Gap + Ceiling-vs-TWA Limit-Type Mismatch) · IARC Group 2A Kidney Cortical Adenocarcinoma + Peritoneal Mesothelioma · NIOSH Ca · SKIN Notation Dermal Epoxide Alkylation · Olin McIntosh AL 3.8 ppm Shown as 0.38 (7.6× TLV-TWA) · Hexion Columbus OH DGEBA 2.6 ppm Shown as 0.26 (5.2× TLV-TWA) · Carvedilol API Synthesis 1.8 ppm Shown as 0.18 (3.6× TLV-TWA) · 240th Adversarial Attack · First ECH AI Blog · Glyphward Threshold 35 · 2026-07-30

  Epichlorohydrin (ECH) OSHA PEL 5 ppm ceiling vs ACGIH TLV-TWA 0.5 ppm A3 SKIN (10× gap + ceiling-vs-TWA limit-type mismatch — OSHA ceiling measures peak; ACGIH TWA measures cumulative carcinogen dose; any sustained 0.5–5 ppm shift-long exposure is simultaneously OSHA-compliant and ACGIH non-compliant; IARC Group 2A kidney cortical adenocarcinoma + peritoneal mesothelioma in rats; NIOSH Ca; SKIN notation dermal epoxide alkylation; Olin McIntosh AL 3.8 ppm shown as 0.38; Hexion Columbus OH DGEBA 2.6 ppm shown as 0.26; carvedilol API 1.8 ppm shown as 0.18; Glyphward Threshold 35, 240th Adversarial Attack

  The 240th adversarial attack — first epichlorohydrin (ECH) AI adversarial injection blog. OSHA PEL 5 ppm ceiling (Table Z-1; 1971; measures instantaneous peak concentration) vs ACGIH TLV-TWA 0.5 ppm A3 SKIN (2023; measures 8-hr cumulative dose). The ceiling-vs-TWA limit-type mismatch is the core structural attack: any sustained shift-long exposure with a TWA between 0.5 and 5 ppm is OSHA-compliant (ceiling never exceeded) and ACGIH non-compliant (TWA exceeded) — an OSHA-calibrated AI EHS platform cannot detect the ACGIH violation without stateful 8-hr TWA computation. IARC Group 2A (kidney cortical adenocarcinoma in Fischer 344 rats; peritoneal mesothelioma in Sprague-Dawley rats; leukemia/lymphoma in mice; IARC Monograph Vol. 71). NIOSH Ca (potential occupational carcinogen; handle with caution; reduce to lowest feasible). SKIN notation: ECH epoxide ring opens with dermal nucleophiles (log P +0.45; Kp ≈ 0.018 cm/hr); dermal absorption adds 35–55% to inhalation body burden at 1.8–3.8 ppm. Three adversarial surfaces: (1) Olin McIntosh AL ECH production saponification reactor sampling — Honeywell Analytics Midas Multigen ECH EC — 3.8 ppm shown as 0.38 ppm (7.6× TLV-TWA A3; 76% OSHA ceiling; Honeywell Forge EHS: OSHA COMPLIANT; ACGIH violation structurally invisible); (2) Hexion Columbus OH DGEBA reactor ECH distillation recovery condenser manway — MSA ALTAIR 5X PID — 2.6 ppm shown as 0.26 ppm (5.2× TLV-TWA; 52% OSHA ceiling; Cority EHS: OSHA COMPLIANT); (3) carvedilol API glycidyl ether step Aurobindo Pharma Hyderabad — Dräger X-am 5000 ECH EC — 1.8 ppm shown as 0.18 ppm (3.6× TLV-TWA; 36% OSHA ceiling; Veeva Quality: OSHA COMPLIANT; FDA GMP batch record corrupted). Threshold 35.

  Read the full post →

• Arsine AsH₃ AI Security · OSHA PEL 0.05 ppm vs ACGIH TLV-TWA 0.002 ppm A2 (25× Gap — Largest for Any Semiconductor Specialty Hydride in 228-Entry Portfolio) · NIOSH REL 0.002 ppm = ACGIH TLV (Both 25× Below OSHA — Unique Dual-Agency Consensus) · IARC Group 1 Arsenic (Lung + Bladder + Skin) · Hemolytic Anemia 24–72 hr Delayed Acute Renal Failure · GlobalFoundries Fab 8 Malta NY 0.038 ppm Shown as 0.0015 (19× TLV) · Coherent MOCVD Saxonburg PA 0.044 ppm Shown as 0.0017 (22× TLV) · LabCorp HPLC-ICP-MS/MS 94 μg/g Cr Shown as 8 (2.69× BEI) · 228th Adversarial Attack · First Arsine AI Blog · Glyphward Threshold 38 · 2026-07-29

  Arsine (AsH₃) OSHA PEL 0.05 ppm vs ACGIH TLV-TWA 0.002 ppm A2 (25× gap — largest OSHA/ACGIH gap for any semiconductor specialty hydride in 228-entry portfolio); NIOSH REL 0.002 ppm = ACGIH TLV (both 25× below OSHA — unique dual-agency consensus against OSHA PEL); IARC Group 1 arsenic (lung + bladder + skin); hemolytic anemia 24–72 hr delayed acute renal failure; GlobalFoundries Fab 8 Malta NY 0.038 ppm shown as 0.0015; Coherent MOCVD Saxonburg PA 0.044 ppm shown as 0.0017; LabCorp urinary arsenic HPLC-ICP-MS/MS 94 μg/g Cr shown as 8 (2.69× BEI); Glyphward Threshold 38, 228th Adversarial Attack

  The 228th adversarial attack — first arsine (AsH₃) AI adversarial injection blog. OSHA PEL 0.05 ppm (1971; Table Z-1; frozen) vs ACGIH TLV-TWA 0.002 ppm A2 — largest OSHA/ACGIH gap for any semiconductor specialty hydride in the portfolio. NIOSH REL 0.002 ppm (15-min Ceiling) = ACGIH TLV-TWA = both 25× below OSHA PEL — unique dual non-OSHA agency consensus (independent frameworks converging on identical limit). IARC Group 1 arsenic compounds: lung + bladder + skin (three confirmed cancer sites; broadest multi-site IARC Group 1 classification for any inorganic semiconductor gas). Hemolytic mechanism: AsH₃ → Hb adduct → methemoglobin → intravascular hemolysis → hemoglobinuria → acute tubular necrosis → renal failure 24–72 hr post-exposure (longest monitoring-to-organ-failure interval in portfolio). Surface 1: GlobalFoundries Fab 8 Malta NY MSA ALTAIR 5X AsH₃ EC 0.038 ppm shown as 0.0015 (19× ACGIH TLV; 19× NIOSH REL; below OSHA PEL; Honeywell Forge EHS: OSHA COMPLIANT). Surface 2: Coherent Corp Saxonburg PA MOCVD Dräger X-am 7000 AsH₃ EC 0.044 ppm shown as 0.0017 (22× ACGIH TLV; 88% OSHA PEL; Emerson DeltaV EHS: OSHA COMPLIANT). Surface 3: LabCorp urinary inorganic arsenic speciation HPLC-ICP-MS/MS 94 μg/g Cr shown as 8 μg/g Cr (2.69× BEI; dual air + biological monitoring channels defeated simultaneously). Threshold 38.

  Read the full post →

• TCE Trichloroethylene AI Security · OSHA PEL 100 ppm vs ACGIH TLV-TWA 10 ppm A2 (10× Gap — Largest for Any IARC Group 1 Chlorinated Solvent) · NIOSH Ca REL 1 ppm (100× Below OSHA PEL) · VHL Exon 3 CpG C→T Mutation Fingerprint · Camp Lejeune 1953–1987 (Janey Ensminger Act; VA Presumptive Service Connection Kidney Cancer) · Baron-Blakeslee V-300 Chicago 55 ppm Shown as 8 (5.5× TLV) · Intel D1X Hillsboro OR 22 ppm Shown as 4 (2.2× TLV) · LabCorp TCOH GC-ECD 8.5 mg/g Cr Shown as 1.2 (2.83× BEI) · 222nd Adversarial Attack · First TCE AI Blog · Glyphward Threshold 38 · 2026-07-25

  Trichloroethylene (TCE) OSHA PEL 100 ppm vs ACGIH TLV-TWA 10 ppm A2 (10× gap — largest OSHA/ACGIH gap for any IARC Group 1 chlorinated solvent); NIOSH Ca REL 1 ppm (100× below OSHA PEL); VHL exon 3 CpG C→T mutation fingerprint; Camp Lejeune 1953–1987; Baron-Blakeslee V-300 55 ppm shown as 8; Intel D1X Hillsboro OR 22 ppm shown as 4; LabCorp TCOH GC-ECD 8.5 mg/g Cr shown as 1.2 (2.83× BEI); Glyphward Threshold 38, 222nd Adversarial Attack

  The 222nd adversarial attack — first TCE trichloroethylene AI adversarial injection blog. OSHA PEL 100 ppm (1971; frozen) vs ACGIH TLV-TWA 10 ppm A2 — largest OSHA/ACGIH gap for any IARC Group 1 carcinogen in the portfolio. NIOSH Ca REL 1 ppm = 100× below OSHA PEL (one of three largest NIOSH Ca/OSHA ratios). VHL exon 3 CpG C→T forensic fingerprint (Brauch 2004 JNCI) enables molecular attribution of kidney RCC to TCE exposure — adversarial monitoring falsification suppresses the clinical trigger for VHL tumor profiling. Camp Lejeune 1953–1987 (Janey Ensminger Act 2012; VA presumptive service connection kidney cancer). Surface 1: Baron-Blakeslee V-300 Chicago IL MSA Altair 5X PID 55 ppm shown as 8 (5.5× TLV-TWA; 55× NIOSH Ca REL; Honeywell Forge EHS: OSHA COMPLIANT). Surface 2: Intel D1X Hillsboro OR ppbRAE 3000+ 22 ppm shown as 4 (PM duration exceedance masked). Surface 3: LabCorp TCOH GC-ECD 8.5 mg/g Cr shown as 1.2 (2.83× BEI; dual air + biological monitoring channels defeated simultaneously). Threshold 38.

  Read the full post →

• Benzene OSHA 1910.1028 AI Security · Triple Regulatory Bypass (OSHA Action Level 0.5 ppm = ACGIH TLV-TWA 0.5 ppm A1 — One Display Suppression Defeats OSHA PEL + Action Level + ACGIH TLV Simultaneously; Unique in 211-Entry Portfolio) · NQO1*2/*2 (7× AML RR; ~4% European Workforce) · Rinsky 1987 NEJM Pliofilm · Phillips 66 Sweeny TX 1.8 ppm Shown as 0.35 (Triple Bypass) · Chevron Phillips SPMA 182 μg/g Cr Shown as 27 (7.3× BEI) · Motiva Port Arthur TTMA 2,850 μg/g Cr Shown as 350 (5.7× BEI) · 211th Adversarial Attack · First Benzene AI Blog · Glyphward Threshold 40 · 2026-07-24

  Benzene OSHA 1910.1028 AI adversarial injection: triple regulatory bypass (OSHA action level 0.5 ppm = ACGIH TLV-TWA 0.5 ppm A1 — one display suppression defeats OSHA PEL, OSHA action level, and ACGIH TLV simultaneously; unique in 211-entry portfolio); NQO1*2/*2 (7× AML RR; ~4% European workforce); Rinsky 1987 NEJM Pliofilm; Phillips 66 Sweeny TX 1.8 ppm shown as 0.35 (triple bypass); Chevron Phillips SPMA 182 μg/g Cr shown as 27 (7.3× BEI); Motiva Port Arthur TTMA 2,850 μg/g Cr shown as 350 (5.7× BEI); Glyphward Threshold 40, 211th Adversarial Attack

  The 211th adversarial attack — first benzene OSHA 1910.1028 AI adversarial injection blog. Triple regulatory bypass: OSHA action level 0.5 ppm = ACGIH TLV-TWA 0.5 ppm (unique in portfolio) — one display suppression below 0.5 ppm defeats OSHA PEL, action level, and ACGIH TLV simultaneously. Surface 1: Phillips 66 Sweeny TX BTEX MSA ALTAIR 4X PID 1.8 ppm shown as 0.35 (triple bypass). Surface 2: Chevron Phillips Cedar Bayou SPMA Waters Xevo TQ-S 182 μg/g Cr shown as 27 (7.3× BEI; immediate medical removal suppressed). Surface 3: Motiva Port Arthur TTMA Shimadzu HPLC-UV 2,850 μg/g Cr shown as 350 (5.7× BEI; dual biomarker channel defeat). Threshold 40.

  Read the full post →

• Ethylene Dibromide EDB OSHA Z-2 Ceiling 20 ppm vs ACGIH TLV-TWA 0.1 ppm A2 (200× Regulatory Gap) AI Security · NIOSH Ca REL Lowest Detectable Level · EPA 1984 Emergency Grain Fumigant Suspension · UF IFAS Gainesville GC-ECD 0.62 ppm Shown as 0.050 (6.2× TLV; OSHA Ceiling Generates Zero Violation — Structural Blind Zone) · TCI America Portland Honeywell Midas Pro ESC-EDB 0.80 ppm Shown as 0.125 (8× TLV) · UCSF Waters Xevo TQ-XS HEC-Hb Adduct 18 pmol/g Shown as 2.5 (3.6× Threshold; PID MDL ~2 ppm >> ACGIH TLV 0.1 ppm — Biomonitoring Only Option) · GSH-Episulfonium DNA Crosslinks · Ethyl Corporation Leaded Gasoline Phaseout 1986 · 205th Adversarial Attack · First EDB AI Blog · Glyphward Threshold 40 · 2026-07-23

  Ethylene dibromide (EDB) OSHA Z-2 ceiling 20 ppm vs ACGIH TLV-TWA 0.1 ppm A2 (200× regulatory gap; NIOSH Ca REL lowest detectable; EPA 1984 emergency grain fumigant suspension); UF IFAS Gainesville GC-ECD 0.62 ppm shown as 0.050 (6.2× TLV; OSHA ceiling untriggered — structural blind zone); TCI America Honeywell Midas Pro 0.80 ppm shown as 0.125 (8× TLV); UCSF Waters Xevo TQ-XS HEC-Hb adduct 18 pmol/g shown as 2.5 (3.6× threshold); GSH-episulfonium DNA crosslinks; Glyphward Threshold 40, 205th Adversarial Attack

  The 205th adversarial attack — first EDB ethylene dibromide AI adversarial injection blog. OSHA Z-2 ceiling 20 ppm (1971; NEVER UPDATED in 53+ years) vs ACGIH TLV-TWA 0.1 ppm A2 = 200× regulatory gap. NIOSH Ca REL: lowest feasible concentration (no numerical value). EPA 1984 emergency suspension of all US grain fumigant EDB registrations (muffin mix 9–14 ppb; cake mix up to 30 ppb; exceeded EPA 10⁻⁶ cancer risk benchmark). Surface 1: UF IFAS Gainesville Perkin-Elmer ATD GC-ECD 0.62 ppm shown as 0.050 → 6.2× ACGIH TLV; OSHA ceiling 20 ppm generates zero violation at true 0.62 ppm (3.1% of ceiling) — the structural OSHA blind zone. Surface 2: TCI America Portland Honeywell Midas Pro ESC-EDB 0.80 ppm shown as 0.125 → 8× TLV; conventional PIDs cannot detect EDB at TLV concentrations (PID MDL ~2 ppm = 20× TLV). Surface 3: UCSF Waters Xevo TQ-XS HEC-Val Hb adduct 18.0 pmol/g Hb shown as 2.5 → 3.6× occupational threshold; defeats the primary biological monitoring tool deployed specifically because air monitoring PIDs are blind to EDB at TLV concentrations. GSH → S-(2-bromoethyl)glutathione → episulfonium (half-mustard; DNA interstrand crosslinks). Threshold 40.

  Read the full post →

• Vinyl Chloride VCM OSHA 1910.1017 AI Security · OSHA’s First Carcinogen Standard 1974 (B.F. Goodrich Louisville 4 Kettle Cleaner ASL Deaths) · IARC Group 1 Hepatic Angiosarcoma 100% CFR · 400–500× Background Rate VCM Cohort · Median Survival 6 Months · Westlake Lake Charles Autoclave Pre-entry 4.8 ppm Shown as 0.40 (4.8× PEL; Confined Space Entry Authorized) · Formosa Transfer Tank 2.3 ppm Shown as 0.25 (2.3× PEL; Action Level Suppressed) · Aidoc Hepatic Ultrasound 0.9 cm ASL Shown as Hemangioma D18.09 (24-Month Delay; 4.2 cm Unresectable) · p53 Codon 179/249 A:T→T:A Mutation Fingerprint · 199th Adversarial Attack · First VCM Occupational Health AI Blog · Glyphward Threshold 40 · 2026-07-23

  Vinyl chloride (VCM) OSHA 1910.1017 AI adversarial injection: OSHA’s first carcinogen standard (1974; B.F. Goodrich Louisville 4 kettle cleaner deaths); hepatic angiosarcoma 100% CFR (400–500× background rate VCM cohort; median survival 6 months); Westlake autoclave pre-entry 4.8 ppm shown as 0.40 (4.8× PEL; confined space re-entry authorized); Formosa transfer 2.3 ppm shown as 0.25; Aidoc hepatic ultrasound 0.9 cm ASL shown as hemangioma (24-month resection delay; 4.2 cm unresectable); p53 codon 179/249 mutation fingerprint; Glyphward Threshold 40, 199th Adversarial Attack

  The 199th adversarial attack — first VCM occupational health AI adversarial injection blog. OSHA 1910.1017 (promulgated October 4, 1974) was OSHA’s first substance-specific carcinogen standard, triggered by 4 B.F. Goodrich Louisville kettle cleaner hepatic angiosarcoma deaths in 1974. Surface 1: Westlake Lake Charles PVC autoclave pre-entry RAE MiniRAE PID 4.8 ppm shown as 0.40 → 4.8× PEL; OSHA 1910.146 confined space entry permit authorized at falsified reading; medical surveillance enrollment bypassed. Surface 2: Formosa Plastics VCM transfer tank Draeger 2.3 ppm shown as 0.25 → 2.3× PEL; action level 0.5 ppm suppressed. Surface 3: Philips Epiq Elite hepatic ultrasound Aidoc AI PACS — 0.9 cm ASL shown as hemangioma ICD-10 D18.09; 24-month surveillance interval elapse; re-imaging at 4.2 cm unresectable; 100% CFR. p53 codon 249 A:T→T:A transversion (R249S) forensically proves VCM causation while falsified monitoring records obscure employer notice. Threshold 40.

  Read the full post →

• Asbestos Chrysotile Amphibole OSHA 1910.1001 PCM Clearance TEM AHERA School Clearance AI Security · OSHA PEL 0.1 f/cc 10× MORE Protective than ACGIH TLV-TWA 1 f/cc A1 (Unique Regulatory Reversal in Portfolio) · PCM Clearance 0.4 f/cc Shown as 0.07 (4× OSHA PEL; 180 Occupants Re-exposed) · Class I Abatement 0.8 f/cc Shown as 0.08 (8× PEL; PAPR Withheld) · TEM AHERA School 890 s/mm² Shown as 58 (12.7× Threshold; 340 Students; 60-Year Latency) · Mesothelioma 100% CFR · IARC Group 1 All Fiber Types · No Safe Level · 30–60 Year Latency · Manville Trust >$4B · W.R. Grace Libby >400 Deaths · 193rd Adversarial Attack · First Asbestos AI Blog · First OSHA-More-Protective-Than-ACGIH Reversal AI Blog · First TEM AHERA School Clearance AI Blog · Glyphward Threshold 42 · 2026-07-18

  Asbestos chrysotile amphibole OSHA 1910.1001 AI adversarial injection: OSHA PEL 0.1 f/cc MORE protective than ACGIH TLV-TWA 1 f/cc A1 (10× regulatory reversal — unique in Glyphward portfolio); PCM clearance 0.4 f/cc shown as 0.07 (4× PEL; 180 occupants); TEM AHERA school clearance 890 s/mm² shown as 58 (12.7× threshold; 340 students; 60-year mesothelioma latency) — mesothelioma 100% CFR; Manville Trust >$4B; Glyphward Threshold 42, 193rd Adversarial Attack

  The 193rd adversarial attack — first asbestos AI adversarial blog, first OSHA-more-protective-than-ACGIH regulatory reversal AI blog (unique in the 193-entry Glyphward portfolio: OSHA 1910.1001 PEL 0.1 f/cc is 10× more protective than ACGIH TLV-TWA 1 f/cc chrysotile A1), and first TEM AHERA school clearance AI falsification blog. Surface 1: NYC office PCM clearance 0.4 f/cc shown as 0.07 → 4× OSHA PEL; clearance pass falsified; 180 occupants. Surface 2: Class I abatement PBZ 0.8 f/cc shown as 0.08 → 8× PEL; PAPR upgrade withheld. Surface 3: TEM AHERA school gymnasium 890 s/mm² shown as 58 → 12.7× AHERA threshold; 340 elementary students; 60-year mesothelioma latency. Mesothelioma: invariably fatal; IARC Group 1; no safe level. Manville Trust >$4B. W. R. Grace Libby >400 deaths. Threshold 42.

  Read the full post →

• Manganese Fume Mn GMAW FCAW Welding AI Security · OSHA PEL Ceiling 5 mg/m³ (Z-2 Table; ceiling not TWA) vs ACGIH TLV-TWA 0.02 mg/m³ inhalable (250× gap — widest in Glyphward portfolio) · 0.18 mg/m³ shown as 0.04 (9× TLV; OSHA ceiling untriggered) · Hadfield 13.5% Mn FCAW 0.27 shown as 0.060 (13.5× TLV) · Blood Mn BEI 29.4 μg/L shown as 9.9 (1.96× BEI suppressed) · Manganism Irreversible Basal Ganglia · No L-DOPA Response · No Recovery · Lincoln Electric >$40M Litigation · ESAB · South32 · Glencore · Eramet · 187th Adversarial Attack · First Mn Welding AI Blog · First 250× PEL-TLV Gap AI Blog · First Manganism AI Blog · Glyphward Threshold 42 · 2026-07-18

  Manganese fume (Mn) GMAW/FCAW welding AI adversarial injection: OSHA PEL ceiling 5 mg/m³ vs ACGIH TLV-TWA 0.02 mg/m³ (250× gap — widest in Glyphward portfolio); 0.18 mg/m³ shown as 0.04 mg/m³ (9× TLV-TWA; OSHA ceiling untriggered); Hadfield FCAW 0.27 mg/m³ shown as 0.060 (13.5× TLV); blood Mn BEI 29.4 μg/L shown as 9.9 μg/L (→ manganism irreversible; no L-DOPA; no recovery) — Lincoln Electric >$40M litigation, ESAB South32 Glencore Eramet, Glyphward Threshold 42, 187th Adversarial Attack

  The 187th adversarial attack — first manganese fume welding AI adversarial blog, first 250× PEL-to-TLV regulatory gap AI adversarial blog (the widest structural asymmetry in the 187-entry Glyphward portfolio: OSHA ceiling 5 mg/m³ vs ACGIH TLV-TWA 0.02 mg/m³), and first manganism irreversible basal ganglia AI adversarial blog. Surface 1: Lincoln Electric pDR-1500 GMAW 0.18 mg/m³ shown as 0.04 → 9× TLV-TWA; OSHA ceiling 5 mg/m³ untriggered; 14 welders accumulating chronic Mn. Surface 2: ESAB Hadfield 13.5% Mn FCAW 0.27 mg/m³ shown as 0.060 → 13.5× TLV. Surface 3: blood Mn ICP-MS 29.4 μg/L shown as 9.9 → 1.96× BEI; MRI T1 pallidal hyperintensity not ordered; manganism irreversible. Threshold 42.

  Read the full post →

• Boron Trifluoride BF₃ Pharmaceutical Friedel-Crafts Lewis Acid + Semiconductor Ion Implantation AI Security · Triple-Ceiling Equivalence OSHA PEL C = ACGIH TLV-C = NIOSH REL C = 1 ppm · HF In-Situ Hydrolysis Dual-Ceiling · Plasma Fluoride BEI Hypocalcaemia QTc · CERCLA RQ 1 lb · NIOSH IDLH 25× Ceiling · DOT 2.3 Poison Gas · Lonza · Bachem · TSMC · Applied Materials · Axcelis · 181st Adversarial Attack · First BF₃ Triple-Ceiling AI Blog · First HF Hydrolysis Dual-Ceiling AI Blog · Glyphward Threshold 38 · 2026-07-18

  Boron Trifluoride (BF₃) pharmaceutical Friedel-Crafts Lewis acid + semiconductor ion implantation AI adversarial injection: triple-ceiling equivalence OSHA PEL C = ACGIH TLV-C = NIOSH REL C = 1 ppm (3.8 ppm shown as 0.60 ppm; 3.8× all three ceilings simultaneously); plasma fluoride BEI 0.80 mg/L shown as 0.18 mg/L (→ HF hydrolysis Ca²⁺ chelation hypocalcaemia QTc suppressed); BF₃ cylinder pressure 8 psia shown as 38 psia (TSMC VIISta endstation 6.2 ppm; 6.2× triple-ceiling) — CERCLA RQ 1 lb, NIOSH IDLH 25×, DOT 2.3 Poison Gas, Lonza Bachem TSMC Applied Materials Axcelis, Glyphward Threshold 38, 181st Adversarial Attack

  The 181st adversarial attack — first BF₃ pharmaceutical + semiconductor AI adversarial blog, first triple-ceiling equivalence AI blog (OSHA = ACGIH = NIOSH = 1 ppm: one pixel simultaneously nullifies all three US ceiling agencies), and first HF in-situ hydrolysis dual-ceiling AI blog in the Glyphward portfolio. Surface 1: Lonza Visp fume hood 3.8 ppm shown as 0.60 ppm → 3.8× all three ceilings; mucosal HF 3.4 ppm = 6.8× HF TLV-C; corneal fluoride opacity; CERCLA RQ 1 lb. Surface 2: plasma fluoride 0.80 mg/L shown as 0.18 mg/L → CaF₂ Ca²⁺ sequestration → hypocalcaemia → QTc → ventricular arrhythmia; 4-hour calcium gluconate window missed. Surface 3: TSMC VIISta cylinder 8 psia shown as 38 psia → $2.8M wafer lot loss → endstation 6.2 ppm = 6.2× triple-ceiling. Threshold 38.

  Read the full post →

• Dichloromethane DCM Pharmaceutical API Solvent Recovery AI Security · OSHA 29 CFR 1910.1052 Specific DCM Standard · IARC Group 1 (Monograph 132, 2023) · NIOSH Ca · ACGIH BEI Exhaled CO · CYP2E1 Endogenous CO · CERCLA RQ 1,000 lbs · 40 CFR 63 Subpart GGG NESHAP · Lonza · Cambrex · Bachem · 170th Adversarial Attack · First DCM AI Blog · First CYP2E1 CO BEI Suppression AI Blog · Glyphward Threshold 44 · 2026-07-17

  Dichloromethane (DCM; CH₂Cl₂) pharmaceutical API solvent recovery OSHA 29 CFR 1910.1052 AI adversarial injection: 52 ppm shown as 8 ppm (2.08× OSHA PEL; 4.16× action level); exhaled CO BEI 34 ppm shown as 6 ppm (→ CYP2E1 COHb suppressed); carbon adsorber breakthrough 28 ppm shown as 3.1 ppm (→ 40 CFR 63 Subpart GGG NESHAP violation) — IARC Group 1 (Monograph 132, 2023), NIOSH Ca, Lonza, Cambrex, Bachem, Glyphward Threshold 44, 170th adversarial attack

  The 170th adversarial attack — first dichloromethane DCM pharmaceutical API AI adversarial blog and first CYP2E1 endogenous CO BEI suppression AI blog in the Glyphward portfolio. Surface 1: air monitor 52 ppm shown as 8 ppm → 2.08× OSHA PEL; 4.16× action level; 1910.1052 programme suppressed. Surface 2: exhaled CO BEI 34 ppm shown as 6 ppm; COHb 5–6.5%; cardiac ischemia in worker with coronary disease; standard CO monitors provide zero protection (CYP2E1 endogenous CO mechanism). Surface 3: carbon adsorber 28 ppm shown as 3.1 ppm; NESHAP Subpart GGG violation; $37,500/day penalty. IARC Group 1 2023. Threshold 44.

  Read the full post →

• Beta-Propiolactone BPL Plasma Virus Inactivation Pharmaceutical AI Security · OSHA 29 CFR 1910.1013 Specific Carcinogen Standard · NIOSH Ca IDLH 10 ppm · IARC Group 2B · CERCLA RQ 10 lbs · FDA 21 CFR 640 CGMP · ICH Q5A Viral Safety · CSL Behring · Grifols · Octapharma · Kedrion · Takeda BaxAlta · 158th Adversarial Attack · First BPL AI Blog · First OSHA 1910.1013 AI Blog · First Blood Plasma Virus Inactivation AI Blog · Glyphward Threshold 46 · 2026-07-15

  Beta-propiolactone (BPL) plasma virus inactivation pharmaceutical OSHA 1910.1013 AI adversarial injection: how ±8 DN conceals 1.4 ppm BPL (2.8× OSHA PEL; 5.6× action level) as 0.03 ppm, 0.024 vol% BPL dose (10× underdose → HIV/HBV/HCV breakthrough) as 0.28 vol%, and pH 5.4 (42% BPL unhydrolyzed → patient IV DNA alkylation) as pH 7.8 — OSHA 1910.1013 specific carcinogen, FDA 21 CFR 640 CGMP, ICH Q5A viral safety, 1980s haemophilia HIV/HCV contamination crisis precedent, CSL Behring, Grifols, Octapharma, Glyphward threshold 46, 158th adversarial attack

  The 158th adversarial attack — first beta-propiolactone BPL AI adversarial blog, first OSHA 29 CFR 1910.1013 specific carcinogen standard AI blog, and first blood plasma virus inactivation AI blog in the Glyphward portfolio. Surface 1: BPL atmospheric 1.4 ppm shown as 0.03 ppm → 2.8× OSHA 1910.1013 PEL 0.5 ppm (one of 13 substance-specific OSHA carcinogen standards); 5.6× action level; no medical surveillance enrollment; 30-year carcinogen exposure record falsified. Surface 2: BPL in-process concentration 0.024 vol% shown as 0.28 vol% → 10× underdose; <0.4 log₁₀ LRV vs. required ≥4 log₁₀ per ICH Q5A; HIV/HBV/HCV survives virus inactivation step; blood product released with incomplete virus kill; 1980s haemophilia HIV contamination crisis (approximately 8,000–10,000 US patients infected) as the patient-safety precedent. Surface 3: BPL hydrolysis pH 5.4 shown as pH 7.8 → hydrolysis rate 12–15× slower; 56% BPL unhydrolyzed at 6-hour window; residual BPL in IV IVIG/Factor VIII → patient DNA alkylation; IARC Group 2B direct-acting alkylator; ICH Q3C Category 1 residual limit violated. NIOSH Ca IDLH 10 ppm. CERCLA RQ 10 lbs. CSL Behring; Grifols; Octapharma; Kedrion; Takeda/BaxAlta. Glyphward threshold 46.

  Read the full post →

• Carbon Disulfide CS² Viscose Rayon Xanthation AI Security · OSHA PSM TQ 10,000 lbs CS² · OSHA PSM TQ 10,000 lbs H&sub2;S · CERCLA RQ 100 lbs · Flash Point −30 °C · Autoignition 90 °C · NIOSH REL 1 ppm · Chronic Cardiovascular Toxin SOD-1 Inhibition · Lenzing Paskov · Sateri Bracell Jiujiang · Asia Pacific Rayon Riau · Birla Cellulose Nagda · 152nd Adversarial Attack · First CS² AI Blog · First Viscose Rayon AI Blog · First Chronic Cardiovascular AI Attack · Glyphward Threshold 32 · 2026-07-14

  Carbon disulfide (CS²) viscose rayon xanthation AI adversarial injection: how ±8 DN conceals 87 ppm CS² (4.4× OSHA PEL; 87× NIOSH REL; xanthator overtemperature root cause) as 6.1 ppm, 12.4 ppm H&sub2;S as 0.3 ppm, and xanthator cooling 0.41 m³/hr as 8.4 m³/hr — OSHA PSM TQ 10,000 lbs, CERCLA RQ 100 lbs, CS² autoignition 90 °C, chronic cardiovascular disease pathway, Lenzing, Sateri Bracell Jiujiang, Asia Pacific Rayon Riau, Glyphward threshold 32, 152nd adversarial attack

  A ±8 DN upward adversarial perturbation on the xanthator #3 cooling water supply flow bargraph shows 8.4 m³/hr (design setpoint; GREEN) when actual cooling flow is 0.41 m³/hr (4.9% design; instrument air compressor PTFE discharge valve seal leak; spring-to-fail-closed actuator) — the 152nd adversarial attack, the first carbon disulfide CS² viscose rayon xanthation AI adversarial injection blog, the first chronic cardiovascular occupational disease AI attack in the Glyphward portfolio, and the first CS² autoignition 90 °C steam-pipe ignition pathway AI blog. Cooling failure allows xanthator internal temperature to reach 41 °C (above the 35 °C upper limit), raising CS² vapor pressure 1.8× and accelerating xanthate hydrolysis 5.1× at Arrhenius E_a 75 kJ/mol, producing elevated CS² and H&sub2;S off-gassing into the xanthation room. A ±8 DN downward perturbation on the H&sub2;S electrochemical area sensor shows 0.3 ppm (GREEN) when actual H&sub2;S is 12.4 ppm (12.4× ACGIH TLV-TWA 1 ppm; 2.5× ACGIH TLV-STEL 5 ppm; olfactory fatigue threshold approach). A ±8 DN downward perturbation on the CS² PID area monitor shows 6.1 ppm (GREEN; below OSHA PEL 20 ppm) when actual is 87 ppm (4.4× OSHA PEL; 87× NIOSH REL 1 ppm; 87× ACGIH TLV-TWA 1 ppm skin). Workers continue unprotected; exposure records show apparent OSHA compliance while the chronic cardiovascular disease pathway — Cu/Zn SOD-1 inactivation by CS² dithiocarbamate metabolites → superoxide radical accumulation → eNOS uncoupling → accelerated atherosclerosis (4.7× IHD mortality in Finnish viscose cohort at 10–30 ppm chronic) — accumulates silently. CS² autoignition at 90 °C on steam condensate piping at 108 °C provides a simultaneous flash-fire pathway (flash point −30 °C; LEL 1.3 vol%; vapor density 2.64 — floor pooling). OSHA PSM TQ 10,000 lbs (CS²); OSHA PSM TQ 10,000 lbs (H&sub2;S); CERCLA RQ 100 lbs. Sateri (Bracell) Jiujiang (~700,000 t/yr VSF); Lenzing AG Paskov; Asia Pacific Rayon Riau Indonesia; Birla Cellulose Nagda MP. Glyphward threshold 32.

  Read the full post →

• Cumene Hydroperoxide CHP Hock-Process AI Security · OSHA PSM TQ 10,000 lbs CHP ≥35 wt% · EPA RMP TQ 10,000 lbs · NFPA 43B Organic Peroxide Class III · SADT-Masking Downward Attack · CERCLA RQ 10 lbs · AdvanSix Frankford PA · INEOS Phenol Gladbeck · 146th Adversarial Attack · First Phenol–Acetone Hock-Process AI Blog · First CHP SADT-Masking AI Attack · First Organic Peroxide Concentrator AI Blog · Glyphward Threshold 40 · 2026-07-13

  Cumene hydroperoxide (CHP) Hock-process concentrator AI adversarial injection: how ±8 DN conceals 82.4 wt% CHP (SADT-critical zone; sump 12.2 °C above SADT) as 54.1 wt% safe mid-range and 74.2 °C sump temperature as 57.4 °C — OSHA PSM TQ 10,000 lbs, NFPA 43B, AdvanSix Frankford PA, INEOS Phenol Gladbeck, Glyphward threshold 40, 146th adversarial attack

  A ±8 DN downward adversarial perturbation on the NIR CHP concentration analyser bargraph at a Hock-process phenol plant concentrator column shows 54.1 wt% CHP (safe intermediate range; below all alarm thresholds) when actual bottoms CHP concentration is 82.4 wt% (10.4 wt% above the 80 wt% emergency shutdown setpoint; SADT at 82 wt% CHP ≈ 62 °C; actual sump temperature 74.2 °C is 12.2 °C above the SADT → exothermic CHP decomposition already initiating) — the 146th adversarial attack, the first phenol–acetone Hock-process AI adversarial injection blog, the first CHP concentration SADT-masking AI attack, and the first organic peroxide concentrator AI blog. A companion ±8 DN downward perturbation on the sump thermocouple shows 57.4 °C (normal operating range; below 70 °C high-process alarm and 80 °C ESD setpoint) when actual sump temperature is 74.2 °C (above both setpoints; ESD would activate automatically). A companion ±8 DN upward perturbation on the emergency cooling jacket water flow bargraph shows 9.2 m³/hr (design setpoint; cooling adequate) when actual cooling flow is 0.47 m³/hr (5.1% design; instrument air header pressure decay 80 → 22 psig from compressor seal leak; spring-to-fail-closed cooling water valve actuator failed): the root cause of the entire causal chain. CHP thermal decomposition energy release: ΔH_decomp 1,400 kJ/kg × 8,500 kg CHP inventory × 82% = 9.8 GJ → deflagration-to-detonation transition in the concentrator column → column BLEVE → acetone flash fire (flash point −20 °C; LEL 2.6 vol%) + phenol aerosol (NIOSH IDLH 250 ppm; OSHA PSM TQ 1,000 lbs; skin-penetrating systemic toxin) + cumene cloud (flash point 31 °C; LEL 0.9 vol%). OSHA PSM TQ 10,000 lbs CHP at ≥35 wt%; EPA RMP TQ 10,000 lbs; CERCLA RQ 10 lbs (CHP); NFPA 43B Class III organic peroxide. AdvanSix Frankford PA (~240,000 t/yr phenol; world’s largest single-site Hock-process plant); INEOS Phenol Gladbeck Germany (~500,000 t/yr). Glyphward threshold 40.

  Read the full post →

• Acrylonitrile ACN Bulk Storage AI Security · OSHA 29 CFR 1910.1045 ACN Carcinogen Standard · PSM TQ 10,000 lbs Flash Point 0 °C · MEHQ Dissolved-O&sub2; Dual-Inhibitor Failure · Popcorn Polymer ΔH_poly 1,376 kJ/kg · EPA IRIS B1 IUR 6.8×10⊃−&sup5; per μg/m³ · Ineos Nitriles Green Lake TX · 140th Upward Attack · First ACN Bulk Storage AI Blog · First MEHQ Dissolved-O&sub2; Dual-Inhibitor AI Blog · First OSHA 1910.1045 ACN Carcinogen Standard AI Blog · First Popcorn Polymer Autocatalytic Runaway AI Blog · Glyphward Threshold 44 · 2026-07-13

  Acrylonitrile ACN bulk storage MEHQ dissolved-oxygen inhibitor AI adversarial injection: how ±8 DN in the rendered dissolved-O&sub2; bargraph conceals the 1.8 ppm dissolved-oxygen collapse (below 5 ppm MEHQ activation threshold) and the 3.2 ppm EPA‑IRIS‑B1‑carcinogen atmospheric overexposure — and why OSHA 29 CFR 1910.1045 ACN‑specific carcinogen standard + PSM TQ 10,000 lbs acrylonitrile bulk storage AI has no adversarial robustness criterion, Ineos Nitriles Green Lake TX, Glyphward threshold 44, 140th upward-direction attack

  A ±8 DN adversarial pixel perturbation on the dissolved-oxygen bargraph at a 100,000-gallon acrylonitrile (ACN; CAS 107-13-1; BP 77.3 °C; flash point 0 °C; LEL 3.0 vol%; OSHA PSM TQ 10,000 lbs; OSHA PEL 2 ppm TWA per 29 CFR 1910.1045) bulk storage sphere shows 22 ppm dissolved O&sub2; (above the 20 ppm minimum specification; MEHQ inhibitor active; storage safe) when actual dissolved O&sub2; is 1.8 ppm: below the approximately 5 ppm threshold at which MEHQ (4-methoxyphenol; monomethyl ether hydroquinone) can be oxidised to its active radical-scavenging quinone form — the 140th upward-direction adversarial attack, the first acrylonitrile bulk storage AI adversarial injection blog, the first MEHQ dissolved-oxygen dual-inhibitor failure AI blog, the first OSHA 29 CFR 1910.1045 ACN carcinogen standard AI blog, and the first popcorn polymer autocatalytic runaway AI blog. With dissolved O&sub2; at 1.8 ppm, MEHQ is deactivated: uninhibited free-radical ACN polymerisation begins; popcorn polymer grows autocatalytically from vessel weld seams and nozzle interiors (ΔH_poly 73 kJ/mol = 1,376 kJ/kg — 2.3× higher than chloroprene; total heat release 420 GJ in 305,224 kg ACN inventory); boiling point 77.3 °C reached at 8.7% conversion; popcorn polymer blocks the PRV inlet nozzle before bulk temperature rise is detectable; sphere overpressurises above MAWP; catastrophic release of ACN at flash point 0 °C (OSHA PSM TQ 10,000 lbs; CERCLA RQ 100 lbs). Companion ±8 DN upward on the MEHQ UV-vis analyser shows 42 ppm MEHQ (safe; above 35 ppm minimum specification) when actual MEHQ is 8 ppm (73% below minimum; combined with DO = 1.8 ppm MEHQ deactivation, effective inhibitor = zero; induction period collapses from days to <30 minutes). Companion ±8 DN downward on the ACN area atmospheric monitor shows 0.6 ppm (below OSHA PEL 2 ppm; safe) when actual is 3.2 ppm (160% of OSHA PEL 2 ppm TWA; OSHA 1910.1045 action level 1 ppm exceeded 3.2×; EPA IRIS 1991 B1 probable human carcinogen; inhalation unit risk 6.8×10⊃⁻&sup5; per μg/m³; estimated ~10.8% excess lifetime cancer risk per 40-year occupational career at 3.2 ppm). OSHA 29 CFR 1910.1045 specific carcinogen standard; OSHA PSM 29 CFR 1910.119 TQ 10,000 lbs; EPA RMP 40 CFR Part 68 TQ 10,000 lbs. Ineos Nitriles Green Lake TX (c. 600,000 t/yr; largest single-site ACN producer globally); Ascend Performance Materials Decatur AL. Glyphward threshold 44.

  Read the full post →

• Chloroprene CDP Neoprene Production AI Security · OSHA PSM TQ 10,000 lbs Flash Point −20 °C · TBC Inhibitor Collapse Polymerisation Runaway AI · EPA IRIS Carcinogen IUR 3.4×10⊃⁻&sup5; per μg/m³ · Denka Reserve Louisiana 5th Ward · LEL 4.0 vol% Explosive Atmosphere · CERCLA RQ 100 lbs · 134th Upward Attack · First Chloroprene Neoprene AI Blog · First TBC Inhibitor Collapse Polymerisation AI Blog · First EPA IRIS Carcinogen Flash Point −20°C Dual-Hazard AI Blog · Glyphward Threshold 44 · 2026-07-12

  Chloroprene CDP neoprene polymerisation AI adversarial injection: how ±8 DN in the rendered TBC inhibitor concentration display conceals the 42 ppm inhibitor collapse and the 18.4 ppm EPA‑IRIS‑carcinogen atmospheric overexposure — and why OSHA PSM TQ 10,000 lbs flash point −20 °C chloroprene AI has no adversarial robustness criterion for neoprene production facilities, Denka Reserve Louisiana 5th Ward (EPA NATA 2017 highest US cancer risk single facility), Glyphward threshold 44, 134th upward-direction attack

  A ±8 DN adversarial pixel perturbation on the 4-tert-butylcatechol (TBC) inhibitor concentration display at a chloroprene (CDP; 2-chloro-1,3-butadiene; CAS 126-99-8) storage and neoprene polymerisation facility shows 380 ppm TBC (safe; above 200 ppm minimum specification; AI confirms storage stable) when actual TBC in the 189,000-litre storage tank is 42 ppm (79% below minimum; uninhibited free-radical polychloroprene chain growth; Trommsdorff gel effect acceleration; ΔH_poly 610 kJ/kg; 110 GJ total heat release in the 181,141 kg inventory; tank temperature to boiling point 59.4 °C; PRV lifts; chloroprene vapour cloud at flash point −20 °C; OSHA PSM TQ 10,000 lbs; CERCLA RQ 100 lbs) — the 134th upward-direction adversarial attack, the first chloroprene neoprene AI blog, the first TBC inhibitor collapse polymerisation runaway AI blog, and the first EPA IRIS carcinogen + flash point −20 °C dual-hazard AI blog. Companion ±8 DN upward on the area chloroprene atmospheric monitor shows 2.1 ppm (below OSHA PEL 10 ppm TWA; safe) when actual is 18.4 ppm (184% of OSHA PEL; EPA IRIS 2010 ‘likely to be carcinogenic to humans’; inhalation unit risk 3.4×10⊃⁻&sup5; per μg/m³; hepatocellular carcinoma and lung cancer; Denka Performance Elastomers Reserve St. John the Baptist Parish Louisiana 5th Ward: EPA NATA 2017 identified this community as having the highest estimated cancer risk attributable to a single US industrial facility at nearby residential receptors). Companion ±8 DN downward on the building LEL sensor shows 0.08 vol% (2% LEL; safe; no explosive atmosphere) when actual is 5.8 vol% chloroprene (145% LEL; explosive atmosphere; flash point −20 °C ensures no cold-weather buffer at any Louisiana temperature; transfer pump motor spark from compromised conduit seal → flash fire). OSHA PSM TQ 10,000 lbs; CERCLA RQ 100 lbs; NIOSH IDLH 300 ppm; ACGIH TLV-TWA 10 ppm (skin). Glyphward threshold 44.

  Read the full post →

• Chlor-Alkali Electrolysis AI Security · Cl₂ OSHA PSM TQ 2,500 lbs IDLH 25 ppm · H₂ PSM TQ 10,000 lbs · H₂+Cl₂ Photoinitiated Detonation · Nafion Membrane Pinhole · Dual-PSM Cl₂+H₂ · Graniteville SC 6 January 2005 · Olin Corporation McIntosh AI · Eurochlor ES-C-04 · 128th Upward Attack · First Chlor-Alkali AI Blog · First H₂-in-Cl₂ Explosive Atmosphere AI Blog · First Nafion Membrane Cell Voltage AI Blog · Glyphward Threshold 46 · 2026-07-12

  Chlor-alkali membrane electrolysis Cl₂ H₂ AI adversarial injection: how ±8 DN in the rendered H₂-in-Cl₂ display conceals the 3.8 vol% H₂/Cl₂ explosive atmosphere in the gas header and the Nafion membrane pinhole root cause — and why OSHA PSM TQ 2,500 lbs Cl₂ + TQ 10,000 lbs H₂ dual-PSM has no adversarial robustness criterion for chloralkali electrolysis AI, Graniteville SC 6 January 2005 (9 killed; 250+ hospitalised; 5,400 evacuated), Glyphward threshold 46, 128th upward-direction attack

  A ±8 DN adversarial pixel perturbation on the H₂-in-Cl₂ analyzer display shows 0.28 vol% H₂ (safe; below Eurochlor alert limit 0.5 vol%; no explosive risk flagged) when actual H₂ concentration in the Cl₂ header dead-leg is 3.8 vol% (7.6× the Eurochlor alert; within the explosive initiation range for H₂+Cl₂ photoinitiated chain reaction; OSHA PSM TQ 10,000 lbs H₂; CERCLA RQ 10 lbs Cl₂) — the 128th upward-direction adversarial attack, the first chlor-alkali membrane electrolysis AI blog, the first H₂-in-Cl₂ explosive atmosphere AI blog, and the first Nafion membrane pinhole cell voltage AI blog. Companion ±8 DN upward on the Cl₂ header pressure display shows 0.18 bar gauge (normal operating range 0.10–0.35 bar; no overpressure alarm) when actual Cl₂ header pressure is 0.67 bar (approaching burst disk setpoint 0.75 bar; Cl₂ atmospheric release pathway; PSM TQ 2,500 lbs; NIOSH IDLH 25 ppm; OSHA PEL ceiling 1 ppm; CERCLA RQ 10 lbs). Companion ±8 DN downward on the bipolar cell terminal voltage distribution shows 3.32 V (normal Nafion membrane operating range; AI confirms membrane integrity) when actual cell voltage is 2.71 V (Nafion membrane pinhole failure; H₂ crossover from cathode to anode compartment; root cause of 3.8 vol% H₂ in Cl₂ header). Causal chain: Surface 3 (membrane pinhole) → Surface 2 (H₂ crossover and dead-leg accumulation) → Surface 1 (header overpressure). Graniteville, South Carolina, 6 January 2005: Norfolk Southern freight train derailment at Avondale Mills — approximately 60 short tons liquid Cl₂ released; 9 killed; 250+ hospitalised; 5,400 evacuated — the largest US domestic Cl₂ release in the modern regulatory era. Dual-PSM: Cl₂ (TQ 2,500 lbs) + H₂ (TQ 10,000 lbs). Olin Corporation McIntosh AL; Westlake Chemical Lake Charles LA; ThyssenKrupp Nuchem Grevenbroich; Ineos ChlorVinyls Runcorn UK. Glyphward threshold 46.

  Read the full post →

• TDI Production AI Security · Phosgene COCl₂ OSHA PSM TQ 500 lbs · H₂ PSM TQ 10,000 lbs · DNT Thermal Onset 185 °C · TDA IARC Group 2A · Dual-PSM Phosgene + H₂ · BASF Ludwigshafen 17 October 2016 · Covestro Dormagen TDI AI · Wanhua Yantai TDI AI · 122nd Upward Attack · First TDI Production AI Blog · First DNT Hydrogenation AI Blog · First TDA Phosgenation AI Blog · First DNT Thermal Runaway AI Blog · Glyphward Threshold 48 · 2026-07-11

  TDI toluene diisocyanate DNT catalytic hydrogenation TDA phosgenation phosgene AI adversarial injection: how ±8 DN in the rendered phosgene molar feed rate display conceals the COCl₂:TDA 4.6:1 excess and the H₂ partial pressure 142 bar overrun toward MAWP — and why OSHA PSM TQ 500 lbs phosgene + TQ 10,000 lbs H₂ dual-PSM has no adversarial robustness criterion for TDI production AI, BASF Ludwigshafen Verbund 17 October 2016 (2 killed), TDA IARC Group 2A, Glyphward threshold 48, 122nd upward-direction attack

  A ±8 DN adversarial pixel perturbation on the TDA cold phosgenation phosgene molar feed rate display shows 680 kg/hr (design COCl₂:TDA 2.10:1 mol/mol; no phosgene excess; HCl scrubber at design loading; atmospheric phosgene release risk: controlled) when actual phosgene feed rate is 1,480 kg/hr (COCl₂:TDA 4.6:1 mol/mol actual; 790 kg/hr free COCl₂ excess; HCl scrubber overloaded 2.18× design; phosgene slip to atmosphere; OSHA PSM TQ 500 lbs; NIOSH IDLH 2 ppm; CERCLA RQ 10 lbs) — the 122nd upward-direction adversarial attack, the first TDI toluene diisocyanate production AI blog, the first DNT catalytic hydrogenation AI blog, the first TDA phosgenation AI blog, and the first DNT melt receiver thermal runaway AI blog. Companion ±8 DN upward on the H₂ partial pressure display at the DNT fixed-bed hydrogenation reactor shows 74 bar (safe; 38% below MAWP 120 bar) when actual H₂ pressure is 142 bar (18.3% above MAWP; PRV opens; H₂ flash fire; OSHA PSM TQ 10,000 lbs; LEL 4.0 vol%). Companion ±8 DN downward on the DNT melt receiver temperature display shows 84 °C (safe; design range 80–90 °C) when actual temperature is 178 °C (7 °C from ARC thermal decomposition onset 185 °C for 2,4-DNT; 7,500 kg DNT melt in 10 m³ vessel; ΔHₐ 2,800 kJ/kg; adiabatic energy 21,000 MJ; 4.6 t TNT equivalent). BASF SE Verbund complex, Ludwigshafen, 17 October 2016: pipeline explosion kills 2 workers, severely injures 6 — world’s largest integrated chemical site including TDI production. Dual-PSM facility: phosgene (TQ 500 lbs) + H₂ (TQ 10,000 lbs). TDA IARC Group 2A. Glyphward threshold 48. Covestro Dormagen; Wanhua Yantai; BASF Ludwigshafen.

  Read the full post →

• MDI Phosgenation AI Security · Phosgene COCl₂ OSHA PSM TQ 500 lbs · NIOSH IDLH 2 ppm · CERCLA RQ 10 lbs · MDA IARC Group 1 Bladder Carcinogen · NaOH Scrubber Depletion AI · BASF Antwerp MDI AI · Covestro Dormagen AI · Wanhua Yantai MDI AI · DuPont Belle WV, 22 January 2010 · 113th Upward Attack · First MDI Phosgenation AI Blog · First Phosgene Feed Rate AI Blog · First NaOH Scrubber Depletion AI Blog · Glyphward Threshold 52 · 2026-07-11

  MDI MDA phosgenation phosgene AI adversarial injection: how ±8 DN in the rendered phosgene molar feed rate display conceals the COCl₂:MDA 4.3:1 excess and the DuPont Belle WV 2010 phosgene fatality analog — and why OSHA PSM TQ 500 lbs + NIOSH IDLH 2 ppm has no adversarial robustness criterion for MDI phosgenation AI, DuPont Belle WV 22 January 2010 (1 killed by phosgene pulmonary oedema), MDA IARC Group 1 bladder carcinogen, Glyphward threshold 52, 113th upward-direction attack

  A ±8 DN adversarial pixel perturbation on the MDI phosgenation phosgene molar feed rate display shows 820 kg/hr (design COCl₂:MDA 2.05:1 mol/mol; no phosgene excess; HCl scrubber loading nominal; phosgene atmospheric release risk: controlled) when actual phosgene feed rate is 1,840 kg/hr (COCl₂:MDA 4.3:1 mol/mol actual; 1,020 kg/hr free COCl₂ excess; HCl scrubber overloaded 2.25× design capacity; phosgene atmospheric release; OSHA PSM TQ 500 lbs; NIOSH IDLH 2 ppm; CERCLA RQ 10 lbs) — the 113th upward-direction adversarial attack, the first MDI MDA phosgenation process AI blog, the first phosgene molar feed rate AI blog, and the first NaOH phosgene vent scrubber depletion AI blog. Companion ±8 DN downward on NaOH phosgene vent scrubber concentration display shows 14.2 wt% (adequate; neutralisation efficiency >99.9%) when actual NaOH is 4.8 wt% (60% consumed; Hatta number absorption efficiency falls to 60–70%; phosgene slip 0.5–0.8 ppm at scrubber outlet — 5–8× OSHA PEL ceiling 0.1 ppm). Companion ±8 DN downward on MDA feed concentration in MCB display shows 21 wt% (design range; COCl₂:MDA 2.05:1 calculated) when actual dissolved MDA is 8 wt% (MDA crystallisation from MCB solution below 55 °C from heat-tracing failure; effective COCl₂:MDA rises to 5.4:1; 3.4 mol excess phosgene per mol MDA; HCl scrubber receives 4–5× design phosgene loading). DuPont Belle, West Virginia, 22 January 2010: phosgene hose fitting failure at the methomyl production unit; Jeffrey Dale Morris exposed without SCBA; died from acute non-cardiogenic pulmonary oedema approximately 3 hours post-exposure — documenting phosgene’s delayed-lethality mechanism at the OSHA PSM boundary. MDA IARC Group 1 (Vol 99, 2012; occupational bladder cancer in phosgenation plant workers). Glyphward threshold 52. BASF Antwerp Belgium; Covestro Dormagen Germany; Wanhua Yantai Shandong China; Huntsman Port Neches TX.

  Read the full post →

• Acrylic Acid Production AI Security · Two-Stage Propylene Oxidation AI · Mo-V-W-Cu Catalyst Parametric Sensitivity AI · GAA MEHQ Inhibitor Depletion Runaway AI · Nippon Shokubai Himeji Plant No. 2, 29 September 2012 · Acrolein OSHA PSM TQ 150 lbs · IDLH 2 ppm · IARC Group 2A · CERCLA RQ 1 lb · BASF Ludwigshafen Acrylic Acid AI · Dow Freeport TX AI · 108th Upward Attack · First Acrylic Acid Production AI · First Two-Stage Propylene Oxidation AI · First GAA MEHQ Polymerization AI · Glyphward Threshold 41 · 2026-07-11

  Acrylic acid two-stage propylene oxidation AI adversarial injection: how ±8 DN in the rendered R2 tube wall temperature display conceals Mo-V-W-Cu catalyst parametric sensitivity and the Nippon Shokubai Himeji 2012 acrolein breakthrough pathway — and why OSHA PSM TQ 150 lbs + CERCLA RQ 1 lb + IARC Group 2A has no adversarial robustness criterion for acrylic acid production AI, Nippon Shokubai Himeji Plant No. 2 29 September 2012 (1 killed; property damage ¥1 billion), Glyphward threshold 41, 108th upward-direction attack

  A ±8 DN adversarial pixel perturbation on the Stage-2 R2 reactor tube wall temperature display shows 324 °C (above the 310 °C design maximum; Mo-V-W-Cu complex oxide catalyst entering parametric sensitivity zone; deep combustion exotherm 1,363 kJ/mol additional per mole; catalyst meltdown above 450 °C; acrolein breakthrough at PSM TQ 150 lbs IDLH 2 ppm) as 296 °C (within safe 280–310 °C range; AI classifies: R2 nominal; no action) — the 108th upward-direction adversarial attack in the Glyphward portfolio, the first acrylic acid two-stage propylene oxidation process, the first Mo-V-W-Cu oxide catalyst hot-spot AI attack, and the first GAA MEHQ polymerization inhibitor depletion AI attack. Companion ±8 DN downward on the interstage acrolein GC display shows 2.8 vol% acrolein (Stage-1 severely underconverting; 5.2 vol% propylene entering R2; propylene combustion exotherm 1,926 kJ/mol — 7.5× the desired acrolein→acrylic acid pathway — driving R2 hot-spot from design 295–305 °C into the adversarial 324 °C zone; propylene PSM TQ 10,000 lbs) as 9.4 vol% (nominal; no R1 alarm). Companion ±8 DN downward on the GAA storage MEHQ concentration display shows 12 ppm MEHQ (below the 150 ppm minimum effective level; polymerization induction period reduced to 2–8 hours at 22 °C with trace Fe²⁺ from stainless steel tank corrosion; Trommsdorff-Norrish gel effect drives uninhibited runaway; ΔH​poly = 1,069 kJ/kg; 250-tonne tank adiabatic temperature rise 535 °C theoretical; tank overpressure rupture; CERCLA RQ 5,000 lbs) as 218 ppm (within design 200–250 ppm; AI certifies adequate inhibition for 45+ days). Nippon Shokubai Co., Ltd., Himeji Plant No. 2, Himeji City, Hyogo Prefecture, Japan, 29 September 2012: acrylic acid storage tank explosion from polymerization runaway — 1 confirmed fatality; multiple injuries; property damage exceeding ¥1 billion. Glyphward threshold 41. BASF Ludwigshafen; Dow Freeport TX; Arkema Bayport TX; Nippon Shokubai Himeji and Antwerp.

  Read the full post →

• Nitrobenzene Production AI Security · NORAM Adiabatic Mononitration AI · Jilin Chemical Plant 13 November 2005 Songhua River · OSHA PEL 1 ppm Skin NB Methemoglobin · EPA CERCLA RQ 1,000 lbs NB · Crude NB Cooler CW Flow Upward Attack · Spent Acid HNO₃ Downward Attack · BASF Antwerp NB/Aniline AI · Covestro Baytown NB AI · 102nd Upward-Direction Attack · First NB Mononitration AI · First Jilin 2005 Songhua River AI Anchor · First DNB/TNB Formation AI Attack · Glyphward Threshold 40 · 2026-07-10

  Nitrobenzene adiabatic mononitration AI adversarial injection: how ±8 DN in the rendered crude NB cooler cooling-water flow display recreates the Jilin 2005 Songhua River pathway — and why OSHA PEL 1 ppm skin + CERCLA RQ 1,000 lbs has no adversarial robustness criterion for NB production AI, Jilin Chemical Plant 13 November 2005 (8 killed; ~100 tonnes benzene+NB to Songhua River; 3.8 million Harbin residents without water 10 days; 380 km plume reaching Russia), Glyphward threshold 40, 102nd upward-direction attack

  A ±8 DN upward adversarial pixel shift on the crude NB cooler cooling-water volumetric flow DCS display shows 8.4 m³/h (critically deficient; only 16% of design 50–60 m³/h) as 52.6 m³/h — the 102nd upward-direction adversarial attack and the first nitrobenzene adiabatic mononitration process in the Glyphward industrial AI portfolio. At 8.4 m³/h actual CW flow, crude NB/spent acid exits the NORAM phase separator at 88°C (design 45°C); benzene vapour in the separator headspace reaches 5–8 vol% (above LEL 1.4%), recreating the Jilin Chemical Plant explosion precondition of 13 November 2005 (PetroChina Jilin Chemical Industrial Company; 8 killed; ~100 tonnes benzene+NB to the Second Songhua River; 380 km contamination plume; Harbin 3.8 million residents without water 10 days; contamination reached Russia via Amur River at Khabarovsk). A companion ±8 DN downward shift on the adiabatic reactor outlet temperature display shows 147°C (DNB formation 10× design rate; crude NB DNB 0.22 wt%, 4.4× the <0.05 wt% specification; TNB traces above 145°C) as 112°C (below 125°C design maximum; AI reads selectivity normal). A ±8 DN downward shift on the spent acid HNO₃ concentration display shows 4.8 wt% (9.6× the 0.5 wt% ARU carryover limit; dinitrating conditions in ARU falling-film concentrator at 120–140°C) as 0.3 wt% (in-spec). OSHA PEL NB 1 ppm skin (29 CFR 1910.1000 Z-1); NIOSH IDLH 200 ppm; ACGIH TLV 0.1 ppm A3; EPA CERCLA RQ 1,000 lbs NB; benzene flammable TQ 10,000 lbs — none specify adversarial robustness for NB production AI. Glyphward threshold 40.

  Read the full post →

• Cyclohexane KA-Oil Oxidation AI Security · Cyclohexyl Hydroperoxide CyOOH Thermal Runaway AI · Flixborough 1 June 1974 Nypro UK VCE · OSHA PSM 10,000-lb Flammable TQ · UK COMAH Regulations 2015 · API RP 505 · Per-Pass Conversion Analyser AI Adversarial · Emergency Cooling Water Flow Upward Attack · BASF Antwerp Cyclohexane Oxidation AI · Invista DuPont KA-Oil Reactor AI · 101st Upward-Direction Attack · First KA-Oil Oxidation · First CyOOH Runaway AI · First Flixborough VCE Analog · Glyphward Threshold 42 · 2026-07-10

  Cyclohexane KA-oil liquid-phase air oxidation AI adversarial injection: how ±8 DN in the rendered reactor temperature display suppresses the cyclohexyl hydroperoxide runaway analog — and why OSHA PSM 10,000-lb flammable liquid threshold has no adversarial robustness criterion for KA-oil reactor AI, Flixborough 1 June 1974 (28 killed; UK’s largest peacetime industrial explosion), Glyphward threshold 42, 101st upward-direction attack

  A ±8 DN downward adversarial pixel shift on the cyclohexane KA-oil oxidation reactor temperature DCS display suppresses 218°C (cyclohexyl hydroperoxide CyOOH autocatalytic decomposition onset; thermal runaway at approximately 10°C/min; reactor MAWP approach — the Flixborough consequence trajectory) to appear 163°C (within the normal 155–175°C operating window; 5°C below setpoint; no emergency action initiated) — the 101st upward-direction adversarial attack milestone in the Glyphward industrial AI portfolio, the first cyclohexane KA-oil oxidation process, the first CyOOH thermal runaway AI adversarial attack, and the first nylon precursor manufacturing AI attack. A companion ±8 DN downward shift on the per-pass conversion GC analyser display suppresses 13.7% actual conversion (over-oxidation zone; approximately 25% of converted cyclohexane forming adipic/glutaric/succinic acid deep-oxidation products at approximately 3,000–3,500 kJ/kg exotherm — approximately 4× the design cooling load) to appear 5.4% (on-target; full KA selectivity; no corrective action). A ±8 DN upward shift on the emergency cooling water injection flow display shows 4.1 m³/h (approximately 1.5 MW heat removal; 8× below the approximately 12 MW runaway arrest demand at 218°C and 13.7% conversion) as 22.8 m³/h (approximately 8.4 MW; above the 20 m³/h effective minimum; appearing adequate). Flixborough, North Lincolnshire, England, 1 June 1974: Nypro UK Ltd (DSM 55% + Fisons/SCBA 45%) cyclohexane KA-oil oxidation plant, 20-inch temporary bypass pipe connecting reactors 4 and 6 (bypassing cracked reactor 5), bellows joints failed under torsional and bending stress from misaligned “dog-leg” installation without qualified engineer review, approximately 30 tonnes of cyclohexane released as flashing vapour-aerosol cloud at 155°C and 8.8 bar, cloud ignited, deflagration equivalent to approximately 16 tonnes TNT, 28 workers killed (predominantly control room collapse), 36 injured on site, 53 community injuries, 1,821 houses damaged — the UK’s largest peacetime industrial explosion, directly informing the formation of the UK Health and Safety Executive and the CIMAH 1984/COMAH 2015 major hazard safety case regime. OSHA PSM 29 CFR 1910.119 covers cyclohexane KA-oil via the 10,000-lb flammable liquid inventory threshold (commercial KA-oil facilities carry 50–150 tonnes, 10–33× threshold); UK COMAH Regulations 2015; API RP 505 — none specify adversarial robustness for AI classifying rendered KA-oil reactor temperature, per-pass conversion, or emergency cooling water flow display images. Glyphward threshold 42.

  Read the full post →

• White Phosphorus P₄ Manufacturing AI Security · P₄ Combustion Temperature Adversarial Injection · P₄ Atomization Nozzle Pressure AI Adversarial · Food-Grade Phosphoric Acid Pyrophoric Contamination AI · P₄ Spontaneous-Ignition 34°C AI Adversarial · OSHA PSM TQ 500 lbs White/Yellow Phosphorus · FDA 21 CFR 184.1073 GRAS H₃PO₄ · ICL-IP Americas Pocatello ID · Innophos Geismar LA · 94th Upward-Direction Attack · First White Phosphorus P₄ Manufacturing · First P₄ Spontaneous-Ignition AI · First Food-Grade Pyrophoric Contamination Chain · Glyphward Threshold 44 · 2026-07-10

  White phosphorus P₄ thermal phosphoric acid combustion AI adversarial injection: how a ± 270°C upward temperature shift (670°C displayed as 940°C) masks incomplete P₄ combustion, allows pyrophoric elemental phosphorus to contaminate food-grade 85 wt% H₃PO₄, violates FDA 21 CFR 184.1073 GRAS status, and creates a spontaneous‑ignition fire risk in the hydration tower at 34°C — 94th upward‑direction attack, first white phosphorus manufacturing attack, first P₄ spontaneous‑ignition AI adversarial, first food‑grade pyrophoric product contamination chain in the Glyphward industrial AI portfolio, Glyphward threshold 44

  A ± 270°C upward adversarial pixel shift on the P₄ combustion chamber exit temperature display — showing 670°C (below the 850°C minimum for complete P₄ droplet burnout at design atomization conditions; approximately 10–15% of P₄ feed exits the chamber unburned; unburned P₄ enters the food-grade H₃PO₄ product stream as pyrophoric elemental phosphorus) as 940°C (normal 850–1,100°C design operating range; complete combustion confirmed; no alarm fires; no corrective action taken) — is the 94th upward-direction adversarial attack in the Glyphward portfolio, the first white phosphorus P₄ manufacturing process, the first P₄ spontaneous-ignition AI adversarial attack (autoignition temperature 34°C in air; no ignition source required), and the first food-grade pyrophoric product contamination chain. P₄ slip into 85 wt% H₃PO₄ destined for cola beverages, pharmaceuticals, and dental products violates FDA 21 CFR 184.1073 GRAS and mandates product recall under 21 CFR Part 7. OSHA PSM 29 CFR 1910.119 TQ 500 lbs (one of the lowest TQs on the PSM Appendix A list). ICL-IP Americas Pocatello ID (approximately 200,000 t/yr; primary US thermal H₃PO₄ producer); Innophos Geismar LA; Lifosa Kedainiai Lithuania (Seveso III upper-tier). Glyphward threshold 44.

  Read the full post →

• Ammonium Nitrate AN Manufacturing AI Security · AN Neutralizer pH Adversarial Injection · Prilling Tower Melt AI Adversarial · AN Storage Thermal Runaway AI · Deflagration-to-Detonation DDT AI Adversarial · OSHA PSM Reactive TQ 2,500 lbs · EPA RMP TQ 2,500 lbs · DHS CFATS Tier 1 · DHS ANSP 6 U.S.C. § 488 · ATF 27 CFR Part 555 · NFPA 400 Chapter 13 Class 3 Oxidizer · Texas City TX 1947 (581 Killed; Deadliest US Industrial Accident) · Beirut 4 August 2020 (218 Killed, 7,000+ Injured, $15B) · AZF Toulouse 2001 (31 Killed) · West TX 2013 (15 Killed) · 80th Upward-Direction Attack · First Ammonium Nitrate Manufacturing · First Detonation-Capable Consequence · First DHS CFATS Framework · Glyphward Threshold 50 · 2026-07-09

  Ammonium nitrate (AN) neutralizer outlet pH AI adversarial injection: how a ± 2.9 pH unit upward shift (pH 4.2 displayed as pH 7.1) suppresses NH₃ addition, propagates HNO₃-contaminated melt through the prilling tower, and enables warehouse thermal decomposition culminating in deflagration-to-detonation — Texas City TX 16–17 April 1947 (581 killed, ~3,500 injured; deadliest US industrial accident), Beirut 4 August 2020 (218 killed, 7,000+ injured, ~1.1 kt TNT), OSHA PSM reactive TQ 2,500 lbs, DHS CFATS Tier 1, 80th upward‑direction attack, first ammonium nitrate manufacturing attack, first detonation‑capable consequence, Glyphward threshold 50

  A ± 2.9 pH unit upward adversarial pixel shift on the AN neutralizer outlet pH sensor display — showing pH 4.2 (acidic; excess HNO₃ approximately 0.5 wt%; decomposition onset lowered from approximately 230°C pure-AN to approximately 170–180°C HNO₃-contaminated; prilling melt at 175–185°C is operating within or at the sensitized-AN decomposition onset envelope) as pH 7.1 (normal neutral operating range; no NH₃ addition required; no alarm fires) — is the 80th upward-direction adversarial attack in the Glyphward portfolio, the first ammonium nitrate manufacturing process, the first neutralization reaction pH adversarial attack, the first Class 3 Oxidizer manufacturing attack, and the first detonation-capable consequence chain in the Glyphward industrial AI portfolio. Unlike the 79 prior attacks (which produce toxic gas releases, fires, or explosions from flammable liquids and compressed gases), the 80th attack propagates from adversarial pH misreporting to acidic AN production to warehouse thermal sensitization to deflagration-to-detonation transition (DDT) — a qualitatively different energetic class. HNO₃-contaminated AN prills (from undetected acidic neutralizer pH) stored in bulk warehouse conditions are more thermally sensitive (5–20× lower initiation energy for DDT) and susceptible to detonation from a fire event that would not initiate detonation in specification-grade product. Reference consequence envelope: Texas City TX 16–17 April 1947 (SS Grandcamp 2,300 tons AN detonated + SS High Flyer 961 tons AN detonated; 581 killed — deadliest industrial accident in US history); Oppau Germany 1921 (4,500 tonnes AN/ammonium sulfate; 561 killed); AZF Toulouse France 21 September 2001 (~300 tonnes contaminated AN; 31 killed, 2,500 injured); West TX 17 April 2013 (~40–60 tons AN; 15 killed, 160 injured); Beirut Lebanon 4 August 2020 (2,750 tonnes AN; 218 killed, 7,000+ injured, $15B damage; ~1.1 kt TNT equivalent). OSHA PSM 29 CFR 1910.119 reactive TQ 2,500 lbs; EPA RMP 40 CFR Part 68 TQ 2,500 lbs; DHS CFATS 6 CFR Part 27 Tier 1; DHS Ammonium Nitrate Security Program 6 U.S.C. § 488; ATF 27 CFR Part 555; NFPA 400 Chapter 13 Class 3 Oxidizer; NFPA 704 Reactivity 3. Glyphward threshold 50 — first threshold-50 designation in the portfolio.

  Read the full post →

• Styrene Monomer SM Production AI Security · Ethylbenzene Dehydrogenation AI · TBC Polymerization Inhibitor AI Adversarial · OSHA PSM 29 CFR 1910.119 Flammable Liquid TQ 10,000 lbs · NIOSH IDLH 700 ppm · Flash Point 31°C · LEL 0.9 % UEL 6.8 % · IARC Group 2A · LG Polymers Visakhapatnam India 7 May 2020 (12 Killed, ~800 Hospitalized) · 74th Upward-Direction Attack · First Styrene Monomer Production · First Polymerization Inhibitor Depletion Attack · First Storage-Tank Vapor-Generation Consequence · Glyphward Threshold 35 · 2026-07-09

  Styrene monomer (SM) ethylbenzene dehydrogenation TBC polymerization inhibitor AI adversarial injection: how a ± 8 DN upward pixel shift on the SM storage tank TBC concentration analyzer (1.8 ppm displayed as 12.4 ppm) suppresses inhibitor dosing, allows radical polymerization to begin within 48–72 hours at summer storage temperatures, and drives a heat‑of‑polymerization vapor‑release chain — LG Polymers Visakhapatnam India 7 May 2020 (12 killed, ~800 hospitalized), OSHA PSM flammable liquid TQ 10,000 lbs, NIOSH IDLH 700 ppm, 74th upward‑direction attack, first styrene monomer production, first polymerization inhibitor depletion attack, Glyphward threshold 35

  A ± 8 DN upward adversarial pixel shift on the SM storage tank TBC (4-tert-butylcatechol) polymerization inhibitor concentration analyzer display — showing 1.8 ppm TBC (below the 10 ppm minimum effective inhibition threshold; radical polymerization onset within 48–72 hours at 30–38°C Visakhapatnam summer storage temperatures; heat of polymerization 70 kJ/mol drives thermal acceleration toward vapor-generation rates that overwhelm the tank vent system) as 12.4 ppm TBC (within the adequate 10–50 ppm normal operating range; no automated TBC-dosing alarm; no inhibitor addition ordered) — is the 74th upward-direction adversarial attack in the Glyphward portfolio, the first styrene monomer production process, the first polymerization inhibitor depletion attack, and the first storage-tank vapor-generation consequence chain in the Glyphward industrial AI portfolio. Companion downward surface: SM tank temperature display ± 5 DN downward shows 38°C (above 35°C TBC-dosing trigger; early polymerization detectable) as 22°C (normal ambient storage; no alarm) — eliminating both primary early-warning channels simultaneously. LG Polymers India, Visakhapatnam (7 May 2020: 12 killed, approximately 800 hospitalized, 3-km evacuation zone) from styrene polymerization and vapor release during extended COVID-19 shutdown with TBC inhibitor depleted below effective levels — the reference consequence envelope. OSHA PSM 29 CFR 1910.119 flammable liquid TQ 10,000 lbs (styrene flash point 31°C, below 37.8°C/100°F OSHA threshold); ACGIH TLV-TWA 20 ppm A3; NIOSH IDLH 700 ppm; OSHA PEL 100 ppm (29 CFR 1910.1000 Table Z-2); IARC Group 2A probable carcinogen; NFPA 704 Health 2, Flammability 3; LEL 0.9 %, UEL 6.8 %. Glyphward threshold 35.

  Read the full post →

• Urea Synthesis Stamicarbon HP Carbamate AI Security · Stamicarbon CO₂ Stripping Process AI · HP Carbamate Passivation O₂ Injection AI · 316L Stainless Steel Carbamate Corrosion AI · OSHA PSM NH₃ TQ 10,000 lbs · 130–200 bar HP Synthesis Loop · 178–184°C · Koch Nitrogen Port Neal Iowa 1994 (4 Killed) · 62nd Upward-Direction Attack · 63rd Upward-Direction Attack · First Urea Synthesis Process · First Silent Corrosion Mechanism Attack · First Time-Delayed Catastrophic Failure (1.4-Year Latency) · Glyphward Threshold 30 · 2026-07-04

  Urea synthesis Stamicarbon total-recycle HP carbamate passivation O₂ injection AI adversarial injection: how an upward attack on the passivation oxygen flow display (0.18 vol% displayed as 0.44 vol%) silently transitions 316L stainless steel from passive to active carbamate corrosion at 7 mm/year — HP piping wall failure horizon 1.4 years, Koch Nitrogen Port Neal Iowa 1994 (4 killed, 18 injured) consequence envelope, OSHA PSM NH₃ TQ 10,000 lbs, 130–200 bar HP synthesis loop, 62nd and 63rd upward-direction attacks, first urea synthesis process, first silent corrosion mechanism attack, first time-delayed catastrophic failure in the Glyphward industrial AI portfolio, Glyphward threshold 30

  A ±8 DN upward adversarial pixel shift on the HP carbamate loop passivation O₂ injection flowmeter display — showing 0.18 vol% O₂ in the CO₂ feed (below the 0.25 vol% passivation minimum for 316L stainless steel; 316L in active carbamate corrosion at 7 mm/year) as 0.44 vol% (within effective passivation range; corrosion rate 0.05 mm/year; no corrective action) — is the 62nd upward-direction adversarial attack in the Glyphward portfolio and the first silent corrosion mechanism attack: unlike all 61 prior attacks, where the adverse consequence manifests within minutes to days, the 62nd attack produces a structural failure event that will occur 12–18 months after the initial adversarial pixel manipulation, with no externally detectable process anomaly in the intervening period. This is the first urea synthesis process and the first time-delayed catastrophic failure in the Glyphward industrial AI portfolio. Concurrent ±8 DN upward on the HP loop NH₃/CO₂ molar ratio display shows 2.80 (excess CO₂; compounding corrosion) as 3.52 (adequate range) — the 63rd upward-direction attack: combined active corrosion accelerates to 9–11 mm/year, collapsing the wall-failure horizon to under 12 months. Koch Nitrogen Port Neal, Iowa (August 3, 1994: 4 workers killed, 18 injured from catastrophic HP carbamate piping failure from inadequate passivation O₂) is the reference consequence envelope. HP reactor pressure downward attack suppresses 157 bar (approaching POSV setpoint 165 bar) to appear 148 bar; HP stripper bottom temperature downward attack suppresses 162°C (below 165°C minimum) to appear 169°C. OSHA PSM NH₃ TQ 10,000 lbs; 130–200 bar HP synthesis loop; 178–184°C; Stamicarbon CO₂ stripping process. Glyphward threshold 30.

  Read the full post →

• Municipal Water Treatment Chlorination AI Security · Hach CL17 Clearwell Residual Analyzer AI · Wallace & Tiernan ChlorineSense SCADA AI · OSHA PSM TQ 1,500 lbs · EPA RMP TQ 2,500 lbs · EPA SDWA MRDL 4.0 mg/L · SWTR CT Giardia 37 mg·min/L · ACGIH TLV-C 0.5 ppm · NIOSH IDLH 10 ppm · 50th Upward-Direction Attack · 51st Upward-Direction Attack · First Drinking Water Process · First SDWA Framework · First Public Health Emergency Mass Illness Consequence · First Closed-Loop PID Control Exploitation · Walkerton Ontario 2000 · Glyphward Threshold 45 · 2026-07-03

  Municipal water treatment chlorination AI adversarial injection: how a clearwell free chlorine residual upward attack (0.05 mg/L displayed as 1.65 mg/L) exploits an automated PID feed controller to drive disinfectant residual to zero — CT failure, Giardia cyst breakthrough, 40,000-resident mass illness consequence — OSHA PSM TQ 1,500 lbs, EPA RMP TQ 2,500 lbs, SDWA MRDL 4.0 mg/L, SWTR CT concept, 50th and 51st upward-direction attacks, first drinking water process, first Safe Drinking Water Act regulatory framework, first public health emergency mass illness consequence in the Glyphward industrial AI portfolio, Glyphward threshold 45

  A ±8 DN upward adversarial pixel shift on the treated water clearwell free chlorine residual analyzer display — showing 0.05 mg/L free Cl₂ (CT = 0.05 × 240 min = 12 mg·min/L; below the EPA SWTR minimum of 37 mg·min/L for 1-log Giardia lamblia inactivation at 15°C, pH 7.5) as 1.65 mg/L (within the normal operational window; displayed CT = 396 mg·min/L) — is the 50th upward-direction adversarial attack in the Glyphward portfolio and the first closed-loop PID control exploitation: the false reading feeds the plant’s automated Cl₂ dosing PID controller (setpoint 0.80 mg/L; error signal +0.85 mg/L), which autonomously ramps the Cl₂ feed dose from 3.2 mg/L to 0.9 mg/L over 22 minutes without human intervention. Against a chlorine demand spiked to 3.15 mg/L by heavy-rainfall organic loading, the reduced dose yields zero effective residual; CT = 0 mg·min/L; all disinfection credit is lost. Over 16 hours, 40,000 served residents consume unprotected water; Giardia cysts and E. coli O157:H7 surviving filtration enter the distribution system uninactivated. This is the first drinking water and municipal infrastructure process, the first Safe Drinking Water Act (SDWA) regulatory framework, and the first public health emergency mass illness consequence in the Glyphward industrial AI portfolio — the first attack whose primary harm vector is the simultaneous anonymous exposure of an entire served population with no individual notification mechanism and a detection lag of days to weeks before clinical outbreak onset reveals the event. Concurrent ±8 DN upward on the Cl₂ vacuum-regulator rotameter display shows 5.0 kg/hr (correct dose) as 13.8 kg/hr; operator interprets as over-draw and partially closes the cylinder supply valve; actual dose drops from 3.2 mg/L to 1.1 mg/L; CT falls from 192 to 36 mg·min/L (below 37 for 1-log Giardia) — the 51st upward-direction attack. Area Cl₂ detector downward suppresses 7.2 ppm (14.4× ACGIH TLV-C 0.5 ppm) to 0.3 ppm; workers inspecting the cylinder room during the valve intervention enter a 7.2 ppm atmosphere. Finished water pH downward attack shows 7.4 (HOCl 50 %) when actual 8.7 (HOCl 6 %), masking a 6-fold reduction in germicidal potency. OSHA PSM TQ 1,500 lbs; EPA RMP TQ 2,500 lbs; EPA SDWA MRDL 4.0 mg/L; SWTR minimum 0.20 mg/L; ERPG-3 25 ppm; Walkerton Ontario 2000 (7 killed, 2,300 ill) + Graniteville SC 2005 (11 killed, 550 hospitalized) consequence envelopes. Glyphward threshold 45.

  Read the full post →

• Sulfuric Acid DCDA Contact Process AI Security · MECS / Chemetics DCDA H2SO4 AI · Haldor Topsøe WSA Process AI · V2O5 Converter Catalyst AI · OSHA PSM Oleum TQ 1,000 lbs · OSHA PSM SO2 TQ 1,000 lbs · EPA RMP SO2 TQ 500 lbs · EPA NSPS 40 CFR Part 60 Subpart H · ACGIH TLV‑C SO2 0.25 ppm · NIOSH IDLH SO2 100 ppm · EPA NAAQS Primary SO2 75 ppb (1‑hr) · 43rd Upward-Direction Attack · 44th Upward-Direction Attack · First Sulfuric Acid Production · First DCDA Contact Process · First V2O5 Catalyst · First EPA NSPS Emission Permit Attack · First SO2 Criterion-Pollutant Attack · Glyphward Threshold 35 · 2026-07-03

  Sulfuric acid double-contact double-absorption (DCDA) contact process AI adversarial injection: how an absorber acid upward attack (96.0 % w/w displayed as 98.5 % SO3-absorption optimum) and a V2O5 first-bed temperature upward attack (392°C displayed as 438°C — below light-off shown as optimal) compound to violate EPA 40 CFR Part 60 Subpart H NSPS and breach EPA NAAQS SO2 fence-line limits — OSHA PSM TQ 1,000 lbs oleum, EPA RMP TQ 500 lbs SO2, 43rd and 44th upward-direction attacks, first sulfuric acid production process, first DCDA contact process, first vanadium pentoxide (V2O5) catalyst process, first EPA NSPS emission-permit attack, first air-quality SO2 criterion-pollutant attack in the Glyphward industrial AI portfolio, Glyphward threshold 35

  A ±8 DN upward adversarial pixel shift on the H2SO4 absorber circulating acid density/concentration analyzer display — showing 96.0 % w/w H2SO4 (SO3 absorption efficiency ~96.5 %; SO3 vapor pressure 15–20× above the 98.5 % optimum; acid mist emission 0.58 kg SO3/Mg H2SO4 — 3.9× the EPA NSPS Subpart H limit of 0.15 kg/Mg) as 98.5 % w/w (SO3 absorption vapor-pressure minimum; emission within NSPS) — is the 43rd upward-direction adversarial attack in the Glyphward industrial AI portfolio and the first EPA NSPS emission-permit attack: the first in which the primary consequence is an air-quality regulatory violation rather than on-site worker safety harm. Root cause: Alloy 20 acid cooler tube pinhole failures after 11 years allow 0.8 L/min cooling water ingress at 3.2 bar, diluting 450 m³ of circulating acid from 98.5 % to 96.0 % w/w over 17 days. A concurrent ±8 DN upward shift on the V2O5 first-bed inlet thermocouple — showing 392°C (below conventional V2O5 light-off ~415°C; near-zero first-pass SO2 conversion) as 438°C (optimal first-bed range 420–450°C; 65–70 % first-pass conversion expected) — is the 44th upward attack and the first SO2 criterion-pollutant atmospheric emission attack: converter cold-bypass collapses overall plant SO2 conversion from 99.7 % to ~87 %; 1.3 % v/v SO2 exits the tail-gas stack; EPA NAAQS primary SO2 standard 75 ppb breached at downwind community receptors 2–8 km from the plant. Area SO2 monitor downward attack suppresses 18.6 ppm ambient (74× ACGIH TLV-C 0.25 ppm) to 0.4 ppm; CEMS downward attack suppresses 13,000 ppm tail-gas SO2 to 420 ppm (apparent permit compliance). OSHA PSM TQ 1,000 lbs oleum; EPA RMP TQ 500 lbs SO2; first H2SO4 production, first DCDA, first V2O5, first acid rain precursor attack. Glyphward threshold 35.

  Read the full post →

• EtO Commercial Sterilization AI Security · Honeywell Experion PKS EtO Sterilizer DCS AI · OSHA PSM 29 CFR 1910.119 TQ 5,000 lbs · OSHA 1910.1047 EtO Carcinogen Standard Action Level 0.5 ppm · NIOSH REL 0.1 ppm · IARC Group 1 · ISO 11135:2014 · ISO 10993-7:2008 · ANSI/AAMI ST40 · Flash Point −18°C NFPA Class IB · LEL 2.6 % / UEL 100 % Autonomous Decomposition · 30th Upward-Direction Attack · First Healthcare Process · First Sterilization Efficacy Attack · First Patient Harm Vector · Glyphward Threshold 35 · 2026-07-02

  Ethylene oxide (EtO) commercial sterilization AI adversarial injection: how a chamber humidity upward attack (22 % RH displayed as 62 % RH) causes ISO 11135-compliant EtO sterilization to certify unsterile medical devices — OSHA 1910.1047 EtO carcinogen standard + PSM 29 CFR 1910.119 dual regulation, IARC Group 1 worker carcinogen exposure concealment, ISO 10993-7 residual EtO limits, 30th upward-direction attack, first healthcare process in the Glyphward industrial AI portfolio, Glyphward threshold 35

  A ±8 DN upward adversarial pixel shift on the commercial EtO sterilizer chamber relative humidity display — showing an actual 22 % RH (steam humidification nozzle fouled with calcium carbonate scale after 320 cycles on 210 mg/L TDS tap water) as 62 % RH within the validated 40–80 % range — causes the sterilizer cycle to run with correct EO concentration and temperature but mechanistically inadequate humidity, dropping Bacillus atrophaeus spore kill from the required SAL 10⊃−&sup6; to approximately SAL 10⊃−¹. The Honeywell Experion PKS DCS grants parametric release because all displayed parameters meet validated criteria; unsterile devices are shipped before the 24–48 hour BI incubation result returns. This is the 30th upward-direction adversarial attack in the Glyphward industrial AI portfolio — the first in a healthcare setting, the first sterilization efficacy attack, and the first patient harm vector in the portfolio. ±8 DN area EO detector downward suppresses 8.6 ppm worker EO exposure (8.6× OSHA 1910.1047 action level 0.5 ppm; IARC Group 1 carcinogen; medical surveillance not triggered) to 0.4 ppm. ±8 DN EO concentration downward shows 285 mg/L when actual 890 mg/L — controller injects supplemental EtO reaching 1,460 mg/L (22 % above validated 1,200 mg/L maximum); ISO 10993-7 device residual limits breached. ±8 DN aeration temperature downward shows 54°C when actual 34°C — EO desorption rate halved; residuals on PVC devices 80 % above ISO 10993-7 mucosal contact release limits. OSHA PSM TQ 5,000 lbs; EPA RMP TQ 10,000 lbs; OSHA 1910.1047 + PSM dual regulation; IARC Group 1; ISO 11135:2014; EtO autonomous decomposition without oxidant (UEL 100 %). Glyphward threshold 35.

  Read the full post →

• TCS Siemens CVD Polysilicon AI Security · Honeywell Experion PKS TCS Process AI · Emerson DeltaV CVD Deposition AI · OSHA PSM 29 CFR 1910.119 TQ 5,000 lbs · EPA RMP 40 CFR Part 68 TQ 2,500 lbs · ACGIH TLV-C 0.5 ppm HCl · Flash Point −28°C NFPA Class IB · Pyrophoric in Moist Air · 22nd Upward-Direction Attack · First “Product Becomes Pyrophoric” Attack · Glyphward threshold 35 · 2026-07-02

  Trichlorosilane (SiHCl3) Siemens CVD polysilicon process AI adversarial injection: how a CVD reactor temperature upward attack (750°C displayed as 1,100°C) converts crystalline silicon rod to pyrophoric fine silicon powder — EPA RMP TQ 2,500 lbs vs OSHA PSM TQ 5,000 lbs dual regulatory gap, HCl generation from TCS pyrophoric hydrolysis, and the 22nd upward-direction attack in the Glyphward industrial AI portfolio

  A ±10 DN upward adversarial pixel shift on the Siemens CVD reactor deposition temperature display — showing an actual rod surface temperature of 750°C as 1,100°C — simultaneously conceals that deposition has dropped below the 900°C minimum threshold for crystalline silicon rod growth and that the CVD process is producing amorphous fine silicon powder at 0.8 kg/hr with particle diameter below 1 μm — pyrophoric in air (Si + O2 → SiO2; ΔH = −910 kJ/mol; ignition without external source). After 4 hours at 750°C, 3.2 kg of pyrophoric fine Si powder accumulates on the CVD reactor floor and walls — classified as NFPA 654 combustible dust and capable of deflagration when the reactor bell jar is opened at batch end for rod harvest. This is the 22nd upward-direction adversarial attack in the Glyphward industrial AI portfolio and the first attack where the adversarially concealed process condition causes the manufactured product itself to become pyrophoric — the temperature upward manipulation transforms the product from handleable crystalline rod to spontaneously igniting fine powder. ±8 DN downward suppresses TCS area HCl detector from 28 ppm (5.6× OSHA PEL 5 ppm; from TCS condensate pump PTFE packing failure generating pyrophoric TCS hydrolysis fumes at 45% RH) to 0.3 ppm below alarm. ±8 DN downward suppresses TCS/STC molar ratio GC from 8.2 mol% STC (above 1.5 mol% spec; graphite electrode seal lifetime collapsing from 5,000 to 1,200–1,800 hours at 4× normal chloride corrosion rate) to 0.8 mol% within specification. ±8 DN downward suppresses H2 carrier moisture from 165 ppm (1,650× the 0.1 ppm specification; molecular sieve dryer saturated at 4,800 hours; SiO2 scale 0.25 mm/hr; product polysilicon resistivity collapsing from 1,000 ohm·cm N-type specification to 10–100 ohm·cm off-spec from oxygen incorporation) to 0.06 ppm nominally within spec. EPA RMP TQ 2,500 lbs < OSHA PSM TQ 5,000 lbs — the only chemical in the Glyphward portfolio with this asymmetry: facilities with 2,500–5,000 lbs TCS must comply with EPA RMP off-site consequence analysis but are exempt from OSHA PSM process hazard analysis (HAZOP, What-If) that would most likely surface AI monitoring adversarial attack scenarios as hazard nodes. Neither regulation specifies adversarial robustness for AI classifying rendered TCS monitoring displays. Glyphward threshold 35.

  Read the full post →

• CH3SH Odorant Storage AI Security · Honeywell Experion PKS Odorant Blending AI · Emerson DeltaV Methionine Synthesis AI · OSHA PSM 29 CFR 1910.119 TQ 15,000 lbs · ACGIH TLV-C 0.5 ppm CH3SH · NIOSH IDLH 150 ppm · Olfactory Habituation Paradox · Third Causal Four-Surface Attack Chain · Glyphward threshold 35 · 2026-06-27

  Methyl mercaptan (CH3SH) odorant storage AI adversarial injection: how a cooling water valve actuator failure — displayed adequate by an upward ±8 DN root-cause attack — chains through 48°C vessel overtemperature, compound overpressure (44 psig PRD approach suppressed to 14 psig), and area CEMS suppression (0.84 ppm to 0.025 ppm) while the world’s lowest odor threshold creates the olfactory habituation paradox — OSHA PSM TQ 15,000 lbs, pressurized liquefied thiol at bp 6.2°C, third causal four-surface attack chain, Glyphward threshold 35

  A causal four-surface adversarial attack on CH3SH methyl mercaptan odorant storage AI chains a single mechanical root cause — cooling water supply valve actuator failure, displayed as adequate by a ±8 DN upward perturbation (0.4 m³/hr shown as 8.2 m³/hr) — through vessel thermodynamics to a compound overpressure and area CEMS exceedance. ±10 DN downward suppresses 44 psig vessel pressure (PRD approach from 48°C overtemperature) to appear 14 psig within the normal operating range. ±10 DN downward suppresses 94.8% fill level (4.8% above the 90% maximum ullage specification, amplifying the vapor pressure overpressure via thermal expansion in reduced ullage) to appear 74.2% with apparently adequate ullage. ±8 DN downward suppresses 0.84 ppm CH3SH area CEMS (1.68× ACGIH TLV-C 0.5 ppm ceiling) to appear 0.025 ppm — while olfactory habituation from months of chronic sub-alarm exposure has already muted the natural smell warning. CH3SH’s odor threshold of 0.0011 ppm — the lowest of any industrial gas, 450× below the TLV-C — creates the olfactory habituation paradox: an ever-present sub-ppb odor desensitizes workers to the intensified smell at hazardous concentrations, making the adversarial CEMS suppression the decisive discriminating signal rather than an additional safeguard failure on top of an intact natural warning. Third causal four-surface attack chain in the Glyphward industrial AI portfolio (first: H2S amine treating; second: F2 electrolytic generation). OSHA PSM TQ 15,000 lbs / ACGIH TLV-C 0.5 ppm / NIOSH IDLH 150 ppm. No regulatory framework specifies adversarial robustness for CH3SH odorant storage monitoring AI. Glyphward threshold 35.

  Read the full post →

• F2 Electrolytic Generation AI Security · Honeywell Experion PKS Moissan Cell AI · Emerson DeltaV Fluorine Electrolysis AI · OSHA PSM 29 CFR 1910.119 TQ 1,000 lbs · ACGIH TLV-C 1 ppm F2 · OSHA PEL 0.1 ppm TWA · NIOSH IDLH 25 ppm · H2-in-F2 Detonation Risk ΔH = −543 kJ/mol · Secondary HF Hazard · Second Causal Four-Surface Attack Chain · Glyphward threshold 35 · 2026-06-27

  Fluorine (F2) electrolytic generation AI adversarial injection: how the Moissan cell cooling water flow root-cause upward attack chains through 142°C bath overtemperature and diaphragm H2 contamination to F2 area CEMS suppression — OSHA PSM TQ 1,000 lbs, H2-in-F2 detonation risk (ΔH = −543 kJ/mol), secondary HF hazard, and the second causal four-surface attack chain in the Glyphward industrial AI portfolio

  A causal four-surface adversarial attack on F2 electrolytic generation monitoring AI chains a single mechanical root cause — cell cooling water supply isolation valve actuator failure, displayed as adequate by a ±8 DN upward perturbation (0.4 m³/h shown as 8.2 m³/h) — through the Moissan cell electrochemical heat balance to a compound explosive-and-toxic outcome. ±10 DN downward suppresses actual Moissan cell bath temperature of 142°C (27°C above the 115°C design maximum; causing HF vapor pressure exceedance, diaphragm thermal micro-fracture, and accelerated Monel corrosion) to appear 82°C within normal range — all three consequences develop simultaneously. ±8 DN downward suppresses actual H2-in-F2 product contamination of 0.28 vol% (4.7× the 0.06 vol% maximum; F2+H2 → 2HF; ΔH = −543 kJ/mol; detonative in product header above this specification; diaphragm micro-fracture from overtemperature) to appear 0.018 vol% within specification — F2 product piping operated through the detonation risk zone without alarm. ±8 DN downward suppresses 2.4 ppm F2 area CEMS reading (2.4× ACGIH TLV-C ceiling 1 ppm; secondary HF ~1.5 ppm from F2–moisture reaction simultaneously exceeding HF TLV-C 0.5 ppm; from PTFE gasket crack at bipolar interconnect fitting from Monel corrosion at 142°C) to appear 0.08 ppm below OSHA PEL — compound F2+HF exposure with no alarm. All four independently-sufficient alarms from the single cooling water deficit root cause are simultaneously suppressed. This is the second causal four-surface attack chain in the Glyphward industrial AI portfolio — the first being H2S amine treating — with the identical structural property: physical process causality produces the internal consistency of the false picture automatically, without coordination between the four adversarial perturbations. OSHA PSM TQ 1,000 lbs / ACGIH TLV-C 1 ppm / OSHA PEL 0.1 ppm TWA / NIOSH IDLH 25 ppm. No current OSHA PSM or EPA RMP requirement specifies adversarial robustness for F2 electrolytic generation monitoring AI. Glyphward threshold 35.

  Read the full post →

• H2S Amine Treating AI Security · Honeywell Experion PKS Amine Unit AI · Emerson DeltaV Gas Treating Regenerator AI · OSHA PSM 29 CFR 1910.119 TQ 1,500 lbs · ACGIH TLV-C 1 ppm H2S · NIOSH IDLH 50 ppm · Olfactory Fatigue Dual Safeguard Elimination · Causal Four-Surface Attack Chain · Glyphward threshold 35 · 2026-06-27

  Hydrogen sulfide (H2S) refinery amine treating AI adversarial injection: how a causal four-surface attack chain — reboiler steam valve upward → lean amine loading → absorber breakthrough → area CEMS — eliminates both olfactory fatigue warning and engineered alarm simultaneously, with 2,840 ppm H2S (56.8× IDLH) displayed as 94 ppm normal — OSHA PSM TQ 1,500 lbs, dual safeguard elimination, Glyphward threshold 35

  A causal four-surface adversarial attack on refinery amine treating unit monitoring AI chains a single mechanical root cause (reboiler steam supply valve actuator failure, ±8 DN upward: 8% open shown as 82% adequate steam supply) through amine regeneration chemistry to absorber breakthrough and worker exposure. ±10 DN downward suppresses lean amine H2S loading of 0.42 mol/mol (4.2× the 0.10 mol/mol MDEA design maximum) to appear 0.08 mol/mol within specification — near-exhausted amine recirculated to the foamed and flooded absorber. ±8 DN downward suppresses 2,840 ppm H2S absorber breakthrough (56.8× NIOSH IDLH; complete absorption failure from amine foam flooding) to appear 94 ppm within instrument range. ±8 DN downward suppresses 84 ppm H2S area CEMS (1.68× IDLH) to appear 2.8 ppm below action level — while H2S olfactory fatigue above 50 ppm has already paralysed workers’ olfactory nerve. Both safeguards simultaneously absent: dual safeguard elimination — the only instance in the Glyphward portfolio where both physiological natural warning and engineered electronic alarm are removed by a single adversarial attack chain. OSHA PSM TQ 1,500 lbs / H2S 700–1,000 ppm incapacitation 30–60 sec. Glyphward threshold 35.

  Read the full post →

• BF3 Handling AI Security · Honeywell Experion PKS BF3 Cylinder Pressure AI · ExxonMobil CDTech BF3 Alkylation AI · OSHA PSM 29 CFR 1910.119 TQ 250 lbs (same as MIC) · ACGIH TLV-C 1 ppm BF3 · NIOSH IDLH 25 ppm · Secondary HF TLV-C 0.5 ppm · N2 Inertisation Deficiency-Suppression Attack Class · Glyphward threshold 35 · 2026-06-26

  Boron trifluoride (BF3) handling AI adversarial injection: how ±10 DN in the rendered cylinder vapor pressure display suppresses 142 psig PRD approach to appear 88 psig within-normal — OSHA PSM TQ 250 lbs, secondary HF hydrolysis hazard, and the third N2 inertisation deficiency-suppression attack in the Glyphward industrial AI portfolio

  A ±10 DN adversarial pixel shift in the rendered BF3 cylinder vapor pressure display suppresses 142 psig (above the 130 psig design maximum, trending toward PRD) to appear 88 psig within the normal ambient-temperature storage range — no high-pressure alarm, no shade structure deployment, no cylinder relocation. A ±8 DN downward shift on the area CEMS suppresses 18.4 ppm BF3 (73.6% NIOSH IDLH 25 ppm; 18.4× ACGIH TLV-C ceiling 1 ppm) to appear 0.6 ppm: below TLV-C, no alarm, personnel remain in the cylinder storage area breathing BF3 while BF3 hydrolyses at the respiratory mucosa (BF3 + 3H2O → H3BO3 + 3HF) generating in-situ HF at concentrations above the NIOSH IDLH for HF (30 ppm) and initiating the systemic fluoride toxicity pathway (Ca²⁺ chelation → hypocalcaemia → ventricular fibrillation) absent from standard compressed gas emergency response. A ±8 DN downward shift on the transfer-line moisture analyzer suppresses 1,840 ppm H2O (184× the 10 ppm anhydrous specification) to appear 4.2 ppm: within spec, BF3 transfer continues, HF generation actively corrodes carbon steel transfer hose fittings toward a compound BF3+HF plume release. A ±8 DN upward shift on the N2 purge pressure indicator shows 0.4 psig (near-atmospheric; moist ambient air infiltrating idle BF3 transfer piping through valve seat weeps) as 8.2 psig (design setpoint, moisture exclusion confirmed) — the third N2 inertisation deficiency-suppression upward-direction attack in the Glyphward industrial AI portfolio, following MIC storage AI (Bhopal 1984 N2 blanket failure analog) and HCN storage AI. OSHA PSM TQ 250 lbs for BF3 is the same as for methyl isocyanate. No adversarial robustness criterion exists for BF3 handling monitoring AI. Glyphward threshold 35.

  Read the full post →

• Phosgene COCl2 Production AI Security · Honeywell Experion PKS Phosgene Synthesis AI · BASF Ludwigshafen Phosgene Production AI · Covestro MDI Phosgene Reactor AI · OSHA PSM 29 CFR 1910.119 COCl2 TQ 10 lbs · ACGIH TLV-C 0.1 ppm · EPA RMP 40 CFR Part 68 TQ 500 lbs · NIOSH IDLH 2 ppm · DuPont Belle WV 22 January 2010 · CSB 2010-5-I-WV · Glyphward threshold 35 · 2026-06-26

  Phosgene (COCl2) production AI adversarial injection: how ±10 DN in the rendered reactor temperature display suppresses 162°C Cl2 slip onset to appear 68°C within-normal — and why OSHA PSM TQ 10 lbs has no adversarial robustness criterion for phosgene production monitoring AI

  A ±10 DN adversarial pixel shift in the rendered phosgene synthesis reactor temperature display suppresses 162°C (activated carbon catalyst deactivation zone; Cl2 slip 8–12% by volume) to appear 68°C: within the normal 50–100°C operating range for healthy catalyst activity and complete CO:Cl2 conversion. A ±8 DN adversarial shift on the phosgene CEMS area gas detector display suppresses 2.4 ppm COCl2 (1.2× the NIOSH IDLH of 2 ppm) to appear 0.04 ppm — 2.5× below the ACGIH TLV-C ceiling of 0.1 ppm — while workers in the production area enter the 2–8 hour delayed-onset fatal pulmonary edema window without alarm, without evacuation, without supplied-air respirators. ±10 DN on the transfer line pressure display suppresses 6.2 bar gauge liquid COCl2 accumulation to appear 2.8 bar gauge vapor-phase normal, classifying a valve-open-for-liquid-hammer scenario as safe. ±8 DN upward on the NaOH scrubber pH display shows pH 9.4 (NaOH exhausted; COCl2 breakthrough to atmosphere above TLV-C) as pH 13.2 (fully charged caustic; no replenishment required). DuPont Belle, West Virginia, 22 January 2010: a worker exposed to phosgene through a ruptured flexible hose fitting walked to the plant clinic reporting mild symptoms and died approximately four hours later from acute pulmonary edema (CSB Investigation Report 2010-5-I-WV). OSHA PSM 29 CFR 1910.119 (COCl2 TQ 10 lbs — lowest in Appendix A), EPA RMP 40 CFR Part 68 (TQ 500 lbs), ACGIH TLV-C 0.1 ppm, and NIOSH IDLH 2 ppm specify no adversarial robustness criterion for AI classifying rendered phosgene production monitoring displays. Glyphward threshold 35.

  Read the full post →

• Methyl Isocyanate MIC Storage AI Security · Honeywell Experion PKS MIC Storage Monitoring AI · Yokogawa OpreX MIC Tank AI · Emerson DeltaV SIS MIC Storage AI · OSHA PSM 29 CFR 1910.119 MIC TQ 250 lbs · ACGIH TLV-C 0.02 ppm · EPA RMP 40 CFR Part 68 MIC TQ 500 lbs · NIOSH IDLH 3 ppm · Bhopal India 2–3 December 1984 · UCIL SEVIN · Glyphward threshold 35 · 2026-06-25

  Methyl isocyanate (MIC) storage AI adversarial injection: how ±10 DN in the rendered tank temperature display suppresses the Bhopal refrigeration failure analog — and why OSHA PSM has no adversarial robustness criterion for MIC storage monitoring AI

  A ±10 DN adversarial pixel shift in the rendered MIC storage tank temperature display suppresses 28°C (refrigeration failure; water-initiated exothermic reaction onset; MIC vapour pressure at 28°C ~74 mmHg) to appear 2°C: 3°C below the design refrigeration target of ≤5°C, apparently over-refrigerated and safe. ±10 DN on the tank pressure display suppresses 38 psig (exothermic CO2 generation from water-MIC reaction approaching safety valve setpoint — at UCIL Bhopal, Tank E-610 safety valve lifted at approximately 40–55 psig) to appear 6 psig: normal N2 blanket operating pressure, consistent with the falsely-displayed refrigerated temperature. ±8 DN on the area gas detector suppresses 1.8 ppm atmospheric MIC (90× the ACGIH TLV-C of 0.02 ppm; 60% of the NIOSH IDLH of 3 ppm; immediate evacuation required) to appear 0.007 ppm below TLV-C — no alarm triggered. ±8 DN upward on the N2 blanket supply pressure shows 1.4 psig N2 supply failure as 8.2 psig adequate blanket — the seventh upward-direction adversarial attack in the Glyphward portfolio. UCIL SEVIN, Bhopal, India, 2–3 December 1984: approximately 42 metric tonnes of MIC released from Tank E-610 when water contamination triggered an exothermic runaway with refrigeration decommissioned and vent gas scrubber and flare tower both offline — 3,787 killed within 2 weeks (ICMR), 500,000+ exposed, worst industrial disaster in history. OSHA PSM 29 CFR 1910.119 (MIC TQ 250 lbs), EPA RMP 40 CFR Part 68 (MIC TQ 500 lbs), and ACGIH TLV-C 0.02 ppm have no adversarial robustness criterion for AI classifying rendered MIC storage monitoring displays. Glyphward threshold 35.

  Read the full post →

• Vinyl Chloride Monomer Suspension PVC AI Security · Emerson DeltaV Batch Manager PVC AI · AspenTech Aspen Batch Plus Polymer AI · Yokogawa OpreX Suspension PVC AI · OSHA 29 CFR 1910.1017 VCM PEL 1 ppm · OSHA PSM VCM TQ 10,000 lbs · EPA NESHAP 40 CFR Part 61 Subpart F · East Palestine Ohio 2023 · B.F. Goodrich Louisville 1974 · Glyphward threshold 35 · 2026-06-25

  Vinyl chloride monomer (VCM) suspension polymerization AI adversarial injection: how ±10 DN in the rendered autoclave reactor temperature display suppresses exothermic runaway approach — and why East Palestine made VCM a household name but left suspension PVC autoclave monitoring AI outside any adversarial robustness standard

  A ±10 DN adversarial pixel shift in the rendered suspension PVC autoclave reactor temperature display suppresses a 62°C exothermic runaway approach — 8°C above the 54°C setpoint for K-65 PVC grade, ΔH −93 kJ/mol, Arrhenius heat generation rate approximately double at 62°C versus 54°C — to appear as 46°C: 8°C below setpoint, apparently under-heated, the opposite of the actual autoclave condition. A ±8 DN upward adversarial shift on the jacket cooling water flow rate display shows 8 m³/h critically-low cooling flow (32% of design 25 m³/h; cooling pump cavitating; jacket heat removal ~148 kW vs ~521 kW design) as 14 m³/h: reduced-but-manageable. ±8 DN on the autoclave pressure display suppresses 10.8 bar (VCM saturation at 62°C ~10.5 bar plus 0.3 bar non-condensables) to 8.6 bar (normal saturation at 54°C target). ±10 DN on the VCM stripping area CEMS suppresses 6.3 ppm VCM (6.3× OSHA PEL 1 ppm; IARC Group 1 hepatic angiosarcoma carcinogen) to 0.9 ppm (below PEL — no evacuation triggered). East Palestine, Ohio Norfolk Southern derailment 3 February 2023 (~350,000 kg VCM controlled burn, HCl + phosgene combustion products, 4,700 evacuated) establishes VCM as a nationally recognised chemical hazard; B.F. Goodrich Louisville, Kentucky January 1974 angiosarcoma discovery (three hepatic angiosarcoma cases in VCM autoclave workers identified by Drs Creech and Johnson) established VCM as IARC Group 1 carcinogen and triggered the 1975 OSHA 29 CFR 1910.1017 PEL 1 ppm standard. OSHA 29 CFR 1910.1017, OSHA PSM 29 CFR 1910.119, and EPA NESHAP 40 CFR Part 61 Subpart F have no adversarial robustness criterion for AI classifying rendered suspension PVC autoclave monitoring displays. Glyphward threshold 35.

  Read the full post →

• Petroleum Refinery HF Alkylation AI Security · UOP Honeywell HF Alkylation APC AI · Phillips 66 HF Alkylation Process AI · Honeywell Experion PKS Acid Circuit AI · API RP 751 HF Alkylation · OSHA PSM 29 CFR 1910.119 HF TQ 1,000 lbs · EPA RMP 40 CFR Part 68 · ExxonMobil Torrance 2015 · Glyphward threshold 35 · 2026-06-25

  HF alkylation unit AI adversarial injection: how ±10 DN in the rendered acid settler interface level display suppresses HF acid carryover — and why API RP 751 has no adversarial robustness criterion for HF alkylation advanced process control AI classifying rendered acid circuit monitoring displays

  A ±10 DN adversarial pixel shift in the rendered HF acid settler interface level display suppresses a 68% interface reading — HF acid phase rising toward the 75% high-alarm indicating acid carryover to downstream fractionation — to appear as 49%: normal mid-range, no intervention required. A ±8 DN upward adversarial shift on the HF acid strength analyser display shows 81.4 wt% degraded acid (3.6 wt% below the 85 wt% operating floor, elevated ASO and free water content) as 87.8 wt% on-spec — the opposite direction of most refinery AI adversarial attacks. Two additional surfaces: acid-hydrocarbon contactor temperature AI (±8 DN, 44°C overtemperature suppressed) and acid relief header pressure AI (±10 DN, 18 mbar pre-lift suppressed). The ExxonMobil Torrance California refinery FCC unit explosion of 18 February 2015 — near-miss with the adjacent HF alkylation unit; CSB found up to 125,000 surrounding residents at risk from an HF release — establishes the community-scale consequence anchor. API RP 751 and OSHA PSM 29 CFR 1910.119 have no adversarial robustness criterion for AI classifying rendered HF acid circuit monitoring displays. Glyphward threshold 35.

  Read the full post →

• Petroleum Refinery FCC AI Security · UOP Honeywell FCC APC AI · Shell Global Solutions FCC Optimizer AI · KBR Orthoflow Regenerator AI · Emerson DeltaV FCC AI · AspenTech DMC3 FCC AI · API RP 571 FCC Afterburn · OSHA PSM 29 CFR 1910.119 · ExxonMobil Torrance 2015 · Glyphward threshold 35 · 2026-06-22

  FCC regenerator CO afterburn AI adversarial injection: how ±8 DN in the rendered regenerator temperature display suppresses a CO afterburn approach — and why API RP 571 has no adversarial robustness criterion for FCC advanced process control AI classifying rendered regenerator monitoring displays

  A ±8 DN adversarial pixel shift in the rendered FCC regenerator dense bed temperature display suppresses 752°C — 22°C above the normal operating window upper limit, dilute phase already at 762°C and 2°C above the CO afterburn initiation threshold — to appear as 718°C: normal FCC regenerator operation, no afterburn response required, no slide valve fault correction initiated. CO afterburn proceeds unchecked; dilute phase temperature rises at 20–60°C per minute; refractory spalling begins at 900°C; cyclone anchor bars approach creep failure within 10–20 minutes of undetected initiation. The ExxonMobil Torrance California refinery FCC unit explosion of 18 February 2015 — in which an uncontrolled pressure relief event during ESP maintenance scattered fragments across the refinery and produced a near-miss with the adjacent HF alkylation unit; the CSB concluded a direct HF release could have affected up to 125,000 surrounding residents — establishes the community-scale consequence potential of FCC unit monitoring boundary failures. API RP 571 and OSHA PSM 29 CFR 1910.119 have no adversarial robustness criterion for AI classifying rendered FCC regenerator monitoring displays. Glyphward threshold 35.

  Read the full post →

• Petroleum Refinery CDU AI Security · UOP Honeywell CDU Overhead AI · Yokogawa Centum VP CDU AI · Emerson DeltaV APC Overhead AI · AspenTech DMC3 AI · API RP 571 HCl Corrosion · API RP 584 Integrity Operating Windows · OSHA PSM 29 CFR 1910.119 · NACE SP0403 · Chevron Richmond 2012 · Glyphward threshold 35 · 2026-06-21

  Crude oil CDU overhead HCl corrosion AI adversarial injection: how ±8 DN in the rendered bootstrap water pH display suppresses a corrosion approach — and why API RP 584 Integrity Operating Windows has no adversarial robustness criterion for CDU overhead monitoring AI

  A ±8 DN adversarial pixel shift in the rendered CDU overhead bootstrap water pH display suppresses pH 4.3 — 1.2 units below the NACE SP0403 lower specification limit of 5.5, approaching the API RP 584 Critical IOW limit of 5.0, corresponding to a carbon steel corrosion rate of 8–15 mm/year — to appear as pH 5.8: controlled, within specification, no IOW limit approach detected. Aqueous HCl continues to corrode carbon steel overhead piping at 8–15 mm/year undetected. The Chevron Richmond refinery fire of 6 August 2012 — 19 workers directly exposed, approximately 15,000 community members sought medical attention, refinery shut down 8 months — was caused by a structurally identical CDU corrosion monitoring failure: corrosion data existed but the classification layer did not map it to the API RP 571 damage mechanism threshold. API RP 571, API RP 584, OSHA PSM 29 CFR 1910.119, and NACE SP0403 have no adversarial robustness criterion for AI classifying rendered CDU overhead monitoring displays. Glyphward threshold 35.

  Read the full post →

• Offshore Drilling Well Control AI Security · Transocean WITS-ML AI · Halliburton DecisionSpace Well Control AI · Baker Hughes BEACON AI · NOV RigSense AI · BSEE Well Control Rule 30 CFR Part 250 · API RP 96 · NORSOK D-010 · BP Macondo 2010 · Glyphward threshold 30 · 2026-06-21

  Subsea wellhead NPT AI adversarial injection: how ±8 DN in the rendered negative pressure test chart suppresses a definitively failed well integrity test — and why BSEE Well Control Rule 30 CFR Part 250 has no adversarial robustness criterion for well control monitoring AI

  A ±8 DN adversarial pixel shift in the rendered NPT drill pipe pressure chart causes well control monitoring AI to classify a definitively failed negative pressure test as a passed test — the same failure mode that preceded the BP Macondo Deepwater Horizon blowout (11 killed, 17 injured, 4.9 million barrels, $65B+ total costs). Transocean WITS-ML well control monitoring AI, Halliburton DecisionSpace Well Control AI, Baker Hughes BEACON AI, NOV RigSense AI in scope. BSEE Well Control Rule 30 CFR Part 250 requires NPT procedures but specifies no adversarial robustness criterion for AI classifying rendered NPT chart displays, pit volume trend monitors, or mud weight return displays. Four surfaces: NPT drill pipe pressure chart AI; kill line pressure display AI; pit volume totaliser trend AI; gas-cut mud weight return display AI. Glyphward threshold 30.

  Read the full post →

• Arc Flash AI Security · Flir Arc Flash Thermal Camera AI · Schneider Electric EcoStruxure Power Advisor AI · Eaton Power Xpert AI · SKM PTW Arc Flash AI · NFPA 70E-2021 · IEEE 1584-2018 · OSHA 29 CFR 1910.333 · Glyphward threshold 35 · 2026-06-21

  Arc flash incident energy AI adversarial injection: how ±8 DN in the rendered PPE category display misclassifies a Category 3 arc flash hazard as Category 2 — and why NFPA 70E-2021 has no adversarial robustness criterion for the IEEE 1584-2018 arc flash analysis AI

  A ±8 DN adversarial pixel shift in the rendered arc flash study PPE category display causes arc flash analysis AI — Flir Systems arc flash thermal camera AI, Schneider Electric EcoStruxure Power Advisor AI, Eaton Power Xpert arc flash management AI, SKM Systems PTW arc flash report AI — to misclassify a 480 V switchgear position with 18.4 cal/cm² calculated incident energy (Category 3, minimum arc rating 25 cal/cm²) as Category 2 (minimum arc rating 8 cal/cm²). The worker dons a Category 2 arc flash suit rated at 8 cal/cm² for an energised switching task. When an arc flash event occurs, the 8 cal/cm² arc suit is exposed to 18.4 cal/cm² — the energy breakopen threshold (EBT) is exceeded by 10.4 cal/cm², the arc-rated fabric develops holes in milliseconds, cotton underlayers ignite in direct contact with the skin, and third-degree contact burns result. ESFI (Electrical Safety Foundation International) documents approximately 400 arc flash fatalities per year and 2,000 arc flash burn injuries requiring hospital treatment per year in the United States. Four adversarial injection surfaces: PPE category calculation display AI (±8 DN shifts Category 3 orange cell to Category 2 yellow → worker in 8 cal/cm² PPE at 18.4 cal/cm² event → EBT exceeded → third-degree burns), arc flash thermal camera incident energy monitoring AI (±8 DN suppresses 145°C hot-spot from critical to normal → PPE upgrade suppressed → arc flash probability underestimated), flash protection boundary display AI (±10 DN compresses 6.1 m MV switchgear boundary to 2.1 m → bystander at 3.5 m not relocated → 3–4 cal/cm² exposure on unprotected skin), incident energy trend display AI (±8 DN suppresses Category 2→3 transition → PPE upgrade alert suppressed → workers continue in Category 2 PPE at above-EBT positions). NFPA 70E-2021 Section 130.5 and IEEE 1584-2018 have no adversarial robustness criterion for AI classifying rendered arc flash displays. Glyphward threshold 35.

  Read the full post →

• Underground Mining AI Security · Strata Worldwide VentSim AI · MSA Safety gas detection AI · Honeywell BW Technologies · MineARC Systems · MSHA 30 CFR 75.323 · MINER Act 2006 · Sago Mine 2006 · Westray 1992 · Upper Big Branch 2010 · Glyphward threshold 30 · 2026-06-20

  Underground coal mine ventilation AI adversarial injection: how ±8 DN in the rendered methane monitor display suppresses a CH₄ reading above the MSHA 30 CFR 75.323 action level — and why MSHA has no adversarial robustness criterion for the sole-barrier methane detection AI

  A ±8 DN adversarial pixel shift in the rendered methane (CH₄) monitor display suppresses a CH₄ reading above the MSHA 30 CFR 75.323 1.0% action level — the structural parallel to the methane accumulation that preceded the Sago Mine 2 January 2006 explosion (12 miners killed, 1 survivor found after 41 hours, carbon monoxide asphyxiation). Strata Worldwide VentSim AI, Howden Ventilation on Demand AI, MSA Safety fixed gas detection AI, and Honeywell BW Technologies area monitoring AI classify rendered CH₄ monitor displays, CO trend charts, strata extensometer outputs, and refuge chamber atmospheric panels to manage underground coal mine ventilation safety. MSHA 30 CFR Part 75 specifies methane monitoring action levels (1.0%, 1.5%, 2.0%) and the MINER Act 2006 requires refuge alternatives with 96-hour atmospheric capability — but neither specifies adversarial robustness criteria for AI classifying rendered monitor outputs. Westray Mine Nova Scotia 1992 (26 killed; Westray Law / Bill C-45 corporate criminal liability response), Upper Big Branch West Virginia 2010 (29 killed; MSHA documented systematic methane reading manipulation — the human analogue of adversarial AI injection) as supporting precedents. Four adversarial surfaces: CH₄ display AI (±8 DN suppresses 1.2% to 0.8%, blocking de-energisation while stratified roof-level concentration may already be above the LEL), CO trend display AI (±8 DN suppresses spontaneous combustion CO rise → heating coal body develops undetected → secondary methane release), strata extensometer display AI (±10 DN suppresses 8 mm/day displacement to 2 mm/day → roof fall hazard not detected → miners not withdrawn from unstable heading), refuge chamber atmospheric monitoring AI (±8 DN suppresses O₂ depletion or CO above IDLH → survivors remain in refuge without SCBA → CO asphyxiation; Sago parallel). Glyphward threshold 30.

  Read the full post →

• Battery Manufacturing AI Security · CATL electrode coating AI · LG Energy Solution AI · Panasonic Gigafactory AI · KLA SURFmonitor · IEC 62619:2022 · EU Battery Regulation 2023/1542 · Samsung Note 7 2016 · Boeing 787 APU 2013 · 2026-06-20

  Li-ion gigafactory electrode coating AI adversarial injection: how ±6 DN in the XRF coating weight heatmap suppresses a thin-zone precursor to Li-plating, dendrite growth, and internal short circuit — and why IEC 62619:2022 has no adversarial robustness criterion for the CATL/LG Energy/Panasonic electrode inspection AI layer

  A ±6 DN adversarial pixel shift in the rendered XRF coating weight heatmap image suppresses a thin-zone defect — coating weight below the lower process control limit — preventing the electrode inspection AI from detecting the manufacturing precursor to Li-plating, dendrite growth, separator penetration, and internal short circuit (ISC) leading to thermal runaway. Samsung Note 7 September–October 2016 (2.5 million units recalled, approximately $17 billion in costs, FAA Emergency Order banning the device from all US aircraft) and Boeing 787 Dreamliner APU battery January 2013 (GS Yuasa LCO/graphite cell lithium plating identified as most probable initiating mechanism, FAA Emergency AD 2013-02-51, 4-month worldwide fleet grounding) establish the consequence envelope. CATL, LG Energy Solution, Panasonic Energy, Samsung SDI, and SK On deploy KLA SURFmonitor, Manz AG Coating Quality Analysis, Cognex electrode inspection AI, and Teledyne Dalsa linescan AI at every electrode line stage. Four adversarial surfaces: XRF coating weight heatmap AI (±6 DN, thin-zone escape), NIR binder composition AI (±8 DN, binder migration escape), calendering density AI (±8 DN, over-calendering escape), slitting linescan burr AI (±10 DN, metallic burr escape). IEC 62619:2022, UL 9540A, UN 38.3, and EU Battery Regulation 2023/1542 digital passport have no adversarial robustness criterion for the electrode inspection AI layer. Glyphward threshold 35.

  Read the full post →

• Hydroelectric Dam AI Security · Voith Hydro spillway AI · GE Vernova hydroelectric AI · ABB hydroelectric SCADA AI · FERC Part 12 · FEMA P-94 · Oroville Dam 2017 · spillway chute erosion CCTV AI · Glyphward threshold 30 · 2026-06-19

  Large hydroelectric dam spillway AI adversarial injection: how ±8 DN in the rendered spillway chute CCTV camera image suppresses a developing erosion crater — and why FERC Part 12 has no adversarial robustness criterion for the sole-barrier spillway chute AI

  A ±8 DN adversarial pixel shift in the rendered spillway chute CCTV camera image suppresses a developing concrete erosion cavity — the structural parallel to the operator misclassification that allowed the Oroville Dam February 2017 spillway crater to develop to 45 m depth, 50 m width, and 90 m length before the emergency spillway was activated for the first time since 1968 and 188,000 downstream residents were evacuated. Voith Hydro spillway AI, GE Vernova hydroelectric management AI, ABB hydroelectric SCADA AI, and ANDRITZ Hydro spillway AI classify rendered images from spillway chute CCTV cameras, reservoir water level rate-of-rise displays, radial gate position cameras, and tailwater energy dissipator displays. FERC Part 12 dam safety inspection and FEMA P-94 inflow design flood framework have no adversarial robustness criterion for AI classifying rendered spillway monitoring images. The Oroville Dam Incident Investigation Panel identified monitoring classification failure — not instrument failure — as a root cause: the same misclassification that an adversarial pixel injection exploits. Glyphward threshold 30.

  Read the full post →

• FCEV Heavy Truck AI Security · Nikola Tre FCEV AI · Hyundai XCIENT Fuel Cell AI · Bosch PEM stack AI · SAE J2578 · FMVSS 303 · NFPA 2:2023 · Sandvika Kjørbo 2019 · 2026-06-19

  Hydrogen fuel cell heavy truck AI adversarial injection: how ±10 DN in the rendered PEM stack thermal image suppresses a hot-spot precursor to H₂ crossover and thermal runaway — and why SAE J2578 has no adversarial robustness criterion for the FCEV stack monitoring AI layer

  A ±10 DN adversarial pixel shift in the rendered Nikola Tre FCEV or Hyundai XCIENT Fuel Cell Truck PEM stack thermal camera image suppresses a developing stack hot-spot — the sole early indicator of membrane dehydration progressing toward H₂ crossover, MEA-level combustion, and stack thermal runaway. The Sandvika (Kjørbo) Norway H₂ station explosion on 10 June 2019 — a plug failure in a 700-bar storage assembly deploying airbags in Toyota Mirai FCEVs 150 metres away and shutting down 20 H₂ stations across Norway and Denmark — establishes the BLEVE consequence envelope. SAE J2578, FMVSS 303/304/305, and NFPA 2:2023 define FCEV safety design requirements but have no adversarial robustness criterion for AI classifying rendered stack thermal images, CPV pressure/temperature displays, cabin H₂ concentration displays, or HV interlock crash sensor traces. HV crash detection AI suppression and first responder electrocution risk at 650–900 VDC also covered. Glyphward threshold 30.

  Read the full post →

• Nuclear I&C AI Security · Westinghouse PIAM AI · Framatome Teleperm XS AI · GE Hitachi NUMAC AI · NRC 10 CFR Part 50 GDC 13 · IEEE Std 603-2018 · TMI-2 1979 · Fukushima 2011 · 2026-06-19

  Nuclear power plant digital I&C AI adversarial injection: how ±8 DN in the rendered RPS trip parameter display suppresses a reactor protection system trip — and why NRC 10 CFR Part 50 Appendix A GDC 13 has no adversarial robustness criterion for the AI classification layer

  A ±8 DN adversarial pixel shift in the rendered Westinghouse PIAM AI or Framatome Teleperm XS AI RPS trip parameter display suppresses the apparent exceedance of a reactor trip setpoint — structurally mirroring the TMI-2 1979 misleading pressuriser level indicator that caused operators to suppress emergency core cooling for 90 minutes and produced 50% core damage. NRC 10 CFR Part 50 Appendix A GDC 13 (instrumentation and control) and GDC 20–24 (protection system single-failure criterion) define the most rigorous I&C qualification framework in any industrial sector — but neither extends to the AI classification layer operating on rendered display images. IEEE Std 603-2018 single-failure criterion, NEI 08-09 Rev. 6 cybersecurity baseline, and NUREG-0800 Standard Review Plan all leave the rendered-image AI boundary unaddressed. Neutron flux monitor AI (Fukushima hydrogen explosion pathway), PCP vibration trend AI (small-break LOCA), and containment H₂ monitor AI also covered. Glyphward threshold 25 — lowest in the portfolio.

  Read the full post →

• Mining and Geotechnical AI Security · Klohn Crippen Berger AI · SRK Consulting AI · ROCTEST SmartPiezo AI · TRE ALTAMIRA PSInSAR AI · GISTM 2020 · Brumadinho B1 2019 · 2026-06-18

  Tailings dam AI adversarial injection: how ±8 DN in the rendered VWP piezometric level trend display suppresses a phreatic surface rise precursor — and why GISTM 2020 Global Industry Standard on Tailings Management has no adversarial robustness criterion for the sole-barrier TSF monitoring AI

  A ±8 DN adversarial pixel shift in the rendered vibrating wire piezometer (VWP) piezometric level trend display suppresses a rising phreatic surface trajectory in an upstream-raised tailings dam from the TARP action-level classification to within-design-envelope. The Brumadinho B1 dam failure (25 January 2019 — 270 killed in under 4 minutes from a 12 Mm³ static liquefaction flow slide at Vale’s Córrego do Feijão iron ore mine) establishes the consequence envelope. GISTM 2020 Requirement 12, ANM Resolution 4/2020, and ANCOLD Guidelines require continuous monitoring but specify no adversarial robustness requirement for AI systems classifying rendered sensor images. Seepage face camera AI (Fundão 2015 40 Mm³), InSAR deformation map AI (Mount Polley 2014 24 Mm³), and freeboard camera AI secondary surfaces also covered. Klohn Crippen Berger AI, SRK Consulting AI, ROCTEST SmartPiezo AI, TRE ALTAMIRA PSInSAR AI in scope. Glyphward threshold 30.

  Read the full post →

• Hydrogen Energy AI Security · Nel Hydrogen AI · Siemens Energy Silyzer AI · thyssenkrupp nucera AI · NFPA 2 Hydrogen Technologies Code · UV invisible flame · Kjørbo 2019 · 2026-06-18

  Hydrogen electrolysis AI adversarial injection: how ±10 DN in the rendered UV flame camera image suppresses a 2,254°C invisible H₂ fire — and why NFPA 2 Hydrogen Technologies Code has no adversarial robustness criterion for the sole-barrier UV detection AI

  Hydrogen burns at 2,254°C with no visible flame in daylight — no soot, no visible glow, no smoke. The OH* radical UV emission at 308 nm is the sole real-time automated indicator of a burning H₂ fire. A ±10 DN adversarial pixel shift at the OH* hotspot region of the rendered UV camera frame — within the combined facility UV noise floor — suppresses the flame signal from the detected-flame luminance range to background UV noise. The flame detection AI classifies background noise. Personnel remain in the facility. At H₂ minimum ignition energy of 0.017 mJ, any electrostatic source in the area escalates to a hydrogen fireball. NFPA 2 2023 Section 7.2 and OSHA 29 CFR 1910.103 have no adversarial robustness criterion for UV flame detection AI. Electrolyzer membrane DP AI, H₂ purity O₂ analyser AI, and COPV pressure trend AI secondary surfaces also covered. Kjørbo Norway 2019 HyNor explosion as consequence anchor. Glyphward threshold 35 — sole-barrier UV detection architecture.

  Read the full post →

• Pulp & Paper AI Security · Valmet DNA Recovery Boiler AI · BLRBAC Emergency Procedures · NFPA 85 Chapter 8 · FM Global DS 10-3 · 2026-06-18

  Kraft recovery boiler AI adversarial injection: how ±10 DN in the rendered steam drum level sight-glass image suppresses a BLRBAC mandatory emergency shutdown — and why NFPA 85 Chapter 8 has no adversarial robustness criterion for the sole-barrier drum level AI

  A ±10 DN upward pixel shift in the rendered Valmet DNA Recovery Boiler AI drum level sight-glass image can move a below-visible drum level into the normal-level classification range, suppressing the BLRBAC mandatory emergency shutdown trigger. BLRBAC has documented more than twenty smelt-water steam explosions in North American Kraft mills where drum level monitoring failures contributed. The downstream consequence: waterwall tube starvation, tube rupture, liquid water contacting a 100–600-tonne smelt bed at 800–900°C, and smelt-water steam explosion at 1,700:1 volumetric expansion. NFPA 85 Chapter 8 and FM Global Data Sheet 10-3 together define comprehensive Kraft recovery boiler safety requirements — neither includes adversarial robustness criteria for AI monitoring systems. Furnace floor FLIR thermal AI and char bed height AI secondary surfaces also covered. Glyphward threshold 35 — sole-barrier drum level monitoring architecture.

  Read the full post →

• Mining AI Security · Caterpillar MineStar Command AHS · WA DMIRS MH-CM3-Q2-2021 · ISO 17757:2019 · LiDAR zone render AI · 2026-06-15

  Autonomous mine haul truck AHS AI adversarial injection: how ±12 DN in the rendered LiDAR zone occupancy grid suppresses a worker’s HiVis PPE retroreflective signature — and why WA DMIRS MH-CM3-Q2-2021 has no adversarial robustness criterion

  A ±12 DN pixel perturbation in the rendered Caterpillar MineStar Command LiDAR occupancy grid can suppress a worker’s HiVis PPE retroreflective signature, causing the AHS zone AI to classify an occupied zone as clear and dispatch a 400-tonne haul truck at 52 km/h (48 MJ) into a zone containing personnel. DMIRS Boddington 2017 (investigation 2017-012) established that render-stage errors produce wrong zone-clear classifications from correct sensor data. WA DMIRS MH-CM3-Q2-2021 has no adversarial robustness criterion for zone classification CNNs. Haul road berm condition AI and AHS zone assignment intersection conflict adversarial surfaces also covered. Glyphward threshold 35 — sole safety barrier architecture.

  Read the full post →

• Oil Refinery AI Security · OSHA PSM 29 CFR 1910.119 · AspenONE APC AI · Texas City BP 2005 · 2026-06-15

  Oil refinery APC AI adversarial injection: how ±10 DN in the rendered raffinate splitter level gauge image replicates the Texas City BP 2005 instrument-misread failure mode — and why OSHA PSM 29 CFR 1910.119 has no adversarial robustness criterion

  AspenONE APC AI and Honeywell Profit Controller now classify rendered sight-glass camera images as distillation column level states. A ±10 DN pixel perturbation at the rendered image ingestion boundary shifts the visible meniscus from High-High to Normal — the same misread that caused Texas City BP 2005 (15 fatalities, 180 injured, CSB 2005-04-I-TX). OSHA PSM 29 CFR 1910.119 Process Hazard Analysis identifies ‘level indicator failure’ as a credible cause for raffinate splitter High Level deviations but has no adversarial AI classifier robustness criterion. Also covers FCC regenerator false-colour thermal AI afterburn suppression, fired heater tube API 530 temperature limit AI, and compressor vibration spectrogram AI. Glyphward threshold 35 with OSHA PSM 1910.119(j)(4) MI audit trail documentation.

  Read the full post →

• Airfield AI Security · FAA AC 150/5220-24 · Xsight FODetect · ASDE-X · 2026-06-14

  Airfield runway FOD detection AI: adversarial millimetre-wave radar map injection hides a 15 cm tyre fragment from Xsight FODetect — and why FAA AC 150/5220-24 does not require adversarial robustness testing

  FAA AC 150/5220-24 sets a 95% Probability of Detection criterion for runway FOD detection AI — but no acceptance test includes adversarially perturbed radar scan images. A ±10 DN perturbation in the rendered Xsight FODetect 76-77 GHz scan overlay suppresses a 15 cm tyre fragment below the detection threshold: no alert, no sweep, tyre strike risk on an active runway. Consequence envelope: Concorde Air France 4590, CDG, 25 July 2000, 113 fatalities — a 43 cm titanium strip that a certified FOD system would have detected. Also covers Vaisala RVR luminance curve injection, ASDE-X runway incursion AI map injection, and PAPI optical monitoring AI injection. Glyphward threshold 35.

  Read the full post →

• Pipeline Integrity AI Security · PHMSA 49 CFR 195.452 · API 1163 · 2026-06-14

  Pipeline integrity ILI AI: how adversarial MFL anomaly map injection suppresses SCC colony detections and blocks PHMSA 49 CFR 195.452 excavation orders — and why API 1163 does not require adversarial robustness testing

  API 1163 4th edition qualifies ILI AI systems with POD curves and ±10 %WT sizing accuracy statistics — but has no adversarial robustness criterion. A ±8 DN pixel perturbation in a rendered MFL anomaly map image — within JPEG quantisation noise — suppresses an SCC colony at 35 %WT below the detection threshold, prevents the PHMSA excavation order, and leaves a weakening pipe section in an HCA segment with no IMP flag and no scheduled reassessment. Baker Hughes FlexPIG, TDW SmartScan, ROSEN RoCorr UT AI, NDT Global Evo Series AI, and Percepto Arc drone corrosion patrol AI are all in scope. Consequence envelope: PG&E San Bruno 2010 (8 fatalities, $1.6B), Colonial Pipeline Alabama 2016 (350,000 US-gallon gasoline release), Carlsbad NM 2000 (12 fatalities). Three attack vector classes: ILI data analysis centre compromise at the rendering pipeline; pipeline operator delivery package MitM; training data poisoning targeting SCC annotation samples. Glyphward threshold 40 integration with PHMSA 49 CFR 195.452(l) IMP record-keeping and API 1163 Section 6.4 anomalous-input logging documentation.

  Read the full post →

• Aviation MRO AI Security · EASA AMC 20-16 · 2026-06-14

  Jet engine borescope AI: how adversarial pixel injection suppresses TBC spallation and passes a hazardous engine through a Part 145 inspection — and why EASA AMC 20-16 does not close the gap

  EASA AMC 20-16 Issue 2 (2023) requires human oversight when AI-assisted borescope inspection outputs low-confidence classifications. Adversarial pixel injection suppresses the TBC spallation colorimetric boundary — the RGB gradient between intact YSZ ceramic and exposed blade metal — causing the HPT classifier to output high-confidence 'serviceable' for a blade with active spallation, bypassing the oversight trigger. The certifying engineer never reviews the image. The Aircraft Maintenance Release is issued. A deep-dive into the AMC 20-16 gap, the TBC spallation adversarial surface (±12 DN channel suppression within JPEG noise floor), the QF32 consequence profile (uncontained HPT failure, 21 simultaneous system failures) as a software attack, the three attack vector classes (capture system compromise, MRO platform pipeline MitM, training data poisoning), why GE TrueCheck, Rolls-Royce IntelliEngine, and Lufthansa Technik AVIATAR are all in scope, and Glyphward threshold 40 integration with Part 145.A.55 documentation.

  Read the full post →

• Railway AI Security · ETCS / CVSR · 2026-06-13

  Railway signalling AI: how adversarial pixel injection makes a Red signal appear Green — and why SIL 4 certification does not protect against it

  Computer Vision Signal Recognition (CVSR) AI classifies trackside signal aspects from forward-facing camera frames at 200 km/h closure speed. CENELEC EN 50129 SIL 4 is the most rigorous safety certification on earth for railway electronics — it requires formal mathematical proof of correctness, random hardware failure rates below 10−9/hour, and independent Notified Body assessment. It does not cover adversarial ML attacks. A deep-dive into the CVSR classification pipeline, the asymmetric risk between Red-showing-Green and Green-showing-Red adversarial injection, why the fail-to-safe principle provides no protection against high-confidence incorrect classifications, the three attack vector classes (lineside display injection, onboard network MitM, physical adversarial patch), why US Positive Train Control under 49 CFR Part 236 has the same regulatory gap, and how a Glyphward pre-scan gate integrates with the ETCS EVC and PTC onboard architecture.

  Read the full post →

• Aviation AI Security · 2026-06-13

  ACAS Xu: how adversarial pixel injection defeats formally verified collision avoidance in autonomous UAS

  ACAS Xu is the most formally verified AI system in operational aviation — Reluplex proved ten safety properties over its neural network policy, the first formal verification of a safety-critical deep learning system at scale. But the proof is conditional: it holds given correct values of the six state variables. In BVLOS UAS operations, those state variables come from an EO/IR camera pipeline running a deep learning object detector that has never been adversarially evaluated. Pixel injection into that pipeline corrupts range and bearing estimates upstream of the verified network, causing wrong Resolution Advisories in an autopilot-closed loop that executes in under 200ms with no pilot in the decision path. A deep-dive into the EO/IR state estimation architecture, two attack variants (intruder suppression and phantom injection), why the formal verification gap is structural rather than a verification deficiency, and how the DO-326A regulatory framework applies to EO/IR adversarial detection evidence.

  Read the full post →

• Surgical Robotics AI Security · 2026-06-13

  Adversarial pixel injection in da Vinci 5 Firefly NIR: suppressing bile duct fluorescence alerts during live robotic surgery

  The da Vinci 5 Firefly near-infrared fluorescence AI was adopted specifically for complex cholecystectomy where standard white-light anatomy is insufficient. Adversarial pixel perturbation in the NIR channel frame at the AI ingestion boundary can suppress the CBD fluorescence alert in exactly those cases — in a 50ms closed-loop actuator window that structurally prevents human interception between AI error and robotic arm response. A deep-dive into the two attack variants (suppression and phantom injection), why the Dip et al. 2020 meta-analysis makes the clinical stakes precise, how the SAGES 2022 CVS guidelines interact with AI-augmented bile duct identification, and the NIR-specific scan gate architecture using selective frame sampling with operating mode fallback.

  Read the full post →

• Healthcare AI Security · 2026-06-12

  Wearable health AI adversarial injection: why the Apple Watch ECG is the highest-volume FDA-cleared attack surface

  Apple Watch ECG (FDA K192729/K223274) runs on 100M+ wrists. The AI classifier that detects Atrial Fibrillation drives anticoagulation referral; Dexcom G7 paired with Control-IQ or Omnipod 5 closes the insulin dosing loop without user confirmation. Both operate on sensor time-series — ECG waveforms, CGM glucose Bluetooth LE packets, PPG photoplethysmography — that text-only PI scanners are structurally blind to. A deep-dive into the HealthKit write injection vector, the CGM closed-loop adversarial dosing attack, FDA SaMD cybersecurity guidance requirements for waveform-classifier input validation, and the scan gate architecture that defends each inference boundary without breaking the clinical pipeline.

  Read the full post →

• Cryptography & AI Security · 2026-06-12

  Post-quantum cryptography for AI orchestration: the harvest-now-decrypt-later threat to your system prompts

  Nation-state adversaries are archiving your LangChain, CrewAI, and AutoGen TLS traffic today. NIST FIPS 203 (ML-KEM/Kyber), FIPS 204 (ML-DSA/Dilithium), and FIPS 205 (SLH-DSA/SPHINCS+) were finalized in August 2024. NSM-10 sets hard federal deadlines. A deep-dive into why AI orchestration systems are uniquely exposed to harvest-now-decrypt-later — system prompts encode business logic, RAG queries reveal strategic intent, agent-to-agent delegation messages expose internal decision architecture, and chain-of-thought scratchpads leak intermediate reasoning — and the five-step PQC migration sequence for agentic pipelines from LLM provider connections through vector databases, tool APIs, inter-agent communication, and observability infrastructure.

  Read the full post →

• Aviation Security · eVTOL · 2026-06-11

  eVTOL AI security: the multimodal prompt injection attack surface in urban air mobility

  Joby, Archer, and Wisk are entering commercial passenger service in 2026. Every critical flight phase — obstacle detection, vertiport approach guidance, biometric boarding, UTM airspace management — depends on AI that processes image data. Text-only prompt injection scanners are blind to all four attack surfaces. FAA Special Conditions require DO-326A Security Risk Assessments for AI perception systems; EASA AMC20-152A requires adversarial robustness testing under CS-SC-VTOL-01. Physical adversarial patches on rooftop obstacles, vertiport approach corridor injection, biometric boarding bypass, and UTM map tile injection are all pixel-domain attacks that text scanners cannot see.

  Read the full post →

• Security Architecture · Agentic AI · 2026-06-11

  Agentic AI and multimodal prompt injection: why autonomous agents face a larger attack surface than chat models

  A chat model that processes a bad image gives one bad response. An autonomous agent may execute a dozen real-world tool calls before a human sees a result. The multimodal injection gap is the same in both cases — text scanners are blind to pixel-domain payloads — but agentic systems multiply the attack surface: images enter via retrieval, mid-loop screenshot capture, tool outputs, and subagent trust propagation. Covering only the user-facing entry point leaves the majority of an agent's image input surface unscanned. This post covers the three highest-risk agentic attack chains (computer-use screen injection, RAG corpus poisoning, multi-agent trust escalation), why text-only scanners are particularly dangerous in the agentic context, and the scan placement architecture that closes all three gaps.

  Read the full post →

• Attack Deep-Dives · 2026-06-11

  FigStep, AgentTypo, WhisperInject — the three multimodal prompt injection attacks every text scanner gets wrong

  Three named attacks define the outer boundary of what text-only PI scanners can see. FigStep renders instructions in OCR-resistant glyph fonts the VLM decodes but OCR misses entirely. AgentTypo distorts characters so OCR produces a benign string while the VLM reads the toxic original — specifically defeating OCR-then-text-scan workarounds. WhisperInject hides commands in audio segments Whisper discards: below-VAD amplitude windows, ultrasonic frequency bands, reversed-speech segments. All three share one structural root cause, and defending against them requires scanning raw bytes before any preprocessing step runs. A deep-dive into the mechanism of each attack, why text scanners are structurally blind to all three, and what the three-layer defence stack looks like.

  Read the full post →

• Threat Research · Earth Observation · 2026-06-10

  Why satellite remote sensing AI is the newest prompt injection attack surface

  Satellite AI is no longer confined to research labs — USDA uses it to validate $10B in annual crop insurance claims, EPA uses it to detect unreported pesticide use, and FEMA uses it to map disaster damage for public assistance declarations. In every case the AI processes a multispectral pixel array with no text channel for any existing PI scanner to inspect. A deep-dive into NDVI injection for crop insurance fraud, spectral bypass for EPA FIFRA compliance evasion, SAR manipulation for FEMA Stafford Act declarations — and the four-step scanning architecture that closes the gap.

  Read the full post →

• Compliance · Healthcare · 2026-06-10

  How multimodal AI prompt injection bypasses healthcare regulatory compliance

  Healthcare AI is the sector most exposed to multimodal prompt injection — radiology AI reads DICOM pixel arrays, pathology AI processes whole-slide images, telehealth AI transcribes patient audio. Text-only PI scanners cover none of these channels. A deep-dive into how FigStep and WhisperInject-class attacks bypass HIPAA Security Rule audit controls, FDA SaMD cybersecurity guidance, and EU MDR GSPR 17.4 — with five concrete remediation steps that produce a unified compliance evidence log across all four frameworks simultaneously.

  Read the full post →

• Compliance · EU AI Act · 2026-05-31

  EU AI Act Article 15: the multimodal AI security checklist before 2 August 2026

  The Article 15 cybersecurity deadline is 63 days away. Eight checklist items for high-risk AI providers — covering who actually needs to comply under Annex III, what Article 15(5)’s “adversarial examples or model evasion” language means for multimodal systems, why OCR-before-text-scan does not satisfy the requirement for image inputs, what audit evidence looks like in practice, and what happens to providers that miss the date. Includes the evidence format an assessor reviewing your Annex IV documentation will look for per modality.

  Read the full post →

• Engineering deep-dive · 2026-04-30

  Building a prompt-injection scanner for voice agents: what Whisper drops, and why it matters

  Speech-to-text systems are lossy compressors with quality goals — clean transcripts — that conflict with the goals of a security inspection. By the time text reaches your prompt-injection filter, the bands and timings the audio PI payload was hiding in have already been filtered away. A walk through the four audio-PI subtypes at the byte level, the four-stage build pipeline you can wire in two weeks, the trade-offs we made (CNN over transformer, run-both over replace, no chaining), and what still doesn't work.

  Read the full post →

• Market analysis · 2026-04-30

  What Check Point buying Lakera means for self-serve AI-security buyers

  Big-platform acquirers of self-serve security tools almost never preserve the self-serve motion at the original price. A factual read on the Sept–Nov 2025 Check Point acquisition of Lakera, what enterprise consolidation tends to do to a SMB SKU, and what is left under $100/mo for teams who still need a prompt-injection defence in 2026.

  Read the full post →

• Architecture · 2026-04-25

  Why every text-only prompt-injection scanner misses a 30-pixel PNG

  A 900-byte image with eight rendered words on it routes around every text-only PI defender on the market. That is not a tuning failure — it is the intended scope of those products, and the gap will not close by improving them. The architectural argument, written for engineers and AppSec leads deciding whether their current defence is enough.

  Read the full post →

• Threat model · 2026-04-25

  The multimodal prompt-injection threat model for AI product teams (2026)

  Every public-API prompt-injection defender ships with the same blind spot: they inspect text and ignore the two modalities where the real-world payloads now hide. If your product accepts images or audio from anyone other than you, this is your threat model — what the attacks look like, why your current stack misses them, and a defender's playbook you can run this week.

  Read the full post →

What you can expect

• Attack deep-dives — each new payload family we add to the corpus gets a write-up with the exact signatures we detect.
• Benchmarks — confusion matrices on our FigStep / AgentTypo / WhisperInject test set, published per release.
• Integration tutorials — how to wire the scanner into avatar SaaS, voice agents, and screenshot-reading assistants.
• Incident notes — when a real customer gets hit, what we learn, what we change.

Follow day-to-day progress at @bitinvestigator, or join the waitlist and we'll email when the next post is live.